BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1072320	BB(B)B(B)B(B(B)B)B1CC1CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C24H35B10FN6O3/c1-13(42)23-19-5-15(16-8-36-14(2)37-9-16)3-4-20(19)41(39-23)12-22(43)40-11-18(35)6-21(40)24(44)38-10-17-7-30(17)34(32(27)28)33(29)31(25)26/h3-5,8-9,17-18,21H,6-7,10-12,25-29H2,1-2H3,(H,38,44)/t17?,18-,21+/m1/s1	NUJRIYFGYXHEET-MBSQGRNLSA-N	511691	US11084800, Cpd No. 1	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511691&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153456679	459628943							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072321	CC(=O)c1nn(CC(=O)N2C[C@H]3CCC[C@H]3[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-16(38)27-22-11-18(20-12-31-17(2)32-13-20)9-10-23(22)37(35-27)15-26(39)36-14-19-5-3-6-21(19)28(36)29(40)34-25-8-4-7-24(30)33-25/h4,7-13,19,21,28H,3,5-6,14-15H2,1-2H3,(H,33,34,40)/t19-,21-,28+/m1/s1	DUHQWWOEHIIGNA-LUHXOMTRSA-N	511692	(1S,3a5,6aR)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2- yl)octahydrocyclopenta[c]pyrrole-1- carboxamide::US11084800, Cpd No. 2	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511692&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318018	459628944							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072322	CC(=O)c1nn(CC(=O)N2C3CCC(CC3)[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O3/c1-16-4-11-25(31)34-29(16)35-30(41)28-19-5-8-22(9-6-19)38(28)26(40)15-37-24-10-7-20(21-13-32-18(3)33-14-21)12-23(24)27(36-37)17(2)39/h4,7,10-14,19,22,28H,5-6,8-9,15H2,1-3H3,(H,34,35,41)/t19?,22?,28-/m0/s1	JJHWHEJTQMJEMU-CWYPTGNGSA-N	511698	(1s,4s)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- azabicyclo[2.2.2]octane-3- carboxamide::US11084800, Cpd No. 3	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511698&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319087	459628950							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072323	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCCCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrN8O3/c1-20-7-10-29(35)38-32(20)39-33(46)27-14-34(19-41-11-5-4-6-12-41)15-28(34)43(27)30(45)18-42-26-9-8-23(24-16-36-22(3)37-17-24)13-25(26)31(40-42)21(2)44/h7-10,13,16-17,27-28H,4-6,11-12,14-15,18-19H2,1-3H3,(H,38,39,46)/t27-,28?,34?/m0/s1	ULHCGGGOXGORCY-DMQYXUGCSA-N	511699	(3S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5-(piperidin-1- ylmethyl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 4	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511699&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161123751	459628951							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072324	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCC4(CC4)CC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O3/c1-21-4-7-30(37)40-33(21)41-34(48)28-15-36(20-43-12-10-35(8-9-35)11-13-43)16-29(36)45(28)31(47)19-44-27-6-5-24(25-17-38-23(3)39-18-25)14-26(27)32(42-44)22(2)46/h4-7,14,17-18,28-29H,8-13,15-16,19-20H2,1-3H3,(H,40,41,48)/t28-,29?,36?/m0/s1	FEILZJNJTHZROU-LCOPZMBYSA-N	511700	(3S)-5-(6-azaspiro[2.5]octan-6- ylmethyl)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 5	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511700&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317839	459628952							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072325	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H33BrN8O3/c1-18-5-8-27(33)36-30(18)37-31(44)25-12-32(17-39-9-4-10-39)13-26(32)41(25)28(43)16-40-24-7-6-21(22-14-34-20(3)35-15-22)11-23(24)29(38-40)19(2)42/h5-8,11,14-15,25-26H,4,9-10,12-13,16-17H2,1-3H3,(H,36,37,44)/t25-,26?,32?/m0/s1	KOXHHYOATLVGQX-JVCFOOGBSA-N	511701	(3S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-(azetidin-1- ylmethyl)-N-(6-bromo-3-methylpyridin- 2-yl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 6	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511701&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318328	459628953							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072326	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrF2N8O4/c1-16(43)29-22-8-18(19-11-35-17(2)36-12-19)6-7-23(22)42(39-29)15-28(44)40-13-21(34)10-25(40)31(46)41-14-20(33)9-24(41)30(45)38-27-5-3-4-26(32)37-27/h3-8,11-12,20-21,24-25H,9-10,13-15H2,1-2H3,(H,37,38,45)/t20-,21-,24+,25+/m1/s1	JWIIHYVVCKREFM-ZLSIYFNSSA-N	511702	(2S,4R)-1-((2S,4R)-1-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-4-fluoropyrrolidine-2-carbonyl)-N- (6-bromopyridin-2-yl)-4-fluoropyrrolidine-2- carboxamide::US11084800, Cpd No. 7	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511702&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162459695	459628954							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072327	BBB(B)B(B(B)B)B1CC1CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C24H34B9FN6O3/c1-13(41)23-19-5-15(16-8-35-14(2)36-9-16)3-4-20(19)40(38-23)12-22(42)39-11-18(34)6-21(39)24(43)37-10-17-7-30(17)33(31(26)27)32(28)29-25/h3-5,8-9,17-18,21,29H,6-7,10-12,25-28H2,1-2H3,(H,37,43)/t17?,18-,21+/m1/s1	ZERIDYVVBOKQEJ-MBSQGRNLSA-N	511703	US11084800, Cpd No. 8	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511703&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160157611	459628955							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072328	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-17-6-9-26(32)35-29(17)36-30(43)24-11-31(16-38(4)5)12-25(31)40(24)27(42)15-39-23-8-7-20(21-13-33-19(3)34-14-21)10-22(23)28(37-39)18(2)41/h6-10,13-14,24-25H,11-12,15-16H2,1-5H3,(H,35,36,43)/t24-,25+,31-/m0/s1	FZQZZWBIMMOXNP-NTWBYJAHSA-N	511704	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 9	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511704&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158190295	459628956							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072329	CN(C)C[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-17-6-9-26(32)35-29(17)36-30(43)24-11-31(16-38(4)5)12-25(31)40(24)27(42)15-39-23-8-7-20(21-13-33-19(3)34-14-21)10-22(23)28(37-39)18(2)41/h6-10,13-14,24-25H,11-12,15-16H2,1-5H3,(H,35,36,43)/t24-,25-,31+/m0/s1	FZQZZWBIMMOXNP-AKOVUPKNSA-N	511705	(1S,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 10	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511705&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317565	459628957							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072330	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CC4CCCC4C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O3/c1-20-7-10-31(37)40-34(20)41-35(48)29-12-36(19-43-16-24-5-4-6-25(24)17-43)13-30(36)45(29)32(47)18-44-28-9-8-23(26-14-38-22(3)39-15-26)11-27(28)33(42-44)21(2)46/h7-11,14-15,24-25,29-30H,4-6,12-13,16-19H2,1-3H3,(H,40,41,48)/t24?,25?,29-,30?,36?/m0/s1	ANEXSBSLAWAGAU-QJRRWIALSA-N	511706	(3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5- ((hexahydrocyclopenta[c]pyrrol-2(1H)- yl)methyl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 11	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511706&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318675	459628958							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072331	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CC4CC(C4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O3/c1-19-4-7-30(36)39-33(19)40-34(47)28-11-35(18-42-15-22-8-23(9-22)16-42)12-29(35)44(28)31(46)17-43-27-6-5-24(25-13-37-21(3)38-14-25)10-26(27)32(41-43)20(2)45/h4-7,10,13-14,22-23,28-29H,8-9,11-12,15-18H2,1-3H3,(H,39,40,47)/t22?,23?,28-,29?,35?/m0/s1	XCEWOKZZOZZZAG-BTPLFMCHSA-N	511707	(3S)-5-(3-azabicyclo[3.1.1]heptan-3- ylmethyl)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 12	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511707&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317850	459628959							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072332	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O3/c1-20-5-8-29(36)39-32(20)40-33(47)27-12-35(19-42-17-34(18-42)9-4-10-34)13-28(35)44(27)30(46)16-43-26-7-6-23(24-14-37-22(3)38-15-24)11-25(26)31(41-43)21(2)45/h5-8,11,14-15,27-28H,4,9-10,12-13,16-19H2,1-3H3,(H,39,40,47)/t27-,28?,35?/m0/s1	ADQXQROJYUUIGO-MZJJXFGQSA-N	511708	(3S)-5-(2-azaspiro[3.3]heptan-2-ylmethyl)-2- (2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 13	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511708&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157082089	459628960							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072333	CC(C)c1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H32BrN7O3/c1-16(2)21-7-9-26(32)35-29(21)36-30(42)24-11-31(5)12-25(31)39(24)27(41)15-38-23-8-6-19(20-13-33-18(4)34-14-20)10-22(23)28(37-38)17(3)40/h6-10,13-14,16,24-25H,11-12,15H2,1-5H3,(H,35,36,42)/t24-,25+,31-/m0/s1	RDCKBZYLOJHTIS-NTWBYJAHSA-N	511709	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-isopropylpyridin-2- yl)-5-methyl-hexane-3-carboxamide::US11084800, Cpd No. 14	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511709&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317667	459628961							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072334	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27BrN8O3/c1-14-5-6-23(29)33-26(14)34-27(40)20-8-28(4)9-22(28)37(20)24(39)13-36-21-12-32-19(17-10-30-16(3)31-11-17)7-18(21)25(35-36)15(2)38/h5-7,10-12,20,22H,8-9,13H2,1-4H3,(H,33,34,40)/t20-,22+,28-/m0/s1	AGKIXYNCQISUOU-PGKWVRKKSA-N	511710	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 15	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511710&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137462267	459628962							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072335	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCC23C4C5C6C4C2C6C35)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29FN6O3/c1-12(38)28-17-5-14(15-7-32-13(2)33-8-15)3-4-18(17)37(35-28)10-20(39)36-9-16(31)6-19(36)29(40)34-11-30-25-22-21-23(25)27(30)24(21)26(22)30/h3-5,7-8,16,19,21-27H,6,9-11H2,1-2H3,(H,34,40)/t16-,19+,21?,22?,23?,24?,25?,26?,27?,30?/m1/s1	DUDYWWSQWZYVJG-OQEYVJCDSA-N	511711	(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin- 5-yl)-1H-indazol-1-yl)acetyl)-N-(cuban-1- ylmethyl)-4-fluoropyrrolidine-2-carboxamide::US11084800, Cpd No. 16	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511711&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420396	459628963							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072336	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC\C(F)=C(\C)c2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H35FN6O3/c1-19-11-24(25-15-36-22(4)37-16-25)12-26-31(21(3)42)39-40(32(19)26)18-30(43)41-28(13-34(5)14-29(34)41)33(44)38-17-27(35)20(2)23-9-7-6-8-10-23/h6-12,15-16,28-29H,13-14,17-18H2,1-5H3,(H,38,44)/b27-20+/t28-,29+,34-/m0/s1	BRIJBXMXXBKRPI-PLINUBIESA-N	511712	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-((E)-2-fluoro-3-phenylbut-2-en- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 17::US11084800, Cpd No. 561	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511712&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			149821913	459628964							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072337	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-8-18(19-12-31-17(3)32-13-19)9-20-26(16(2)38)35-36(27(15)20)14-25(39)37-21(10-29(4)11-22(29)37)28(40)34-24-7-5-6-23(30)33-24/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H,33,34,40)/t21-,22+,29-/m0/s1	JJZOEOZVRUYETC-KERYWQKISA-N	511713	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-5-methyl- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 18	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511713&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137462266	459628965							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072338	CN(C)Cc1cc(cc2c(nn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C29H30BrFN8O3/c1-16(40)27-22-9-18(20-11-32-17(2)33-12-20)8-19(13-37(3)4)28(22)39(36-27)15-26(41)38-14-21(31)10-23(38)29(42)35-25-7-5-6-24(30)34-25/h5-9,11-12,21,23H,10,13-15H2,1-4H3,(H,34,35,42)/t21-,23+/m1/s1	UANINMSIQRZGSQ-GGAORHGYSA-N	511714	(2S,4R)-1-(2-(3-acetyl-7- ((dimethylamino)methyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-4- fluoropyrrolidine-2-carboxamide::US11084800, Cpd No. 19	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511714&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318649	459628966							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072339	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(CF)cc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrF2N7O3/c1-14(38)25-20-7-16(18-10-31-15(2)32-11-18)6-17(9-29)26(20)37(35-25)13-24(39)36-12-19(30)8-21(36)27(40)34-23-5-3-4-22(28)33-23/h3-7,10-11,19,21H,8-9,12-13H2,1-2H3,(H,33,34,40)/t19-,21+/m1/s1	WXJUUILFHHFYGE-CTNGQTDRSA-N	511715	(2S,4R)-1-(2-(3-acetyl-7-(fluoromethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-4- fluoropyrrolidine-2-carboxamide::US11084800, Cpd No. 20	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511715&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317817	459628967							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072340	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(Cc3ncc(C)cn3)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H29BrFN9O3/c1-17-11-37-28(38-12-17)9-21-7-20(22-13-35-19(3)36-14-22)8-24-30(18(2)44)41-43(31(21)24)16-29(45)42-15-23(34)10-25(42)32(46)40-27-6-4-5-26(33)39-27/h4-8,11-14,23,25H,9-10,15-16H2,1-3H3,(H,39,40,46)/t23-,25+/m1/s1	QAPODIMXEQADCI-NOZRDPDXSA-N	511716	(2S,4R)-1-(2-(3-acetyl-7-((5- methylpyrimidin-2-yl)methyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-4- fluoropyrrolidine-2-carboxamide::US11084800, Cpd No. 21	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511716&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318975	459628968							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072341	CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCNCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H36BrN9O3/c1-19-4-7-28(34)38-31(19)39-32(46)26-13-33(18-41-10-8-35-9-11-41)14-27(33)43(26)29(45)17-42-25-6-5-22(23-15-36-21(3)37-16-23)12-24(25)30(40-42)20(2)44/h4-7,12,15-16,26-27,35H,8-11,13-14,17-18H2,1-3H3,(H,38,39,46)/t26-,27?,33?/m0/s1	PBHOGNZIGKKWGP-NPBRFHNESA-N	511717	(3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-(piperazin-1-ylmethyl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 22	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511717&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319076	459628969							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072342	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2CC#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H24BrFN8O3/c1-15(39)26-21-9-18(19-11-32-16(2)33-12-19)3-5-22(21)38(36-26)14-25(40)37-13-20(30)10-23(37)28(41)35-27-17(7-8-31)4-6-24(29)34-27/h3-6,9,11-12,20,23H,7,10,13-14H2,1-2H3,(H,34,35,41)/t20-,23+/m1/s1	FWAXXHWBCPZVJC-OFNKIYASSA-N	511718	(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin- 5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- (cyanomethyl)pyridin-2-yl)-4- fluoropyrrolidine-2-carboxamide::US11084800, Cpd No. 23	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511718&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317836	459628970							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072343	CN1CCN(CC23CC2N([C@@H](C3)C(=O)Nc2nc(Br)ccc2C)C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)CC1	InChI=1S/C34H38BrN9O3/c1-20-5-8-29(35)38-32(20)39-33(47)27-14-34(19-42-11-9-41(4)10-12-42)15-28(34)44(27)30(46)18-43-26-7-6-23(24-16-36-22(3)37-17-24)13-25(26)31(40-43)21(2)45/h5-8,13,16-17,27-28H,9-12,14-15,18-19H2,1-4H3,(H,38,39,47)/t27-,28?,34?/m0/s1	YSQDCVNCSQQOAW-DMQYXUGCSA-N	511719	(3S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- yl)-5-((4-methylpiperazin-1-yl)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 24	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511719&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420562	459628971							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072344	COC(=O)c1cc(cc2c(nn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C28H25BrFN7O5/c1-14(38)25-19-7-16(17-10-31-15(2)32-11-17)8-20(28(41)42-3)26(19)37(35-25)13-24(39)36-12-18(30)9-21(36)27(40)34-23-6-4-5-22(29)33-23/h4-8,10-11,18,21H,9,12-13H2,1-3H3,(H,33,34,40)/t18-,21+/m1/s1	XDKBRTFTHDCPBN-NQIIRXRSSA-N	511720	US11084800, Cpd No. 25::methyl 3-acetyl-1-(2-((2S,4R)-2-((6- bromopyridin-2-yl)carbamoyl)-4- fluoropyrrolidin-1-yl)-2-oxoethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazole-7- carboxylate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511720&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317979	459628972							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072345	CC(=O)c1nn(CC(=O)N2C3CC3(CN)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-15-4-7-24(30)34-27(15)35-28(41)22-9-29(14-31)10-23(29)38(22)25(40)13-37-21-6-5-18(19-11-32-17(3)33-12-19)8-20(21)26(36-37)16(2)39/h4-8,11-12,22-23H,9-10,13-14,31H2,1-3H3,(H,34,35,41)/t22-,23?,29?/m0/s1	RARNUAXEHQNQBM-JGXGTMRVSA-N	511721	(3S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-5- (aminomethyl)- N-(6-bromo-3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 26	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511721&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318850	459628973							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072346	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrFN7O3/c1-14-6-18(19-11-33-17(4)34-12-19)8-20-25(16(3)40)37-38(26(14)20)13-24(41)39-22(9-30(5)10-23(30)39)29(42)36-28-15(2)7-21(32)27(31)35-28/h6-8,11-12,22-23H,9-10,13H2,1-5H3,(H,35,36,42)/t22-,23+,30-/m0/s1	CSRSCPMPURKMIO-BURCIIJTSA-N	511722	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 27	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511722&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318624	459628974							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072347	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H30ClFN6O3/c1-16-8-20(21-13-34-18(3)35-14-21)9-22-28(17(2)40)37-38(29(16)22)15-26(41)39-24(10-31(4)11-25(31)39)30(42)36-12-19-6-5-7-23(32)27(19)33/h5-9,13-14,24-25H,10-12,15H2,1-4H3,(H,36,42)/t24-,25+,31-/m0/s1	VEPZBFVLNLUEEI-NTWBYJAHSA-N	511723	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(3-chloro-2-fluorobenzyl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 28	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511723&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161277444	459628975							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072348	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(COCC=C)C[C@H]2C(=O)Nc2nc(Br)ccc2COCC=C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H36BrN7O5/c1-5-11-47-19-24-8-10-30(36)39-33(24)40-34(46)28-14-35(20-48-12-6-2)15-29(35)43(28)31(45)18-42-27-9-7-23(25-16-37-22(4)38-17-25)13-26(27)32(41-42)21(3)44/h5-10,13,16-17,28-29H,1-2,11-12,14-15,18-20H2,3-4H3,(H,39,40,46)/t28-,29-,35+/m0/s1	HXXJYOJMDHFDMA-AZRGUZCDSA-N	511724	(1S,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((allyloxy)methyl)-N-(3- ((allyloxy)methyl)-6-bromopyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 29	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511724&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318165	459628976							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072349	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrFN7O3/c1-15-5-6-24(31)35-28(15)36-29(42)22-9-30(4)10-23(30)39(22)25(41)14-38-27-19(11-32)7-18(20-12-33-17(3)34-13-20)8-21(27)26(37-38)16(2)40/h5-8,12-13,22-23H,9-11,14H2,1-4H3,(H,35,36,42)/t22-,23+,30-/m0/s1	MQTRKGBYASJUQP-BURCIIJTSA-N	511725	(1R,3S,5R)-2-(2-(3-acetyl-7-(fluoromethyl)-5- (2-methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 31	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511725&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318175	459628977							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072350	COCc1cc(cc2c(nn(CC(=O)N3C4CC4(COC)C[C@H]3C(=O)Nc3cccc(Br)n3)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C31H32BrN7O5/c1-17(40)28-22-9-19(21-12-33-18(2)34-13-21)8-20(15-43-3)29(22)38(37-28)14-27(41)39-23(10-31(16-44-4)11-24(31)39)30(42)36-26-7-5-6-25(32)35-26/h5-9,12-13,23-24H,10-11,14-16H2,1-4H3,(H,35,36,42)/t23-,24?,31?/m0/s1	GMJFFYJSOHDDFN-VVTYCJQISA-N	511726	(3S)-2-(2-(3-acetyl-7-(methoxymethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2- (methoxymethyl)-2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 32	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511726&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420451	459628978							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072351	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H28F4N6O4/c1-15-8-18(19-12-36-17(3)37-13-19)9-20-27(16(2)42)39-40(28(15)20)14-25(43)41-22(10-30(4)11-24(30)41)29(44)38-21-6-5-7-23(26(21)32)45-31(33,34)35/h5-9,12-13,22,24H,10-11,14H2,1-4H3,(H,38,44)/t22-,24+,30-/m0/s1	LSHWMTDKXGWJBH-RVVHDCIOSA-N	511727	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(2-fluoro-3- (trifluoromethoxy)phenyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 33	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511727&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318820	459628979							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072352	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)C(F)=C(C)C	InChI=1S/C30H35FN6O3/c1-15(2)26(31)17(4)34-29(40)23-10-30(7)11-24(30)37(23)25(39)14-36-28-16(3)8-20(21-12-32-19(6)33-13-21)9-22(28)27(35-36)18(5)38/h8-9,12-13,17,23-24H,10-11,14H2,1-7H3,(H,34,40)/t17-,23-,24+,30-/m0/s1	JQCQMKBVBSIHSM-ZHDAISQTSA-N	511728	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-((S)-3-fluoro-4-methylpent-3-en- 2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 34	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511728&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318799	459628980							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072353	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2ccn(CC(F)(F)F)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29F3N8O3/c1-15-7-18(19-11-33-17(3)34-12-19)8-20-25(16(2)41)37-39(26(15)20)13-24(42)40-21(9-28(4)10-22(28)40)27(43)35-23-5-6-38(36-23)14-29(30,31)32/h5-8,11-12,21-22H,9-10,13-14H2,1-4H3,(H,35,36,43)/t21-,22+,28-/m0/s1	ZZWKUQUCFFEFFY-TYPXCFOJSA-N	511729	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(1-(2,2,2- trifluoroethyl)-1H-pyrazol-3-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 35	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511729&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317582	459628981							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072354	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(n2)C(F)(F)F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28F3N7O3/c1-15-8-18(19-12-34-17(3)35-13-19)9-20-26(16(2)41)38-39(27(15)20)14-25(42)40-21(10-29(4)11-23(29)40)28(43)37-24-7-5-6-22(36-24)30(31,32)33/h5-9,12-13,21,23H,10-11,14H2,1-4H3,(H,36,37,43)/t21-,23+,29-/m0/s1	QCJZONQCWAPIAV-IXQRDTAUSA-N	511730	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(6- (trifluoromethyl)pyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 36	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511730&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318527	459628982							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072355	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28F3N7O4/c1-15-8-18(19-12-34-17(3)35-13-19)9-20-26(16(2)41)38-39(27(15)20)14-25(42)40-21(10-29(4)11-22(29)40)28(43)37-23-6-5-7-24(36-23)44-30(31,32)33/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H,36,37,43)/t21-,22+,29-/m0/s1	KFXGBUIVCIDUCR-KERYWQKISA-N	511731	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(6- (trifluoromethoxy)pyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 37	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511731&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420439	459628983							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072356	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H32ClFN6O3/c1-19-12-22(23-16-39-21(3)40-17-23)13-26-33(20(2)45)42-43(34(19)26)18-31(46)44-29(14-36(4)15-30(36)44)35(47)41-28-11-7-9-25(32(28)38)24-8-5-6-10-27(24)37/h5-13,16-17,29-30H,14-15,18H2,1-4H3,(H,41,47)/t29-,30+,36-/m0/s1	NBZPQTNDPASRJA-BLBFUMABSA-N	511732	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(2'-chloro-2-fluoro-[1,1- biphenyl]-3-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 38	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511732&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317832	459628984							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072357	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H30ClFN6O3/c1-19(44)33-25-13-21(22-16-38-20(2)39-17-22)11-12-28(25)42(41-33)18-31(45)43-29(14-35(3)15-30(35)43)34(46)40-27-10-6-8-24(32(27)37)23-7-4-5-9-26(23)36/h4-13,16-17,29-30H,14-15,18H2,1-3H3,(H,40,46)/t29-,30+,35-/m0/s1	QTSHMQKMEPBAIX-KQDQWFAOSA-N	511733	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(2'-chloro-2-fluoro-[1,1- biphenyl]-3-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 39	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511733&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420511	459628985							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072358	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C23H23N5O4/c1-12(29)21-16-6-14(15-9-24-13(2)25-10-15)4-5-17(16)27(26-21)11-20(30)28-18(22(31)32)7-23(3)8-19(23)28/h4-6,9-10,18-19H,7-8,11H2,1-3H3,(H,31,32)/t18-,19+,23-/m0/s1	XUJFKPGLYFUGCQ-YYDVJCTNSA-N	511734	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxylic acid::US11084800, Cpd No. 40	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511734&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146404939	459628986							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072359	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(cc(cc12)-c1cnc(C)nc1)C(O)=O	InChI=1S/C27H23BrFN7O5/c1-13(37)24-18-6-15(16-9-30-14(2)31-10-16)7-19(27(40)41)25(18)36(34-24)12-23(38)35-11-17(29)8-20(35)26(39)33-22-5-3-4-21(28)32-22/h3-7,9-10,17,20H,8,11-12H2,1-2H3,(H,40,41)(H,32,33,39)/t17-,20+/m1/s1	YUQKXQBEXPMMDL-XLIONFOSSA-N	511735	3-acetyl-1-(2-((2S,4R)-2-((6-bromopyridin-2- yl)carbamoyl)-4-fluoropyrrolidin-1-yl)-2- oxoethyl)-5-(2-methylpyrimidin-5-yl)-1H- indazole-7-carboxylic acid::US11084800, Cpd No. 41	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511735&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318608	459628987							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072360	CNCC12CC1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O3/c1-16-5-8-25(31)35-28(16)36-29(42)23-10-30(15-32-4)11-24(30)39(23)26(41)14-38-22-7-6-19(20-12-33-18(3)34-13-20)9-21(22)27(37-38)17(2)40/h5-9,12-13,23-24,32H,10-11,14-15H2,1-4H3,(H,35,36,42)/t23-,24?,30?/m0/s1	HMLNIKOFSCABTE-YVEZCHAMSA-N	511736	(3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5- ((methylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 42	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511736&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318292	459628988							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072361	CC(=O)NC[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN8O4/c1-16(40)28-21-9-19(20-12-32-17(2)33-13-20)7-8-22(21)38(37-28)14-27(42)39-23(10-30(11-24(30)39)15-34-18(3)41)29(43)36-26-6-4-5-25(31)35-26/h4-9,12-13,23-24H,10-11,14-15H2,1-3H3,(H,34,41)(H,35,36,43)/t23-,24-,30+/m0/s1	UNIWPUAHWDDAIU-FOUYOVOOSA-N	511737	(1S,3S,5S)-5-(acetamidomethyl)-2-(2-(3- acetyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 43	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511737&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317963	459628989							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072362	CC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN8O4/c1-16(40)28-21-9-19(20-12-32-17(2)33-13-20)7-8-22(21)38(37-28)14-27(42)39-23(10-30(11-24(30)39)15-34-18(3)41)29(43)36-26-6-4-5-25(31)35-26/h4-9,12-13,23-24H,10-11,14-15H2,1-3H3,(H,34,41)(H,35,36,43)/t23-,24+,30-/m0/s1	UNIWPUAHWDDAIU-BBANNHEPSA-N	511738	(1R,3S,5R)-5-(acetamidomethyl)-2-(2-(3- acetyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 44	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511738&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318179	459628990							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072363	COC(=O)N[C@@H](C(C)C)C(=O)NCC12CC1N([C@@H](C2)C(=O)Nc1cccc(Br)n1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C35H38BrN9O6/c1-18(2)30(42-34(50)51-5)33(49)39-17-35-12-25(32(48)41-28-8-6-7-27(36)40-28)45(26(35)13-35)29(47)16-44-24-10-9-21(22-14-37-20(4)38-15-22)11-23(24)31(43-44)19(3)46/h6-11,14-15,18,25-26,30H,12-13,16-17H2,1-5H3,(H,39,49)(H,42,50)(H,40,41,48)/t25-,26?,30-,35?/m0/s1	LARYMMPUOLQPRV-MRYGPSPGSA-N	511739	US11084800, Cpd No. 45::methyl ((2S)-1-((((3S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-3-((6-bromopyridin-2- yl)carbamoyl)-2-azabicyclo[3.1.0]hexan-5- yl)methyl)amino)-3-methyl-1-oxobutan-2- yl)carbamate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511739&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420437	459628991							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072364	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2ccc(F)c(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O3/c1-14-7-17(18-11-32-16(3)33-12-18)8-19-25(15(2)39)36-37(26(14)19)13-24(40)38-21(9-29(4)10-22(29)38)28(41)35-23-6-5-20(31)27(30)34-23/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H,34,35,41)/t21-,22+,29-/m0/s1	QXXCIFHTOMBQNX-KERYWQKISA-N	511740	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-5-fluoropyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 46	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511740&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160549749	459628992							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072365	CCc1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C31H32BrN7O3/c1-6-19-9-20(21-13-33-18(4)34-14-21)10-22-27(17(3)40)37-38(28(19)22)15-26(41)39-23(11-31(5)12-24(31)39)30(42)36-29-16(2)7-8-25(32)35-29/h7-10,13-14,23-24H,6,11-12,15H2,1-5H3,(H,35,36,42)/t23-,24+,31-/m0/s1	UQYVWYBOCXWTIG-JLELKNTQSA-N	511741	(1R,3S,5R)-2-(2-(3-acetyl-7-ethyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 47	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511741&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318828	459628993							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072366	COCc1ccc(Br)c(NC(=O)[C@@H]2CC3(CNC(=O)[C@@H](NC(=O)OC)C(C)C)CC3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C37H42BrN9O7/c1-19(2)31(43-36(52)54-6)35(51)41-18-37-12-28(34(50)44-33-26(38)9-8-24(42-33)17-53-5)47(29(37)13-37)30(49)16-46-27-10-7-22(23-14-39-21(4)40-15-23)11-25(27)32(45-46)20(3)48/h7-11,14-15,19,28-29,31H,12-13,16-18H2,1-6H3,(H,41,51)(H,43,52)(H,42,44,50)/t28-,29?,31-,37?/m0/s1	XQXQMAFAPKEDOB-BORHNLFHSA-N	511742	US11084800, Cpd No. 48::methyl ((2S)-1-((((3S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-3-((3-bromo-6- (methoxymethyl)pyridin-2-yl)carbamoyl)-2- azabicyclo[3.1.0]hexan-5-yl)methyl)amino)- 3-methyl-1-oxobutan-2-yl)carbamate	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511742&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161787307	459628994							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072367	COCc1ccc(Br)c(NC(=O)[C@@H]2CC3(COC)CC3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C31H32BrN7O5/c1-17(40)28-22-9-19(20-12-33-18(2)34-13-20)5-8-24(22)38(37-28)14-27(41)39-25(10-31(16-44-4)11-26(31)39)30(42)36-29-23(32)7-6-21(35-29)15-43-3/h5-9,12-13,25-26H,10-11,14-16H2,1-4H3,(H,35,36,42)/t25-,26?,31?/m0/s1	VLAVFDIMGQBSBT-UHTKEHJDSA-N	511743	(3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-N-(3-bromo-6- (methoxymethyl)pyridin-2-yl)-5- (methoxymethyl)-2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 49	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511743&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161328093	459628995							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072368	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)[nH+]c1	InChI=1S/C30H30BrN7O3/c1-15-6-7-24(31)34-28(15)35-29(41)22-10-30(5)11-23(30)38(22)25(40)14-37-27-16(2)8-19(20-12-32-18(4)33-13-20)9-21(27)26(36-37)17(3)39/h6-9,12-13,22-23H,10-11,14H2,1-5H3,(H,34,35,41)/p+1/t22-,23+,30-/m0/s1	JIHUPBGAEWTVSY-BURCIIJTSA-O	511744	5-(3-acetyl-1-(2-((1R,3S,5R)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-7- methyl-1H-indazol-5-yl)-2- methylpyrimidine 1-oxide::US11084800, Cpd No. 50	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511744&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158924923	459628996							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072369	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)[C@H]1CC1(Cl)Cl	InChI=1S/C29H32Cl2N6O3/c1-14-6-18(19-11-32-17(4)33-12-19)7-20-25(16(3)38)35-36(26(14)20)13-24(39)37-22(9-28(5)10-23(28)37)27(40)34-15(2)21-8-29(21,30)31/h6-7,11-12,15,21-23H,8-10,13H2,1-5H3,(H,34,40)/t15-,21-,22+,23-,28+/m1/s1	LTMNFUPXIREIKO-SZIFNHHISA-N	511745	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-((R)-1-((R)-2,2- dichlorocyclopropyl)ethyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 52	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511745&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317494	459628997							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072370	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cnc(C)c(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-14-6-18(19-10-32-17(4)33-11-19)7-20-25(16(3)39)36-37(26(14)20)13-24(40)38-21(8-29(5)9-22(29)38)28(41)35-23-12-31-15(2)27(30)34-23/h6-7,10-12,21-22H,8-9,13H2,1-5H3,(H,34,35,41)/t21-,22+,29-/m0/s1	VQAPPGMQCBIODG-KERYWQKISA-N	511746	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-5-methylpyrazin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 54	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511746&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318644	459628998							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072371	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(N)=O)c2c1	InChI=1S/C28H27BrN8O3/c1-14-4-7-22(29)33-26(14)34-27(40)20-9-28(3)10-21(28)37(20)23(38)13-36-19-6-5-16(17-11-31-15(2)32-12-17)8-18(19)24(35-36)25(30)39/h4-8,11-12,20-21H,9-10,13H2,1-3H3,(H2,30,39)(H,33,34,40)/t20-,21+,28-/m0/s1	GRPMEANCGJYBSZ-GTNJKRJXSA-N	511747	1-(2-((1R,3S,5R)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5-yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 55	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511747&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318118	459628999							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072372	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H]4C[C@H]4[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(N)=O)c2c1	InChI=1S/C27H25BrN8O3/c1-13-3-6-21(28)32-26(13)33-27(39)24-18-8-16(18)11-35(24)22(37)12-36-20-5-4-15(17-9-30-14(2)31-10-17)7-19(20)23(34-36)25(29)38/h3-7,9-10,16,18,24H,8,11-12H2,1-2H3,(H2,29,38)(H,32,33,39)/t16-,18-,24+/m1/s1	PTGCRDRVJAXYBE-OSWMTFESSA-N	511748	1-(2-((1R,2S,5S)-2-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-3- azabicyclo[3.1.0]hexan-3-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5-yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 56	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511748&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318562	459629000							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072373	Cc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(N)=O)c2c1	InChI=1S/C29H29BrN8O3/c1-14-5-6-22(30)34-27(14)35-28(41)20-9-29(4)10-21(29)38(20)23(39)13-37-25-15(2)7-17(18-11-32-16(3)33-12-18)8-19(25)24(36-37)26(31)40/h5-8,11-12,20-21H,9-10,13H2,1-4H3,(H2,31,40)(H,34,35,41)/t20-,21+,29-/m0/s1	IMLCRNUHDGYXGT-FONBTEPMSA-N	511749	1-(2-((1R,3S,5R)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-7- methyl-5-(2-methylpyrimidin::US11084800, Cpd No. 57	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511749&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317891	459629001							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072374	Cc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=O)c2c1	InChI=1S/C28H27BrN8O3/c1-14-7-16(17-11-31-15(2)32-12-17)8-18-24(26(30)39)35-36(25(14)18)13-23(38)37-19(9-28(3)10-20(28)37)27(40)34-22-6-4-5-21(29)33-22/h4-8,11-12,19-20H,9-10,13H2,1-3H3,(H2,30,39)(H,33,34,40)/t19-,20+,28-/m0/s1	BBUWXAIKZBCESZ-BCDQWZCSSA-N	511750	1-(2-((1R,3S,5R)-3-((6-bromopyridin-2- yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-7- methyl-5-(2-methylpyrimidin-5-yl)-1H- indazole-3-carboxamide::US11084800, Cpd No. 58	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511750&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317560	459629002							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072375	COC(=O)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O5/c1-15(39)27-21-8-17(19-11-32-16(2)33-12-19)4-6-22(21)38(36-27)14-25(40)37-13-20(31)10-23(37)29(42)35-28-18(9-26(41)43-3)5-7-24(30)34-28/h4-8,11-12,20,23H,9-10,13-14H2,1-3H3,(H,34,35,42)/t20-,23+/m1/s1	AZVXTNVYRIGBOL-OFNKIYASSA-N	511751	US11084800, Cpd No. 61::methyl 2-(2-((2S,4R)-1-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-4-fluoropyrrolidine-2- carboxamido)-6-bromopyridin-3-yl)acetate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511751&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318160	459629003							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072376	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2CC(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25BrFN7O5/c1-14(38)26-20-7-16(18-10-31-15(2)32-11-18)3-5-21(20)37(35-26)13-24(39)36-12-19(30)9-22(36)28(42)34-27-17(8-25(40)41)4-6-23(29)33-27/h3-7,10-11,19,22H,8-9,12-13H2,1-2H3,(H,40,41)(H,33,34,42)/t19-,22+/m1/s1	OQQAWNAQXSBJHU-KNQAVFIVSA-N	511752	2-(2-((2S,4R)-1-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-4-fluoropyrrolidine-2- carboxamido)-6-bromopyridin-3-yl)acetic  acid::US11084800, Cpd No. 62	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511752&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319003	459629004							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072377	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc[nH+]c1	InChI=1S/C28H26BrN7O3/c1-15-4-7-23(29)32-26(15)33-27(39)21-9-28(3)10-22(28)36(21)24(38)13-35-20-6-5-17(18-11-30-14-31-12-18)8-19(20)25(34-35)16(2)37/h4-8,11-12,14,21-22H,9-10,13H2,1-3H3,(H,32,33,39)/p+1/t21-,22+,28-/m0/s1	OSZLSKCDFYQOFY-TYPXCFOJSA-O	511753	5-(3-acetyl-1-(2-((1R,3S,5R)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1H- indazol-5-yl)-2-methylpyrimidine 1-oxide::US11084800, Cpd No. 64	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511753&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160089602	459629005							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072378	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CO)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O4/c1-15-4-7-24(30)33-27(15)34-28(41)22-9-29(14-38)10-23(29)37(22)25(40)13-36-21-6-5-18(19-11-31-17(3)32-12-19)8-20(21)26(35-36)16(2)39/h4-8,11-12,22-23,38H,9-10,13-14H2,1-3H3,(H,33,34,41)/t22-,23+,29-/m0/s1	LTEBQGKPQZSZLS-CTWZREHQSA-N	511754	(1R,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(hydroxymethyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 65	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511754&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159449371	459629006							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072379	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrF2N7O3/c1-15-5-6-23(30)35-27(15)36-28(42)22-9-29(32,13-31)14-38(22)24(41)12-39-26-16(2)7-19(20-10-33-18(4)34-11-20)8-21(26)25(37-39)17(3)40/h5-8,10-11,22H,9,12-14H2,1-4H3,(H,35,36,42)/t22-,29-/m0/s1	OKXCKQUMLVXXNS-ZTOMLWHTSA-N	511755	(2S,4R)-1-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 4-fluoro-4-(fluoromethyl)pyrrolidine-2- carboxamide::US11084800, Cpd No. 66	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511755&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318723	459629007							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072380	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O3/c1-20-5-8-29(36)39-32(20)40-33(47)27-12-35(19-42-17-34(18-42)9-4-10-34)13-28(35)44(27)30(46)16-43-26-7-6-23(24-14-37-22(3)38-15-24)11-25(26)31(41-43)21(2)45/h5-8,11,14-15,27-28H,4,9-10,12-13,16-19H2,1-3H3,(H,39,40,47)/t27-,28+,35-/m0/s1	ADQXQROJYUUIGO-UFEHBCDASA-N	511756	(1R,3S,5R)-5-(2-azaspiro[3.3]heptan-2- ylmethyl)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 67	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511756&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157082090	459629008							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072381	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O3/c1-20-5-8-29(36)39-32(20)40-33(47)27-12-35(19-42-17-34(18-42)9-4-10-34)13-28(35)44(27)30(46)16-43-26-7-6-23(24-14-37-22(3)38-15-24)11-25(26)31(41-43)21(2)45/h5-8,11,14-15,27-28H,4,9-10,12-13,16-19H2,1-3H3,(H,39,40,47)/t27-,28-,35+/m0/s1	ADQXQROJYUUIGO-KGTVSZMUSA-N	511757	(1S,3S,5S)-5-(2-azaspiro[3.3]heptan-2- ylmethyl)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-methylpyridin-2- yl)-2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 68	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511757&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157082088	459629009							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072382	CN1CCN(C[C@]23C[C@H]2N([C@@H](C3)C(=O)Nc2nc(Br)ccc2C)C(=O)Cn2nc(C(C)=O)c3cc(cc(C)c23)-c2cnc(C)nc2)CC1	InChI=1S/C35H40BrN9O3/c1-20-6-7-29(36)39-33(20)40-34(48)27-14-35(19-43-10-8-42(5)9-11-43)15-28(35)45(27)30(47)18-44-32-21(2)12-24(25-16-37-23(4)38-17-25)13-26(32)31(41-44)22(3)46/h6-7,12-13,16-17,27-28H,8-11,14-15,18-19H2,1-5H3,(H,39,40,48)/t27-,28+,35-/m0/s1	NBFJYWBPPFMHNG-UFEHBCDASA-N	511758	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazo1-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((4-methylpiperazin-1-yl)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 69	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511758&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318327	459629010							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072383	CN(CC=C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1COCC=C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O4/c1-6-12-43(5)21-36-15-29(35(48)41-34-25(20-49-13-7-2)9-11-31(37)40-34)45(30(36)16-36)32(47)19-44-28-10-8-24(26-17-38-23(4)39-18-26)14-27(28)33(42-44)22(3)46/h6-11,14,17-18,29-30H,1-2,12-13,15-16,19-21H2,3-5H3,(H,40,41,48)/t29-,30+,36-/m0/s1	DODQDWDCYPLIJF-BLBFUMABSA-N	511759	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((allyl(methyl)amino)methyl)-N- (3-((allyloxy)methyl)-6-bromopyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 70	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511759&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317563	459629011							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072384	CC(O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H28BrN7O3/c1-14-4-7-23(29)32-27(14)33-28(39)26-20-9-18(20)12-35(26)24(38)13-36-22-6-5-17(19-10-30-16(3)31-11-19)8-21(22)25(34-36)15(2)37/h4-8,10-11,15,18,20,26,37H,9,12-13H2,1-3H3,(H,32,33,39)/t15?,18-,20-,26+/m1/s1	BMQKUJONDKALCF-OWJAULCESA-N	511760	(1R,2S,5S)-N-(6-bromo-3-methylpyridin-2- yl)-3-(2-(3-(1-hydroxyethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-3-azabicyclo[3.1.0]hexane-2- carboxamide::US11084800, Cpd No. 71	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511760&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157396640	459629012							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072385	CC(O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,16,22-23,38H,10-11,14H2,1-4H3,(H,33,34,40)/t16?,22-,23+,29-/m0/s1	ZRWVDMKXNXFIIM-OZDYMSJPSA-N	511761	(1R,3S,5R)-N-(6-bromo-3-methylpyridin-2- yl)-2-(2-(3-(1-hydroxyethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 72	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511761&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162203499	459629013							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072386	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)cc3ccccc23)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H28BrN7O3/c1-17(41)29-23-10-19(21-14-34-18(2)35-15-21)8-9-24(23)39(38-29)16-28(42)40-25(12-32(3)13-26(32)40)31(43)37-30-22-7-5-4-6-20(22)11-27(33)36-30/h4-11,14-15,25-26H,12-13,16H2,1-3H3,(H,36,37,43)/t25-,26+,32-/m0/s1	OBXVCHMZRIKMLZ-BKQYKDOASA-N	511762	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(3-bromoisoquinolin-1-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 73	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511762&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318971	459629014							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072387	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(CF)c12)-c1cnc(C)nc1	InChI=1S/C32H34BrFN8O3/c1-17-6-7-26(33)37-30(17)38-31(45)24-10-32(16-40(4)5)11-25(32)42(24)27(44)15-41-29-21(12-34)8-20(22-13-35-19(3)36-14-22)9-23(29)28(39-41)18(2)43/h6-9,13-14,24-25H,10-12,15-16H2,1-5H3,(H,37,38,45)/t24-,25+,32-/m0/s1	NEOFUMTZCIOOGP-UNTHUGQZSA-N	511763	(1R,3S,5R)-2-(2-(3-acetyl-7-(fluoromethyl)-5- (2-methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 74	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511763&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420619	459629015							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072388	CN(C)C[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(CF)c12)-c1cnc(C)nc1	InChI=1S/C32H34BrFN8O3/c1-17-6-7-26(33)37-30(17)38-31(45)24-10-32(16-40(4)5)11-25(32)42(24)27(44)15-41-29-21(12-34)8-20(22-13-35-19(3)36-14-22)9-23(29)28(39-41)18(2)43/h6-9,13-14,24-25H,10-12,15-16H2,1-5H3,(H,37,38,45)/t24-,25-,32+/m0/s1	NEOFUMTZCIOOGP-PNRGXICFSA-N	511764	(1S,3S,5S)-2-(2-(3-acetyl-7-(fluoromethyl)- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 75	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511764&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318755	459629016							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072389	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrF3N7O3/c1-15-4-5-23(30)36-27(15)37-28(43)22-8-29(33,13-32)14-39(22)24(42)12-40-26-19(9-31)6-18(20-10-34-17(3)35-11-20)7-21(26)25(38-40)16(2)41/h4-7,10-11,22H,8-9,12-14H2,1-3H3,(H,36,37,43)/t22-,29-/m0/s1	SSLPFPQYAWHBIF-ZTOMLWHTSA-N	511765	(2S,4R)-1-(2-(3-acetyl-7-(fluoromethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 4-fluoro-4-(fluoromethyl)pyrrolidine-2- carboxamide::US11084800, Cpd No. 76	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511765&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160924447	459629017							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072390	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C(F)(F)F	InChI=1S/C30H27BrF3N7O3/c1-14-5-6-23(31)37-27(14)38-28(44)21-9-29(4)10-22(29)41(21)24(43)13-40-26-19(25(39-40)15(2)42)7-17(8-20(26)30(32,33)34)18-11-35-16(3)36-12-18/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H,37,38,44)/t21-,22-,29+/m0/s1	BDHYVQQXYKQRKF-IHMCZWCLSA-N	511766	(1S,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-7-(trifluoromethyl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 77	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511766&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157313549	459629018							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072391	CC(=O)N1CCN(C[C@]23C[C@H]2N([C@@H](C3)C(=O)Nc2nc(Br)ccc2C)C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)CC1	InChI=1S/C35H38BrN9O4/c1-20-5-8-30(36)39-33(20)40-34(49)28-14-35(19-42-9-11-43(12-10-42)23(4)47)15-29(35)45(28)31(48)18-44-27-7-6-24(25-16-37-22(3)38-17-25)13-26(27)32(41-44)21(2)46/h5-8,13,16-17,28-29H,9-12,14-15,18-19H2,1-4H3,(H,39,40,49)/t28-,29+,35-/m0/s1	PWOCGPXDZLVASK-AXJWHKOCSA-N	511767	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((4-acetylpiperazin-1-yl)methyl)- N-(6-bromo-3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 78	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511767&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160329786	459629019							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072392	CC(=O)N1CCN(C[C@@]23C[C@@H]2N([C@@H](C3)C(=O)Nc2nc(Br)ccc2C)C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)CC1	InChI=1S/C35H38BrN9O4/c1-20-5-8-30(36)39-33(20)40-34(49)28-14-35(19-42-9-11-43(12-10-42)23(4)47)15-29(35)45(28)31(48)18-44-27-7-6-24(25-16-37-22(3)38-17-25)13-26(27)32(41-44)21(2)46/h5-8,13,16-17,28-29H,9-12,14-15,18-19H2,1-4H3,(H,39,40,49)/t28-,29-,35+/m0/s1	PWOCGPXDZLVASK-AZRGUZCDSA-N	511768	(1S,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((4-acetylpiperazin-1-yl)methyl)- N-(6-bromo-3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 79	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511768&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160329787	459629020							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072393	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCC(C)(C)C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H38N6O3/c1-17-10-20(21-14-32-19(3)33-15-21)11-22-26(18(2)37)34-35(27(17)22)16-25(38)36-23(12-30(7)13-24(30)36)28(39)31-9-8-29(4,5)6/h10-11,14-15,23-24H,8-9,12-13,16H2,1-7H3,(H,31,39)/t23-,24+,30-/m0/s1	MCWDVBXRPKEAMT-BBANNHEPSA-N	511769	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(3,3-dimethylbutyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 80	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511769&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318113	459629021							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072394	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCOC(F)(F)F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C27H29F3N6O4/c1-14-7-17(18-11-32-16(3)33-12-18)8-19-23(15(2)37)34-35(24(14)19)13-22(38)36-20(9-26(4)10-21(26)36)25(39)31-5-6-40-27(28,29)30/h7-8,11-12,20-21H,5-6,9-10,13H2,1-4H3,(H,31,39)/t20-,21+,26-/m0/s1	LARDVDIZCUUVDH-UZINWLIJSA-N	511770	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(2- (trifluoromethoxy)ethyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 81	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511770&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317887	459629022							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072395	COc1cccc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(cc(C)c23)-c2cnc(C)nc2)n1	InChI=1S/C30H31N7O4/c1-16-9-19(20-13-31-18(3)32-14-20)10-21-27(17(2)38)35-36(28(16)21)15-26(39)37-22(11-30(4)12-23(30)37)29(40)34-24-7-6-8-25(33-24)41-5/h6-10,13-14,22-23H,11-12,15H2,1-5H3,(H,33,34,40)/t22-,23+,30-/m0/s1	CRYXYMMCSNZVIK-BURCIIJTSA-N	511771	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-methoxypyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 82	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511771&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318775	459629023							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072396	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(O)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24FN7O4/c1-14(35)25-19-8-16(17-10-28-15(2)29-11-17)6-7-20(19)34(32-25)13-24(37)33-12-18(27)9-21(33)26(38)31-22-4-3-5-23(36)30-22/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H2,30,31,36,38)/t18-,21+/m1/s1	MJGBRFLTTMXPBH-NQIIRXRSSA-N	511772	(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin- 5-yl)-1H-indazol-1-yl)acetyl)-4-fluoro-N-(6- hydroxypyridin-2-yl)pyrrolidine-2- carboxamide::US11084800, Cpd No. 83	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511772&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319205	459629024							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072397	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(OC2CS(=O)(=O)C2)nc1	InChI=1S/C29H27BrFN7O6S/c1-15-3-6-24(30)34-27(15)35-28(41)23-8-19(31)11-37(23)25(40)12-38-22-5-4-17(7-21(22)26(36-38)16(2)39)18-9-32-29(33-10-18)44-20-13-45(42,43)14-20/h3-7,9-10,19-20,23H,8,11-14H2,1-2H3,(H,34,35,41)/t19-,23+/m1/s1	MRQKZAJXPCWIAH-XXBNENTESA-N	511773	(2S,4R)-1-(2-(3-acetyl-5-(2-((1,1- dioxidothietan-3-yl)oxy)pyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-4-fluoropyrrolidine-2- carboxamide::US11084800, Cpd No. 84	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511773&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318612	459629025							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072398	COCc1ccc(Br)c(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(cc(COC)c23)-c2cnc(C)nc2)n1	InChI=1S/C32H34BrN7O5/c1-17(41)28-23-9-19(21-12-34-18(2)35-13-21)8-20(15-44-4)29(23)39(38-28)14-27(42)40-25(10-32(3)11-26(32)40)31(43)37-30-24(33)7-6-22(36-30)16-45-5/h6-9,12-13,25-26H,10-11,14-16H2,1-5H3,(H,36,37,43)/t25-,26+,32-/m0/s1	MCKULTJPIMXVIJ-BKQYKDOASA-N	511775	(1R,3S,5R)-2-(2-(3-acetyl-7- (methoxymethyl)-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(3-bromo-6- (methoxymethyl)pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 86	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511775&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159526355	459629027							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072399	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCNCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H38BrN9O3/c1-19-5-6-28(35)39-32(19)40-33(47)26-13-34(18-42-9-7-36-8-10-42)14-27(34)44(26)29(46)17-43-31-20(2)11-23(24-15-37-22(4)38-16-24)12-25(31)30(41-43)21(3)45/h5-6,11-12,15-16,26-27,36H,7-10,13-14,17-18H2,1-4H3,(H,39,40,47)/t26-,27+,34-/m0/s1	NFHZIEJDNSPYGV-MZXMJASYSA-N	511776	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(piperazin-1-ylmethyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 88	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511776&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420514	459629028							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072400	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O3/c1-20-6-7-29(37)40-33(20)41-34(48)27-12-36(19-43-17-35(18-43)8-5-9-35)13-28(36)45(27)30(47)16-44-32-21(2)10-24(25-14-38-23(4)39-15-25)11-26(32)31(42-44)22(3)46/h6-7,10-11,14-15,27-28H,5,8-9,12-13,16-19H2,1-4H3,(H,40,41,48)/t27-,28+,36-/m0/s1	AOXBXMCKSKUKQJ-DJSUPVAQSA-N	511777	(1R,3S,5R)-5-(2-azaspiro[3.3]heptan-2- ylmethyl)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 89	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511777&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319176	459629029							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072401	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C1CC1	InChI=1S/C32H32BrN7O3/c1-16-5-8-26(33)36-30(16)37-31(43)24-11-32(4)12-25(32)40(24)27(42)15-39-29-22(19-6-7-19)9-20(21-13-34-18(3)35-14-21)10-23(29)28(38-39)17(2)41/h5,8-10,13-14,19,24-25H,6-7,11-12,15H2,1-4H3,(H,36,37,43)/t24-,25-,32+/m0/s1	HSMRPYPHPQDHLG-PNRGXICFSA-N	511778	(1S,3S,5S)-2-(2-(3-acetyl-7-cyclopropyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 90	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511778&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158574560	459629030							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072402	CN(C)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-17(41)28-22-10-19(21-13-33-18(2)34-14-21)6-8-23(22)39(37-28)16-27(42)40-24(11-31(3)12-25(31)40)30(43)36-29-20(15-38(4)5)7-9-26(32)35-29/h6-10,13-14,24-25H,11-12,15-16H2,1-5H3,(H,35,36,43)/t24-,25+,31-/m0/s1	ACSTVBRCFYVKBL-NTWBYJAHSA-N	511779	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- ((dimethylamino)methyl)pyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 91	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511779&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162459680	459629031							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072403	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)N2C[C@H]3C[C@H]3C2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H35BrN8O4/c1-16-5-6-27(36)39-33(16)40-34(47)31-24-9-22(24)14-43(31)35(48)32-25-10-21(25)13-42(32)28(46)15-44-30-17(2)7-20(23-11-37-19(4)38-12-23)8-26(30)29(41-44)18(3)45/h5-8,11-12,21-22,24-25,31-32H,9-10,13-15H2,1-4H3,(H,39,40,47)/t21-,22-,24-,25-,31?,32+/m1/s1	BWSCIISATHVMFZ-NUBITXFXSA-N	511780	(1R,2S,5S)-3-((1R,2S,5S)-3-(2-(3-acetyl-7- methyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-3- azabicyclo[3.1.0]hexane-2-carbonyl)-N-(6- bromo-3-methylpyridin-2-yl)-3- azabicyclo[3.1.0]hexane-2-carboxamide::US11084800, Cpd No. 92	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511780&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533546	459629032							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072404	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(COCC=C)C[C@H]2C(=O)Nc2nc(Br)ccc2C=C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN7O4/c1-5-11-45-18-33-13-26(32(44)38-31-21(6-2)8-10-28(34)37-31)41(27(33)14-33)29(43)17-40-25-9-7-22(23-15-35-20(4)36-16-23)12-24(25)30(39-40)19(3)42/h5-10,12,15-16,26-27H,1-2,11,13-14,17-18H2,3-4H3,(H,37,38,44)/t26-,27+,33-/m0/s1	DZWXROJQCVFTFC-VCQOIINCSA-N	511781	(1R,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((allyloxy)methyl)-N-(6-bromo- 3-vinylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 93	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511781&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318692	459629033							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072405	CNC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-16-6-7-25(32)36-29(16)37-30(43)23-10-31(15-33-5)11-24(31)40(23)26(42)14-39-28-17(2)8-20(21-12-34-19(4)35-13-21)9-22(28)27(38-39)18(3)41/h6-9,12-13,23-24,33H,10-11,14-15H2,1-5H3,(H,36,37,43)/t23-,24+,31-/m0/s1	BREBRZRWNRQICD-JLELKNTQSA-N	511782	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((methylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 94	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511782&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318958	459629034							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072406	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)C3=C(F)CCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H36BrFN8O4/c1-18-8-9-29(37)42-33(18)43-35(50)27-12-36(17-41-34(49)24-6-5-7-26(24)38)13-28(36)46(27)30(48)16-45-32-19(2)10-22(23-14-39-21(4)40-15-23)11-25(32)31(44-45)20(3)47/h8-11,14-15,27-28H,5-7,12-13,16-17H2,1-4H3,(H,41,49)(H,42,43,50)/t27-,28+,36-/m0/s1	LEJLCMRSCCNSGX-DJSUPVAQSA-N	511783	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(2-fluorocyclopent-1-ene-1- carboxamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 95	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511783&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420576	459629035							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072407	CC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H33BrN8O4/c1-16-6-7-26(33)37-30(16)38-31(45)24-10-32(15-36-20(5)43)11-25(32)41(24)27(44)14-40-29-17(2)8-21(22-12-34-19(4)35-13-22)9-23(29)28(39-40)18(3)42/h6-9,12-13,24-25H,10-11,14-15H2,1-5H3,(H,36,43)(H,37,38,45)/t24-,25+,32-/m0/s1	YXOCPJPZYQUYSC-UNTHUGQZSA-N	511784	(1R,3S,5R)-5-(acetamidomethyl)-2-(2-(3- acetyl-7-methyl-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 96	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511784&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318751	459629036							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072408	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)c3ccccc3F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C37H34BrFN8O4/c1-19-9-10-30(38)43-34(19)44-36(51)28-13-37(18-42-35(50)25-7-5-6-8-27(25)39)14-29(37)47(28)31(49)17-46-33-20(2)11-23(24-15-40-22(4)41-16-24)12-26(33)32(45-46)21(3)48/h5-12,15-16,28-29H,13-14,17-18H2,1-4H3,(H,42,50)(H,43,44,51)/t28-,29+,37-/m0/s1	UIEZZISHHLYMBZ-UOZVSXRSSA-N	511785	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- fluorobenzamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 97	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511785&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317504	459629037							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072409	COC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C31H32BrN7O4/c1-16-6-7-25(32)35-29(16)36-30(42)23-10-31(15-43-5)11-24(31)39(23)26(41)14-38-28-17(2)8-20(21-12-33-19(4)34-13-21)9-22(28)27(37-38)18(3)40/h6-9,12-13,23-24H,10-11,14-15H2,1-5H3,(H,35,36,42)/t23-,24+,31-/m0/s1	BCQGZOWTLGLUSJ-JLELKNTQSA-N	511786	(1R,3S,5S)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(methoxymethyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 98	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511786&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318673	459629038							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072410	COC(=O)N[C@@H](C(C)C)C(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C37H42BrN9O6/c1-18(2)30(43-36(52)53-7)35(51)41-17-37-12-26(34(50)44-33-19(3)8-9-28(38)42-33)47(27(37)13-37)29(49)16-46-32-20(4)10-23(24-14-39-22(6)40-15-24)11-25(32)31(45-46)21(5)48/h8-11,14-15,18,26-27,30H,12-13,16-17H2,1-7H3,(H,41,51)(H,43,52)(H,42,44,50)/t26-,27+,30-,37-/m0/s1	GHOPXJZRBVUQSD-ISGWTQQRSA-N	511787	US11084800, Cpd No. 99::methyl ((S)-1-((((lR,3S,5R)-2-(2-(3-acetyl-7- methyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-2- azabicyclo[3.1.0]hexan-5-yl)methyl)amino)- 3-methyl-1-oxobutan-2-yl)carbamate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511787&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158258458	459629039							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072411	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-17-7-8-26(33)36-30(17)37-31(44)24-11-32(16-39(5)6)12-25(32)41(24)27(43)15-40-29-18(2)9-21(22-13-34-20(4)35-14-22)10-23(29)28(38-40)19(3)42/h7-10,13-14,24-25H,11-12,15-16H2,1-6H3,(H,36,37,44)/t24-,25+,32-/m0/s1	PDQMUAVPZNSVCQ-UNTHUGQZSA-N	511788	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 100	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511788&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			148884108	459629040							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072412	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNS(C)(=O)=O)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O5S/c1-16-6-7-25(32)36-29(16)37-30(43)23-10-31(15-35-46(5,44)45)11-24(31)40(23)26(42)14-39-28-17(2)8-20(21-12-33-19(4)34-13-21)9-22(28)27(38-39)18(3)41/h6-9,12-13,23-24,35H,10-11,14-15H2,1-5H3,(H,36,37,43)/t23-,24+,31-/m0/s1	MODJQQVDOSURDZ-JLELKNTQSA-N	511789	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(methylsulfonamidomethyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 101	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511789&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317857	459629041							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072413	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)CC(F)(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrF3N8O4/c1-16-5-6-25(34)41-30(16)42-31(49)23-9-32(15-40-26(47)11-33(35,36)37)10-24(32)45(23)27(48)14-44-29-17(2)7-20(21-12-38-19(4)39-13-21)8-22(29)28(43-44)18(3)46/h5-8,12-13,23-24H,9-11,14-15H2,1-4H3,(H,40,47)(H,41,42,49)/t23-,24+,32-/m0/s1	PTDJRKQMZOBPLM-XNSHOJTPSA-N	511790	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((3,3,3-trifluoropropanamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 102	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511790&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318564	459629042							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072414	CN(C)Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C31H33BrN8O3/c1-17-6-9-25(32)35-29(17)36-30(43)23-11-31(3)12-24(31)40(23)27(42)16-39-22-8-7-19(10-21(22)28(37-39)18(2)41)20-13-33-26(34-14-20)15-38(4)5/h6-10,13-14,23-24H,11-12,15-16H2,1-5H3,(H,35,36,43)/t23-,24+,31-/m0/s1	HPARFAZEOKQBKG-JLELKNTQSA-N	511791	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- ((dimethylamino)methyl)pyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 103	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511791&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318155	459629043							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072415	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-13-5-18(30)25(29)34-26(13)35-27(41)20-7-28(4)8-22(28)38(20)23(40)12-37-21-11-33-19(16-9-31-15(3)32-10-16)6-17(21)24(36-37)14(2)39/h5-6,9-11,20,22H,7-8,12H2,1-4H3,(H,34,35,41)/t20-,22+,28-/m0/s1	SMNPKPNKRXTIBG-PGKWVRKKSA-N	511792	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 104	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511792&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317953	459629044							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072416	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(O)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29N7O4/c1-15-8-18(19-12-30-17(3)31-13-19)9-20-26(16(2)37)34-35(27(15)20)14-25(39)36-21(10-29(4)11-22(29)36)28(40)33-23-6-5-7-24(38)32-23/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H2,32,33,38,40)/t21-,22+,29-/m0/s1	XCDKPJKSCVHYLS-KERYWQKISA-N	511793	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-hydroxypyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 105	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511793&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318132	459629045							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072417	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(O)nc1	InChI=1S/C28H26BrN7O4/c1-14-4-7-22(29)32-25(14)33-26(39)20-9-28(3)10-21(28)36(20)23(38)13-35-19-6-5-16(17-11-30-27(40)31-12-17)8-18(19)24(34-35)15(2)37/h4-8,11-12,20-21H,9-10,13H2,1-3H3,(H,30,31,40)(H,32,33,39)/t20-,21+,28-/m0/s1	HFOLXWXTGLVWIM-GTNJKRJXSA-N	511794	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- hydroxypyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 106	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511794&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420421	459629046							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072418	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(OC2CS(=O)(=O)C2)nc1	InChI=1S/C31H30BrN7O6S/c1-16-4-7-25(32)35-28(16)36-29(42)23-9-31(3)10-24(31)39(23)26(41)13-38-22-6-5-18(8-21(22)27(37-38)17(2)40)19-11-33-30(34-12-19)45-20-14-46(43,44)15-20/h4-8,11-12,20,23-24H,9-10,13-15H2,1-3H3,(H,35,36,42)/t23-,24+,31-/m0/s1	IYENTOKSPOEAKG-JLELKNTQSA-N	511795	(1R,3S,5R)-2-(2-(3-acetyl-5-(2-((1,1- dioxidothietan-3-yl)oxy)pyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 107	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511795&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318642	459629047							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072419	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(C)=O)c2c1	InChI=1S/C28H26BrN7O4/c1-15(37)25-18-9-16(17-12-30-27(40-3)31-13-17)7-8-19(18)35(34-25)14-24(38)36-20(10-28(2)11-21(28)36)26(39)33-23-6-4-5-22(29)32-23/h4-9,12-13,20-21H,10-11,14H2,1-3H3,(H,32,33,39)/t20-,21+,28-/m0/s1	BCLIAKULIBWOOO-GTNJKRJXSA-N	511796	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methoxypyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-5-methyl- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 108	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511796&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126643154	459629048							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072420	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(O)nc1	InChI=1S/C27H24BrN7O4/c1-14(36)24-17-8-15(16-11-29-26(39)30-12-16)6-7-18(17)34(33-24)13-23(37)35-19(9-27(2)10-20(27)35)25(38)32-22-5-3-4-21(28)31-22/h3-8,11-12,19-20H,9-10,13H2,1-2H3,(H,29,30,39)(H,31,32,38)/t19-,20+,27-/m0/s1	FYKRBGNWCOCIDQ-VKIDHGPPSA-N	511797	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- hydroxypyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-5-methyl- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 109	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511797&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317666	459629049							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072421	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(OC2CS(=O)(=O)C2)nc1	InChI=1S/C30H28BrN7O6S/c1-16(39)27-20-8-17(18-11-32-29(33-12-18)44-19-14-45(42,43)15-19)6-7-21(20)37(36-27)13-26(40)38-22(9-30(2)10-23(30)38)28(41)35-25-5-3-4-24(31)34-25/h3-8,11-12,19,22-23H,9-10,13-15H2,1-2H3,(H,34,35,41)/t22-,23+,30-/m0/s1	YICAHDUCUVGWPJ-BURCIIJTSA-N	511798	(1R,3S,5R)-2-(2-(3-acetyl-5-(2-((1,1- dioxidothietan-3-yl)oxy)pyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromopyridin-2- yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 110	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511798&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161921689	459629050							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072422	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C23H23N5O4/c1-11-4-14(16-7-24-13(3)25-8-16)5-18-20(12(2)29)26-28(21(11)18)10-19(30)27-9-15-6-17(15)22(27)23(31)32/h4-5,7-8,15,17,22H,6,9-10H2,1-3H3,(H,31,32)/t15-,17-,22+/m1/s1	XDPIHLXCPDVGJL-JLDZCNIISA-N	511799	(1R,2S,5S)-3-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-3-azabicyclo[3.1.0]hexane-2- carboxylic acid::US11084800, Cpd No. 111	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511799&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161681450	459629051							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072423	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C1CC1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C33H35BrN8O3/c1-18(43)30-24-11-21(22-14-35-19(2)36-15-22)7-9-25(24)41(39-30)16-29(44)42-26(12-33(13-27(33)42)17-40(3)4)32(45)38-31-23(20-5-6-20)8-10-28(34)37-31/h7-11,14-15,20,26-27H,5-6,12-13,16-17H2,1-4H3,(H,37,38,45)/t26-,27+,33-/m0/s1	PMEWSEBAGUGBRN-VCQOIINCSA-N	511800	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-cyclopropylpyridin- 2-yl)-5-((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 112	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511800&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420401	459629052							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072424	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNCCF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34BrFN8O3/c1-17-5-6-26(33)38-30(17)39-31(45)24-11-32(16-35-8-7-34)12-25(32)42(24)27(44)15-41-29-18(2)9-21(22-13-36-20(4)37-14-22)10-23(29)28(40-41)19(3)43/h5-6,9-10,13-14,24-25,35H,7-8,11-12,15-16H2,1-4H3,(H,38,39,45)/t24-,25+,32-/m0/s1	KOZQTXAQQOEWDT-UNTHUGQZSA-N	511801	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(((2-fluoroethyl)amino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 113	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511801&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317935	459629053							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072425	COCc1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(COC)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C32H34BrN7O5/c1-17-6-7-26(33)36-30(17)37-31(43)24-10-32(16-45-5)11-25(32)40(24)27(42)14-39-29-21(15-44-4)8-20(22-12-34-19(3)35-13-22)9-23(29)28(38-39)18(2)41/h6-9,12-13,24-25H,10-11,14-16H2,1-5H3,(H,36,37,43)/t24-,25+,32-/m0/s1	QNIQNIDDVNKMGY-UNTHUGQZSA-N	511802	(1R,3S,5S)-2-(2-(3-acetyl-7- (methoxymethyl)-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-(methoxymethyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 114	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511802&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420399	459629054							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072426	CC(O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30BrN7O3/c1-14-5-6-23(30)33-28(14)34-29(40)27-21-9-19(21)12-36(27)24(39)13-37-26-15(2)7-18(20-10-31-17(4)32-11-20)8-22(26)25(35-37)16(3)38/h5-8,10-11,16,19,21,27,38H,9,12-13H2,1-4H3,(H,33,34,40)/t16?,19-,21-,27+/m1/s1	PYCOACWCXLNPKJ-KUYVHVALSA-N	511803	(1R,2S,5S)-N-(6-bromo-3-methylpyridin-2- yl)-3-(2-(3-(1-hydroxyethyl)-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-3-azabicyclo[3.1.0]hexane-2- carboxamide::US11084800, Cpd No. 115	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511803&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162459687	459629055							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072427	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(F)cc(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O3/c1-14-5-17(18-11-32-16(3)33-12-18)6-20-26(15(2)39)36-37(27(14)20)13-25(40)38-21(9-29(4)10-22(29)38)28(41)35-24-8-19(31)7-23(30)34-24/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H,34,35,41)/t21-,22+,29-/m0/s1	GGCTWQCWQUWFPJ-KERYWQKISA-N	511804	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-4-fluoropyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 116	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511804&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318092	459629056							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072428	CN(C)C(=O)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H30BrFN8O4/c1-16(41)28-22-9-18(20-12-33-17(2)34-13-20)5-7-23(22)40(37-28)15-27(43)39-14-21(32)11-24(39)30(44)36-29-19(6-8-25(31)35-29)10-26(42)38(3)4/h5-9,12-13,21,24H,10-11,14-15H2,1-4H3,(H,35,36,44)/t21-,24+/m1/s1	ZFTHTYRWTBYHKW-QPPBQGQZSA-N	511805	(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin- 5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- (2-(dimethylamino)-2-oxoethyl)pyridin-2-yl)- 4-fluoropyrrolidine-2-carboxamide::US11084800, Cpd No. 117	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511805&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318135	459629057							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072429	CCN(CC)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C34H39BrN8O3/c1-7-41(8-2)18-34-13-26(33(46)39-32-19(3)9-10-28(35)38-32)43(27(34)14-34)29(45)17-42-31-20(4)11-23(24-15-36-22(6)37-16-24)12-25(31)30(40-42)21(5)44/h9-12,15-16,26-27H,7-8,13-14,17-18H2,1-6H3,(H,38,39,46)/t26-,27+,34-/m0/s1	KVPRFQSRENJPQL-MZXMJASYSA-N	511806	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((diethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 118	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511806&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318187	459629058							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072430	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3C[C@@H]4CCC[C@@H]4C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O3/c1-20-7-10-31(37)40-34(20)41-35(48)29-12-36(19-43-16-24-5-4-6-25(24)17-43)13-30(36)45(29)32(47)18-44-28-9-8-23(26-14-38-22(3)39-15-26)11-27(28)33(42-44)21(2)46/h7-11,14-15,24-25,29-30H,4-6,12-13,16-19H2,1-3H3,(H,40,41,48)/t24-,25+,29-,30+,36-/m0/s1	ANEXSBSLAWAGAU-VRNKOEFYSA-N	511807	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- (((3aR,6a5)-hexahydrocyclopenta[c]pyrrol- 2(1H)-yl)methyl)-2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 119	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511807&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420555	459629059							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072431	CNc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C29H29BrN8O3/c1-15-5-8-23(30)34-26(15)35-27(41)21-10-29(3)11-22(29)38(21)24(40)14-37-20-7-6-17(9-19(20)25(36-37)16(2)39)18-12-32-28(31-4)33-13-18/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H,31,32,33)(H,34,35,41)/t21-,22+,29-/m0/s1	NQILGXFADWXRBI-KERYWQKISA-N	511808	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- (methylamino)pyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 120	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511808&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319060	459629060							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072432	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(O)nc1	InChI=1S/C29H28BrN7O4/c1-14-5-6-22(30)33-26(14)34-27(40)20-9-29(4)10-21(29)37(20)23(39)13-36-25-15(2)7-17(18-11-31-28(41)32-12-18)8-19(25)24(35-36)16(3)38/h5-8,11-12,20-21H,9-10,13H2,1-4H3,(H,31,32,41)(H,33,34,40)/t20-,21+,29-/m0/s1	DRTJZHJWLZJIJH-FONBTEPMSA-N	511809	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- hydroxypyrimidin-5-yl)-7-methyl-1H-indazol- 1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2- yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 121	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511809&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318040	459629061							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072433	CN(CCCCC=C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C=C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C37H41BrN8O3/c1-6-8-9-10-15-44(5)22-37-17-30(36(49)42-35-25(7-2)12-14-32(38)41-35)46(31(37)18-37)33(48)21-45-29-13-11-26(27-19-39-24(4)40-20-27)16-28(29)34(43-45)23(3)47/h6-7,11-14,16,19-20,30-31H,1-2,8-10,15,17-18,21-22H2,3-5H3,(H,41,42,49)/t30-,31+,37-/m0/s1	GLFVUPMHVGLEIK-NKAWTWKPSA-N	511810	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-vinylpyridin-2-yl)-5- ((hex-5-en-1-yl(methyl)amino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 123	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511810&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318124	459629062							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072434	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C#N	InChI=1S/C30H27BrN8O3/c1-15-5-6-24(31)35-28(15)36-29(42)22-9-30(4)10-23(30)39(22)25(41)14-38-27-19(11-32)7-18(20-12-33-17(3)34-13-20)8-21(27)26(37-38)16(2)40/h5-8,12-13,22-23H,9-10,14H2,1-4H3,(H,35,36,42)/t22-,23+,30-/m0/s1	BUXUMVXUKBXLKX-BURCIIJTSA-N	511811	(1R,3S,5R)-2-(2-(3-acetyl-7-cyano-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 124	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511811&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319112	459629063							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072435	CN(C)c1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C30H31BrN8O3/c1-16-6-9-24(31)34-27(16)35-28(42)22-11-30(3)12-23(30)39(22)25(41)15-38-21-8-7-18(10-20(21)26(36-38)17(2)40)19-13-32-29(33-14-19)37(4)5/h6-10,13-14,22-23H,11-12,15H2,1-5H3,(H,34,35,42)/t22-,23+,30-/m0/s1	NLQYKHMGIGAZMQ-BURCIIJTSA-N	511812	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- (dimethylamino)pyrimidin-5-yl)-1H-indazol- 1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2- yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 125	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511812&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317814	459629064							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072436	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C24H25N5O4/c1-12-5-15(16-9-25-14(3)26-10-16)6-17-21(13(2)30)27-28(22(12)17)11-20(31)29-18(23(32)33)7-24(4)8-19(24)29/h5-6,9-10,18-19H,7-8,11H2,1-4H3,(H,32,33)/t18-,19+,24-/m0/s1	VMNBRMSHSXCITM-GLDPYIMESA-N	511813	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxylic acid::US11084800, Cpd No. 126	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511813&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146404666	459629065							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072437	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(COC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O4/c1-19-5-6-28(36)39-32(19)40-33(47)26-9-35(16-42-14-34(15-42)17-48-18-34)10-27(35)44(26)29(46)13-43-31-20(2)7-23(24-11-37-22(4)38-12-24)8-25(31)30(41-43)21(3)45/h5-8,11-12,26-27H,9-10,13-18H2,1-4H3,(H,39,40,47)/t26-,27+,35-/m0/s1	MTNRVLARYUXWHK-ULQPQYINSA-N	511814	(1R,3S,5R)-5-(2-oxa-6-azaspiro[3.3]heptan-6- ylmethyl)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 127	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511814&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318792	459629066							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072438	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3C[C@@H]4CCC[C@@H]4C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C37H41BrN8O3/c1-20-8-9-31(38)41-35(20)42-36(49)29-12-37(19-44-16-24-6-5-7-25(24)17-44)13-30(37)46(29)32(48)18-45-34-21(2)10-26(27-14-39-23(4)40-15-27)11-28(34)33(43-45)22(3)47/h8-11,14-15,24-25,29-30H,5-7,12-13,16-19H2,1-4H3,(H,41,42,49)/t24-,25+,29-,30+,37-/m0/s1	UHRLHYLDQLDIDF-DVELNMADSA-N	511815	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(((3aR,6a5)-hexahydrocyclopenta[c]pyrrol- 2(1H)-yl)methyl)-2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 128	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511815&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318570	459629067							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072439	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(C3)CCCC4)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C37H41BrN8O3/c1-21-7-8-30(38)41-34(21)42-35(49)28-13-37(20-44-18-36(19-44)9-5-6-10-36)14-29(37)46(28)31(48)17-45-33-22(2)11-25(26-15-39-24(4)40-16-26)12-27(33)32(43-45)23(3)47/h7-8,11-12,15-16,28-29H,5-6,9-10,13-14,17-20H2,1-4H3,(H,41,42,49)/t28-,29+,37-/m0/s1	JZOAAZIRASVLKJ-UOZVSXRSSA-N	511816	(1R,3S,5R)-5-(2-azaspiro[3.4]octan-2- ylmethyl)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 129	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511816&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318240	459629068							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072440	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(-c3cnc(C)nc3)c(F)c12	InChI=1S/C29H27BrFN7O3/c1-14-5-8-22(30)34-27(14)35-28(41)20-9-29(4)10-21(29)38(20)23(40)13-37-19-7-6-18(17-11-32-16(3)33-12-17)25(31)24(19)26(36-37)15(2)39/h5-8,11-12,20-21H,9-10,13H2,1-4H3,(H,34,35,41)/t20-,21+,29-/m0/s1	UJDKBUAUVWOLMB-FONBTEPMSA-N	511817	(1R,3S,5R)-2-(2-(3-acetyl-4-fluoro-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 130	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511817&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318331	459629069							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072441	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)CC2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C1CC1	InChI=1S/C32H32BrN7O3/c1-16-5-8-26(33)36-30(16)37-31(43)24-11-32(4)12-25(32)40(24)27(42)15-39-29-22(19-6-7-19)9-20(21-13-34-18(3)35-14-21)10-23(29)28(38-39)17(2)41/h5,8-10,13-14,19,24-25H,6-7,11-12,15H2,1-4H3,(H,36,37,43)/t24?,25-,32+/m1/s1	HSMRPYPHPQDHLG-QWEUKOSNSA-N	511818	(1R,5R)-2-(2-(3-acetyl-7-cyclopropyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 131	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511818	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511818&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158574561	459629070							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072442	CCNC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-6-34-16-32-11-24(31(44)38-30-17(2)7-8-26(33)37-30)41(25(32)12-32)27(43)15-40-29-18(3)9-21(22-13-35-20(5)36-14-22)10-23(29)28(39-40)19(4)42/h7-10,13-14,24-25,34H,6,11-12,15-16H2,1-5H3,(H,37,38,44)/t24-,25+,32-/m0/s1	SBZAIVRBYGXTJX-UNTHUGQZSA-N	511819	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((ethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 132	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511819&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317586	459629071							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072443	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C(F)(F)F	InChI=1S/C30H27BrF3N7O3/c1-14-5-6-23(31)37-27(14)38-28(44)21-9-29(4)10-22(29)41(21)24(43)13-40-26-19(25(39-40)15(2)42)7-17(8-20(26)30(32,33)34)18-11-35-16(3)36-12-18/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H,37,38,44)/t21-,22+,29-/m0/s1	BDHYVQQXYKQRKF-KERYWQKISA-N	511820	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-7-(trifluoromethyl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 133	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511820&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318149	459629072							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072444	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2COCC=C)C=C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN7O4/c1-5-11-45-18-22-8-10-28(34)37-31(22)38-32(44)26-13-33(6-2)14-27(33)41(26)29(43)17-40-25-9-7-21(23-15-35-20(4)36-16-23)12-24(25)30(39-40)19(3)42/h5-10,12,15-16,26-27H,1-2,11,13-14,17-18H2,3-4H3,(H,37,38,44)/t26-,27+,33-/m0/s1	FNTRKJUHIKOIHV-VCQOIINCSA-N	511821	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(3-((allyloxy)methyl)-6- bromopyridin-2-yl)-5-vinyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 134	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511821&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319186	459629073							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072445	CN(C)Cc1ccc(Cl)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H33ClN8O3/c1-17(41)28-22-10-19(21-13-33-18(2)34-14-21)6-8-23(22)39(37-28)16-27(42)40-24(11-31(3)12-25(31)40)30(43)36-29-20(15-38(4)5)7-9-26(32)35-29/h6-10,13-14,24-25H,11-12,15-16H2,1-5H3,(H,35,36,43)/t24-,25+,31-/m0/s1	WBYSXUYMYXLQFG-NTWBYJAHSA-N	511822	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-chloro-3- ((dimethylamino)methyl)pyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 135	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511822&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317882	459629074							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072446	CN(C)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-17-9-21(22-13-34-19(3)35-14-22)10-23-28(18(2)42)38-40(29(17)23)16-27(43)41-24(11-32(4)12-25(32)41)31(44)37-30-20(15-39(5)6)7-8-26(33)36-30/h7-10,13-14,24-25H,11-12,15-16H2,1-6H3,(H,36,37,44)/t24-,25+,32-/m0/s1	BMOPFWQLLMSCMU-UNTHUGQZSA-N	511823	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- ((dimethylamino)methyl)pyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 136	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511823&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318748	459629075							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072447	CN(C)Cc1ccc(Cl)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H35ClN8O3/c1-17-9-21(22-13-34-19(3)35-14-22)10-23-28(18(2)42)38-40(29(17)23)16-27(43)41-24(11-32(4)12-25(32)41)31(44)37-30-20(15-39(5)6)7-8-26(33)36-30/h7-10,13-14,24-25H,11-12,15-16H2,1-6H3,(H,36,37,44)/t24-,25+,32-/m0/s1	GTTMOCFKSJJEFK-UNTHUGQZSA-N	511824	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-chloro-3- ((dimethylamino)methyl)pyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 137	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511824&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319017	459629076							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072448	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCOCC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35BrN8O4/c1-19(43)30-24-12-21(23-15-35-20(2)36-16-23)4-6-25(24)41(39-30)18-29(44)42-26(13-33(3)14-27(33)42)32(45)38-31-22(5-7-28(34)37-31)17-40-8-10-46-11-9-40/h4-7,12,15-16,26-27H,8-11,13-14,17-18H2,1-3H3,(H,37,38,45)/t26-,27+,33-/m0/s1	OJQVSOSLLKLUFT-VCQOIINCSA-N	511825	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- (morpholinomethyl)pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 138	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511825&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420427	459629077							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072449	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Cl)ccc2CN2CCOCC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35ClN8O4/c1-19(43)30-24-12-21(23-15-35-20(2)36-16-23)4-6-25(24)41(39-30)18-29(44)42-26(13-33(3)14-27(33)42)32(45)38-31-22(5-7-28(34)37-31)17-40-8-10-46-11-9-40/h4-7,12,15-16,26-27H,8-11,13-14,17-18H2,1-3H3,(H,37,38,45)/t26-,27+,33-/m0/s1	VXLFHFIBXCVMHS-VCQOIINCSA-N	511827	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-chloro-3- (morpholinomethyl)pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 139	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511827&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317469	459629079							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072450	CC(O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H32BrN7O3/c1-15-6-7-24(31)34-28(15)35-29(41)22-10-30(5)11-23(30)38(22)25(40)14-37-27-16(2)8-19(20-12-32-18(4)33-13-20)9-21(27)26(36-37)17(3)39/h6-9,12-13,17,22-23,39H,10-11,14H2,1-5H3,(H,34,35,41)/t17?,22-,23+,30-/m0/s1	BLPGBHWATWSQEO-JESBJUOXSA-N	511828	(1R,3S,5R)-N-(6-bromo-3-methylpyridin-2- hydroxyethyl)-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 140	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511828&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533547	459629080							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072451	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrN8O3/c1-13-4-5-22(28)32-26(13)33-27(39)25-18-6-16(18)11-35(25)23(38)12-36-21-10-31-20(17-8-29-15(3)30-9-17)7-19(21)24(34-36)14(2)37/h4-5,7-10,16,18,25H,6,11-12H2,1-3H3,(H,32,33,39)/t16-,18-,25+/m1/s1	QJNFPGORDZXYRN-UAYVVIHISA-N	511829	(1R,2S,5S)-3-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-3- azabicyclo[3.1.0]hexane-2-carboxamide::US11084800, Cpd No. 141	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511829&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317853	459629081							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072452	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(C3)CCCC4)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O3/c1-21-6-9-30(37)40-33(21)41-34(48)28-13-36(20-43-18-35(19-43)10-4-5-11-35)14-29(36)45(28)31(47)17-44-27-8-7-24(25-15-38-23(3)39-16-25)12-26(27)32(42-44)22(2)46/h6-9,12,15-16,28-29H,4-5,10-11,13-14,17-20H2,1-3H3,(H,40,41,48)/t28-,29+,36-/m0/s1	SHZNHCXEAZEWAU-WEPHICOPSA-N	511830	(1R,3S,5R)-5-(2-azaspiro[3.4]octan-2- ylmethyl)-2-(2-(3-acetyl-5-methylpyrimidin- 5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 142	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511830&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420505	459629082							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072453	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C#N)c12)-c1cnc(C)nc1	InChI=1S/C32H32BrN9O3/c1-17-6-7-26(33)37-30(17)38-31(45)24-10-32(16-40(4)5)11-25(32)42(24)27(44)15-41-29-21(12-34)8-20(22-13-35-19(3)36-14-22)9-23(29)28(39-41)18(2)43/h6-9,13-14,24-25H,10-11,15-16H2,1-5H3,(H,37,38,45)/t24-,25+,32-/m0/s1	LSWFCBNHOOGNIB-UNTHUGQZSA-N	511831	(1R,3S,5R)-2-(2-(3-acetyl-7-cyano-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 143	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511831&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420489	459629083							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072454	CN(C)C[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C#N)c12)-c1cnc(C)nc1	InChI=1S/C32H32BrN9O3/c1-17-6-7-26(33)37-30(17)38-31(45)24-10-32(16-40(4)5)11-25(32)42(24)27(44)15-41-29-21(12-34)8-20(22-13-35-19(3)36-14-22)9-23(29)28(39-41)18(2)43/h6-9,13-14,24-25H,10-11,15-16H2,1-5H3,(H,37,38,45)/t24-,25-,32+/m0/s1	LSWFCBNHOOGNIB-PNRGXICFSA-N	511832	(1S,3S,5S)-2-(2-(3-acetyl-7-cyano-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 144	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511832&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159446877	459629084							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072455	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(N)=O)c2c1F	InChI=1S/C28H26BrFN8O3/c1-13-4-7-20(29)34-26(13)35-27(41)18-8-28(3)9-19(28)38(18)21(39)12-37-17-6-5-16(15-10-32-14(2)33-11-15)23(30)22(17)24(36-37)25(31)40/h4-7,10-11,18-19H,8-9,12H2,1-3H3,(H2,31,40)(H,34,35,41)/t18-,19+,28-/m0/s1	ZMBGHEOOVLUSMZ-ILLIAVPXSA-N	511833	1-(2-((1R,3S,5R)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-4- fluoro-5-(2-methylpyrimidin-5-yl)-1H- indazole-3-carboxamide::US11084800, Cpd No. 145	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511833	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511833&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420581	459629085							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072456	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C(F)F	InChI=1S/C30H28BrF2N7O3/c1-14-5-6-23(31)36-28(14)37-29(43)21-9-30(4)10-22(30)40(21)24(42)13-39-26-19(25(38-39)15(2)41)7-17(8-20(26)27(32)33)18-11-34-16(3)35-12-18/h5-8,11-12,21-22,27H,9-10,13H2,1-4H3,(H,36,37,43)/t21-,22+,30-/m0/s1	RVGWZCSWEGQODV-ZQLNOWDWSA-N	511834	(1R,3S,5R)-2-(2-(3-acetyl-7-(difluoromethyl)- 5-(2-methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 146	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511834&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318686	459629086							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072457	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(F)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O3/c1-14-5-6-23(30)34-27(14)35-28(41)21-9-29(4)10-22(29)38(21)24(40)13-37-26-19(25(36-37)15(2)39)7-17(8-20(26)31)18-11-32-16(3)33-12-18/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H,34,35,41)/t21-,22+,29-/m0/s1	DBUMAPRSTHIJND-KERYWQKISA-N	511835	(1R,3S,5R)-2-(2-(3-acetyl-7-fluoro-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 147	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511835&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318998	459629087							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072458	CN(C)C(=O)Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C32H33BrN8O4/c1-17-6-9-25(33)36-30(17)37-31(45)23-12-32(3)13-24(32)41(23)28(44)16-40-22-8-7-19(10-21(22)29(38-40)18(2)42)20-14-34-26(35-15-20)11-27(43)39(4)5/h6-10,14-15,23-24H,11-13,16H2,1-5H3,(H,36,37,45)/t23-,24+,32-/m0/s1	AJEDBZIDAYYNCS-XNSHOJTPSA-N	511836	(1R,3S,5R)-2-(2-(3-acetyl-5-(2-(2- (dimethylamino)-2-oxoethyl)pyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 148	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511836&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318582	459629088							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072459	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35BrN8O3/c1-18-6-7-27(34)37-31(18)38-32(45)25-12-33(17-40-8-5-9-40)13-26(33)42(25)28(44)16-41-30-19(2)10-22(23-14-35-21(4)36-15-23)11-24(30)29(39-41)20(3)43/h6-7,10-11,14-15,25-26H,5,8-9,12-13,16-17H2,1-4H3,(H,37,38,45)/t25-,26+,33-/m0/s1	RVCLEBVCIBSXKY-REYAJUCUSA-N	511837	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-(azetidin-1-ylmethyl)-N-(6- bromo-3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 149	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511837&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318267	459629089							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072460	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(F)(F)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H33BrF2N8O3/c1-17-5-6-26(34)39-30(17)40-31(47)24-9-32(14-42-15-33(35,36)16-42)10-25(32)44(24)27(46)13-43-29-18(2)7-21(22-11-37-20(4)38-12-22)8-23(29)28(41-43)19(3)45/h5-8,11-12,24-25H,9-10,13-16H2,1-4H3,(H,39,40,47)/t24-,25+,32-/m0/s1	KJPXHHCPEMFQIH-UNTHUGQZSA-N	511838	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((3,3-difluoroazetidin-1-yl)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 150	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511838&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420592	459629090							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072461	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC3CC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H33BrN8O3/c1-17-4-9-27(33)37-30(17)38-31(44)25-11-32(16-36-22-6-7-22)12-26(32)41(25)28(43)15-40-24-8-5-20(21-13-34-19(3)35-14-21)10-23(24)29(39-40)18(2)42/h4-5,8-10,13-14,22,25-26,36H,6-7,11-12,15-16H2,1-3H3,(H,37,38,44)/t25-,26+,32-/m0/s1	GLNUMJYLJGQQQZ-BKQYKDOASA-N	511839	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((cyclopropylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 151	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511839&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318325	459629091							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072462	COCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(COC)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C31H32BrN7O5/c1-17(40)28-22-9-19(21-12-33-18(2)34-13-21)5-7-23(22)38(37-28)14-27(41)39-24(10-31(16-44-4)11-25(31)39)30(42)36-29-20(15-43-3)6-8-26(32)35-29/h5-9,12-13,24-25H,10-11,14-16H2,1-4H3,(H,35,36,42)/t24-,25+,31-/m0/s1	UMDGFUXLFNFABQ-NTWBYJAHSA-N	511840	(1R,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- (methoxymethyl)pyridin-2-yl)-5- (methoxymethyl)-2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 152	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511840&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318777	459629092							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072463	COCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(CNC(=O)[C@@H](NC(=O)OC)C(C)C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C37H42BrN9O7/c1-19(2)31(43-36(52)54-6)35(51)41-18-37-12-27(34(50)44-33-23(17-53-5)8-10-29(38)42-33)47(28(37)13-37)30(49)16-46-26-9-7-22(24-14-39-21(4)40-15-24)11-25(26)32(45-46)20(3)48/h7-11,14-15,19,27-28,31H,12-13,16-18H2,1-6H3,(H,41,51)(H,43,52)(H,42,44,50)/t27-,28+,31-,37-/m0/s1	JYMLMPLNNJANTK-WNJYGNMVSA-N	511841	US11084800, Cpd No. 153::methyl ((S)-1-((((1R,3S,5R)-2-(2-(3-acetyl-5- (2-methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-3-((6-bromo-3- (methoxymethyl)pyridin-2-yl)carbamoyl)-2- azabicyclo[3.1.0]hexan-5-yl)methyl)amino)- 3-methyl-1-oxobutan-2-yl)carbamate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511841&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420376	459629093							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072464	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(COCC=C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CC=C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H36BrN7O4/c1-6-8-23-12-24(25-16-37-22(5)38-17-25)13-26-31(21(4)44)41-42(32(23)26)18-30(45)43-27(14-35(15-28(35)43)19-47-11-7-2)34(46)40-33-20(3)9-10-29(36)39-33/h6-7,9-10,12-13,16-17,27-28H,1-2,8,11,14-15,18-19H2,3-5H3,(H,39,40,46)/t27-,28+,35-/m0/s1	KLQNREOAFYQVGV-UFEHBCDASA-N	511842	(1R,3S,5S)-2-(2-(3-acetyl-7-allyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((allyloxy)methyl)-N-(6-bromo- 3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 154	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511842&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318883	459629094							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072465	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2c(F)c(ccc12)-c1cnc(C)nc1	InChI=1S/C31H32BrFN8O3/c1-16-6-9-24(32)36-29(16)37-30(44)22-10-31(15-39(4)5)11-23(31)41(22)25(43)14-40-21-8-7-20(19-12-34-18(3)35-13-19)27(33)26(21)28(38-40)17(2)42/h6-9,12-13,22-23H,10-11,14-15H2,1-5H3,(H,36,37,44)/t22-,23+,31-/m0/s1	QJDCMTQHOZKIJW-LWPQGVMLSA-N	511843	(1R,3S,5R)-2-(2-(3-acetyl-4-fluoro-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 155	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511843&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318521	459629095							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072466	CN(C)C[C@@]12C[C@@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2c(F)c(ccc12)-c1cnc(C)nc1	InChI=1S/C31H32BrFN8O3/c1-16-6-9-24(32)36-29(16)37-30(44)22-10-31(15-39(4)5)11-23(31)41(22)25(43)14-40-21-8-7-20(19-12-34-18(3)35-13-19)27(33)26(21)28(38-40)17(2)42/h6-9,12-13,22-23H,10-11,14-15H2,1-5H3,(H,36,37,44)/t22-,23-,31+/m0/s1	QJDCMTQHOZKIJW-WDCWYOMISA-N	511844	(1S,3S,5S)-2-(2-(3-acetyl-4-fluoro-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 156	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511844&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318166	459629096							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072467	CN(C)CCOC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C33H37BrN8O4/c1-19-6-9-28(34)37-31(19)38-32(45)26-13-33(18-46-11-10-40(4)5)14-27(33)42(26)29(44)17-41-25-8-7-22(23-15-35-21(3)36-16-23)12-24(25)30(39-41)20(2)43/h6-9,12,15-16,26-27H,10-11,13-14,17-18H2,1-5H3,(H,37,38,45)/t26-,27+,33-/m0/s1	WHYULPSECVPLRK-VCQOIINCSA-N	511845	(1R,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(2-(dimethylamino)ethoxy)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 157	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511845&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161510018	459629097							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072468	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)C3CCCC3(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H37BrF2N8O4/c1-18-7-8-28(37)43-32(18)44-34(51)26-12-35(17-42-33(50)25-6-5-9-36(25,38)39)13-27(35)47(26)29(49)16-46-31-19(2)10-22(23-14-40-21(4)41-15-23)11-24(31)30(45-46)20(3)48/h7-8,10-11,14-15,25-27H,5-6,9,12-13,16-17H2,1-4H3,(H,42,50)(H,43,44,51)/t25?,26-,27+,35-/m0/s1	MDJZAPUJIIXNGS-HTNYCRAYSA-N	511846	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((2,2-difluorocyclopentane-1- carboxamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 158	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511846&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319035	459629098							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072469	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)C3CCCC3(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H35BrF2N8O4/c1-18-6-9-28(36)42-31(18)43-33(50)26-12-34(17-41-32(49)24-5-4-10-35(24,37)38)13-27(34)46(26)29(48)16-45-25-8-7-21(22-14-39-20(3)40-15-22)11-23(25)30(44-45)19(2)47/h6-9,11,14-15,24,26-27H,4-5,10,12-13,16-17H2,1-3H3,(H,41,49)(H,42,43,50)/t24?,26-,27+,34-/m0/s1	NNIAVZGUJRVMDY-UTFGXMCBSA-N	511847	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((2,2-difluorocyclopentane-1- carboxamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 159	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511847&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319008	459629099							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072470	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNCC(F)(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H32BrF3N8O3/c1-16-5-6-25(33)40-29(16)41-30(47)23-9-31(14-37-15-32(34,35)36)10-24(31)44(23)26(46)13-43-28-17(2)7-20(21-11-38-19(4)39-12-21)8-22(28)27(42-43)18(3)45/h5-8,11-12,23-24,37H,9-10,13-15H2,1-4H3,(H,40,41,47)/t23-,24+,31-/m0/s1	HSZWXFZVJFBAHC-JLELKNTQSA-N	511848	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(((2,2,2-trifluoroethyl)amino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 160	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511848&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318744	459629100							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072471	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNCc3ccccc3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C37H37BrN8O3/c1-21-10-11-31(38)42-35(21)43-36(49)29-14-37(20-39-16-25-8-6-5-7-9-25)15-30(37)46(29)32(48)19-45-34-22(2)12-26(27-17-40-24(4)41-18-27)13-28(34)33(44-45)23(3)47/h5-13,17-18,29-30,39H,14-16,19-20H2,1-4H3,(H,42,43,49)/t29-,30+,37-/m0/s1	SZCJNPQRDDULIP-UKXUPQFXSA-N	511849	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((benzylamino)methyl)-N-(6- bromo-3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 161	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511849&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318270	459629101							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072472	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CC#N)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrN8O3/c1-16-5-6-25(32)36-29(16)37-30(43)23-11-31(7-8-33)12-24(31)40(23)26(42)15-39-28-17(2)9-20(21-13-34-19(4)35-14-21)10-22(28)27(38-39)18(3)41/h5-6,9-10,13-14,23-24H,7,11-12,15H2,1-4H3,(H,36,37,43)/t23-,24+,31-/m0/s1	MNCQGMWAYPNGTQ-JLELKNTQSA-N	511850	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(cyanomethyl)-2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 162	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511850&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317889	459629102							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072473	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrFN7O3/c1-15-5-6-24(31)35-28(15)36-29(42)22-9-30(14-32)10-23(30)39(22)25(41)13-38-27-16(2)7-19(20-11-33-18(4)34-12-20)8-21(27)26(37-38)17(3)40/h5-8,11-12,22-23H,9-10,13-14H2,1-4H3,(H,35,36,42)/t22-,23+,30-/m0/s1	NVIVECQFGPXGHF-BURCIIJTSA-N	511851	(1R,3S,5S)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- (fluoromethyl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 163	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511851&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319103	459629103							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072474	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(O)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H35BrN8O4/c1-17-5-6-27(34)37-31(17)38-32(46)25-9-33(16-40-13-23(44)14-40)10-26(33)42(25)28(45)15-41-30-18(2)7-21(22-11-35-20(4)36-12-22)8-24(30)29(39-41)19(3)43/h5-8,11-12,23,25-26,44H,9-10,13-16H2,1-4H3,(H,37,38,46)/t25-,26+,33-/m0/s1	SLNFJVKUBJGKJZ-REYAJUCUSA-N	511852	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- hydroxyazetidin-1-yl)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 164	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511852&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318170	459629104							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072475	COCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(CNC(C)=O)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C32H33BrN8O5/c1-17(42)29-23-9-20(22-12-34-18(2)35-13-22)5-7-24(23)40(39-29)14-28(44)41-25(10-32(11-26(32)41)16-36-19(3)43)31(45)38-30-21(15-46-4)6-8-27(33)37-30/h5-9,12-13,25-26H,10-11,14-16H2,1-4H3,(H,36,43)(H,37,38,45)/t25-,26+,32-/m0/s1	XBCRFJKJCNGDQL-BKQYKDOASA-N	511853	(1R,3S,5R)-5-(acetamidomethyl)-2-(2-(3- acetyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- (methoxymethyl)pyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 165	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511853&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318156	459629105							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072476	COCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(CN(C)C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O4/c1-18(42)29-23-10-20(22-13-34-19(2)35-14-22)6-8-24(23)40(38-29)15-28(43)41-25(11-32(12-26(32)41)17-39(3)4)31(44)37-30-21(16-45-5)7-9-27(33)36-30/h6-10,13-14,25-26H,11-12,15-17H2,1-5H3,(H,36,37,44)/t25-,26+,32-/m0/s1	RPYOXMXZYXZZAA-BKQYKDOASA-N	511854	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- (methoxymethyl)pyridin-2-yl)-5- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 166	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511854&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318286	459629106							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072477	CN(C)Cc1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-17-7-8-26(33)36-30(17)37-31(44)24-11-32(4)12-25(32)41(24)27(43)16-40-29-21(15-39(5)6)9-20(22-13-34-19(3)35-14-22)10-23(29)28(38-40)18(2)42/h7-10,13-14,24-25H,11-12,15-16H2,1-6H3,(H,36,37,44)/t24-,25+,32-/m0/s1	AGVAHLZURVFPKC-UNTHUGQZSA-N	511855	(1R,3S,5R)-2-(2-(3-acetyl-7- ((dimethylamino)methyl)-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 167	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511855&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318829	459629107							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072478	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)C(F)(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30BrF3N8O4/c1-15-5-6-24(33)40-28(15)41-29(47)22-9-31(14-39-30(48)32(34,35)36)10-23(31)44(22)25(46)13-43-27-16(2)7-19(20-11-37-18(4)38-12-20)8-21(27)26(42-43)17(3)45/h5-8,11-12,22-23H,9-10,13-14H2,1-4H3,(H,39,48)(H,40,41,47)/t22-,23+,31-/m0/s1	CGIXSQAFRWOIGV-LWPQGVMLSA-N	511856	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((2,2,2-trifluoroacetamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 168	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511856&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318761	459629108							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072479	COCc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(COC)c12)-c1cnc(C)nc1	InChI=1S/C32H34BrN7O5/c1-17(41)28-23-9-20(22-12-34-18(2)35-13-22)8-21(16-45-5)29(23)39(38-28)14-27(42)40-24(10-32(3)11-25(32)40)31(43)37-30-19(15-44-4)6-7-26(33)36-30/h6-9,12-13,24-25H,10-11,14-16H2,1-5H3,(H,36,37,43)/t24-,25+,32-/m0/s1	SODJQYINXWYBLN-UNTHUGQZSA-N	511857	(1R,3S,5R)-2-(2-(3-acetyl-7- (methoxymethyl)-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- (methoxymethyl)pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 169	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511857&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153456580	459629109							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072480	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNCc3ccccc3F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C37H36BrFN8O3/c1-20-9-10-31(38)43-35(20)44-36(50)29-13-37(19-40-15-24-7-5-6-8-28(24)39)14-30(37)47(29)32(49)18-46-34-21(2)11-25(26-16-41-23(4)42-17-26)12-27(34)33(45-46)22(3)48/h5-12,16-17,29-30,40H,13-15,18-19H2,1-4H3,(H,43,44,50)/t29-,30+,37-/m0/s1	MNPTXDWESXVJSB-UKXUPQFXSA-N	511858	(1R,3S,5R)-2-(2-(3 acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(((2-fluorobenzyl)amino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 170	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511858&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317570	459629110							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072481	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNS(=O)(=O)CCC=C)C[C@H]2C(=O)Nc2nc(Br)ccc2C=C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H35BrN8O5S/c1-5-7-12-49(47,48)38-19-34-14-27(33(46)40-32-22(6-2)9-11-29(35)39-32)43(28(34)15-34)30(45)18-42-26-10-8-23(24-16-36-21(4)37-17-24)13-25(26)31(41-42)20(3)44/h5-6,8-11,13,16-17,27-28,38H,1-2,7,12,14-15,18-19H2,3-4H3,(H,39,40,46)/t27-,28+,34-/m0/s1	WKBNDCCAQUEXDZ-FPQPQGOJSA-N	511859	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-vinylpyridin-2-yl)-5- ((but-3-en-1-ylsulfonamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 171	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511859&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318309	459629111							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072482	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN8O3/c1-12-4-19(29)25(28)33-26(12)34-27(40)24-17-5-15(17)10-36(24)22(39)11-37-21-9-32-20(16-7-30-14(3)31-8-16)6-18(21)23(35-37)13(2)38/h4,6-9,15,17,24H,5,10-11H2,1-3H3,(H,33,34,40)/t15-,17-,24+/m1/s1	NMSRZSCRPOUXGM-NZEOALSQSA-N	511860	(1R,2S,5S)-3-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-azabicyclo[3.1.0]hexane-2- carboxamide::US11084800, Cpd No. 172	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511860&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420527	459629112							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072483	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)C(N)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN8O4/c1-14-5-6-23(31)35-27(14)36-28(42)21-9-30(29(32)43)10-22(30)39(21)24(41)13-38-26-15(2)7-18(19-11-33-17(4)34-12-19)8-20(26)25(37-38)16(3)40/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H2,32,43)(H,35,36,42)/t21-,22+,30+/m0/s1	JBHYTSPUPZKBOY-IABYTQIASA-N	511861	(1R,3S,5S)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N3-(6-bromo-3-methylpyridin-2- yl)-2-azabicyclo[3 .1.0]hexane-3,5- dicarboxamide::US11084800, Cpd No. 173	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511861&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317672	459629113							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072484	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)C#N)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H27BrN8O3/c1-15-5-6-24(31)35-28(15)36-29(42)22-9-30(14-32)10-23(30)39(22)25(41)13-38-27-16(2)7-19(20-11-33-18(4)34-12-20)8-21(27)26(37-38)17(3)40/h5-8,11-12,22-23H,9-10,13H2,1-4H3,(H,35,36,42)/t22-,23+,30-/m0/s1	PYJIHUHHESTKTP-BURCIIJTSA-N	511862	(1R,3S,5S)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-cyano-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 174	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511862&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319046	459629114							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072485	CC(=O)c1nn(CC(=O)N2C[C@H](C[C@H]2C(=O)Nc2nc(Br)ccc2C)C(F)(F)F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrF3N7O3/c1-14-5-6-23(30)36-27(14)37-28(43)22-9-20(29(31,32)33)12-39(22)24(42)13-40-26-15(2)7-18(19-10-34-17(4)35-11-19)8-21(26)25(38-40)16(3)41/h5-8,10-11,20,22H,9,12-13H2,1-4H3,(H,36,37,43)/t20-,22-/m0/s1	PHHISGNDJUYSAB-UNMCSNQZSA-N	511863	(2S,4S)-1-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- (trifluoromethyl)pyrrolidine-2-carboxamide::US11084800, Cpd No. 175	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511863&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318760	459629115							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072486	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN(CCF)CCF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrF2N8O3/c1-19-5-6-28(35)40-32(19)41-33(48)26-13-34(18-43(9-7-36)10-8-37)14-27(34)45(26)29(47)17-44-31-20(2)11-23(24-15-38-22(4)39-16-24)12-25(31)30(42-44)21(3)46/h5-6,11-12,15-16,26-27H,7-10,13-14,17-18H2,1-4H3,(H,40,41,48)/t26-,27+,34-/m0/s1	YPZZSKQAWMVYQA-MZXMJASYSA-N	511864	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((bis(2- fluoroethyl)amino)methyl)-N-(6-bromo-3- methylpyridin-2-hexane-3-carboxamide::US11084800, Cpd No. 176	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511864&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319334	459629116							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072487	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CC(F)(F)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H31BrF2N8O3/c1-17(44)28-22-8-19(21-11-36-18(2)37-12-21)4-6-23(22)42(40-28)14-27(45)43-24(9-31(3)10-25(31)43)30(46)39-29-20(5-7-26(33)38-29)13-41-15-32(34,35)16-41/h4-8,11-12,24-25H,9-10,13-16H2,1-3H3,(H,38,39,46)/t24-,25+,31-/m0/s1	IHHCZDSVUQKTCQ-NTWBYJAHSA-N	511865	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-((3,3- difluoroazetidin-1-yl)methyl)pyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 177	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511865&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318295	459629117							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072488	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O3/c1-14-7-20(31)26(30)34-27(14)35-28(41)22-9-29(4)10-23(29)38(22)24(40)13-37-21-6-5-17(18-11-32-16(3)33-12-18)8-19(21)25(36-37)15(2)39/h5-8,11-12,22-23H,9-10,13H2,1-4H3,(H,34,35,41)/t22-,23+,29-/m0/s1	MJAVEHPPIDFHMU-CTWZREHQSA-N	511866	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 178	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511866&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318326	459629118							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072489	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C(O)CF	InChI=1S/C31H31BrFN7O4/c1-15-5-6-25(32)36-29(15)37-30(44)22-9-31(4)10-24(31)40(22)26(43)14-39-28-20(23(42)11-33)7-18(19-12-34-17(3)35-13-19)8-21(28)27(38-39)16(2)41/h5-8,12-13,22-24,42H,9-11,14H2,1-4H3,(H,36,37,44)/t22-,23?,24+,31-/m0/s1	FOMWECUZBPQSFS-KYPDNYFVSA-N	511867	(1R,3S,5R)-2-(2-(3-acetyl-7-(2-fluoro-1- hydroxyethyl)-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 179::US11084800, Cpd No. 238	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511867&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158094525	459629119							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072490	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C31H29BrN8O3/c1-16-5-8-25(32)34-29(16)35-30(43)23-11-31(4)12-24(31)40(23)27(42)15-38-22-7-6-19(10-21(22)28(37-38)18(3)41)20-13-33-26-9-17(2)36-39(26)14-20/h5-10,13-14,23-24H,11-12,15H2,1-4H3,(H,34,35,43)/t23-,24+,31-/m0/s1	MCVQKYXKYCZPQG-JLELKNTQSA-N	511868	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrazolo[1,5-a]pyrimidin-6-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 180	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511868&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318168	459629120							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072491	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2ncc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-13-5-19(30)24(29)34-25(13)35-27(41)20-7-28(4)8-21(28)38(20)22(40)12-37-26-18(23(36-37)14(2)39)6-16(9-33-26)17-10-31-15(3)32-11-17/h5-6,9-11,20-21H,7-8,12H2,1-4H3,(H,34,35,41)/t20-,21+,28-/m0/s1	ZKPDPWXJJTYNDK-GTNJKRJXSA-N	511869	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- b]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 182	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511869&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422923	459629121							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072492	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ncc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrN8O3/c1-13-4-5-21(28)32-25(13)33-27(39)24-19-7-17(19)11-35(24)22(38)12-36-26-20(23(34-36)14(2)37)6-16(8-31-26)18-9-29-15(3)30-10-18/h4-6,8-10,17,19,24H,7,11-12H2,1-3H3,(H,32,33,39)/t17-,19-,24+/m1/s1	CIQIHOLGZKIOMJ-YJLYGGOZSA-N	511870	(1R,2S,5S)-3-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- b]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-3- azabicyclo[3.1.0]hexane-2-carboxamide::US11084800, Cpd No. 183	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511870&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420425	459629122							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072493	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(nc12)-c1cnc(C)nc1	InChI=1S/C28H27BrN8O3/c1-14-5-8-22(29)33-26(14)34-27(40)20-9-28(4)10-21(28)37(20)23(39)13-36-19-7-6-18(17-11-30-16(3)31-12-17)32-25(19)24(35-36)15(2)38/h5-8,11-12,20-21H,9-10,13H2,1-4H3,(H,33,34,40)/t20-,21+,28-/m0/s1	PIKVXHKELZXSFX-GTNJKRJXSA-N	511871	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[4,3- b]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 184	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511871&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318255	459629123							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072494	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2ccc(nc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-13-7-17(30)25(29)34-26(13)35-27(41)20-8-28(4)9-21(28)38(20)22(40)12-37-19-6-5-18(16-10-31-15(3)32-11-16)33-24(19)23(36-37)14(2)39/h5-7,10-11,20-21H,8-9,12H2,1-4H3,(H,34,35,41)/t20-,21+,28-/m0/s1	AWMBFWHROYJGJQ-GTNJKRJXSA-N	511872	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[4,3- b]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 185	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511872&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319033	459629124							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072495	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)cc(C)c2C(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrF2N7O3/c1-14-7-23(31)36-28(25(14)27(32)33)37-29(43)21-9-30(4)10-22(30)40(21)24(42)13-39-20-6-5-17(18-11-34-16(3)35-12-18)8-19(20)26(38-39)15(2)41/h5-8,11-12,21-22,27H,9-10,13H2,1-4H3,(H,36,37,43)/t21-,22+,30-/m0/s1	FPGGYLIGIGCTHO-ZQLNOWDWSA-N	511873	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-(difluoromethyl)-4- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 187	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511873&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318721	459629125							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072496	CN(C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C=C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)S(=O)(=O)CCC=C	InChI=1S/C35H37BrN8O5S/c1-6-8-13-50(48,49)42(5)20-35-15-28(34(47)40-33-23(7-2)10-12-30(36)39-33)44(29(35)16-35)31(46)19-43-27-11-9-24(25-17-37-22(4)38-18-25)14-26(27)32(41-43)21(3)45/h6-7,9-12,14,17-18,28-29H,1-2,8,13,15-16,19-20H2,3-5H3,(H,39,40,47)/t28-,29+,35-/m0/s1	BHYZNTAGOVJSBQ-AXJWHKOCSA-N	511874	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-vinylpyridin-2-yl)-5- (((N-methylbut-3-en-1- yl)sulfonamido)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 188	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511874&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420460	459629126							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072497	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(COCC=C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CCC=C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H38BrN7O4/c1-6-8-9-24-13-25(26-17-38-23(5)39-18-26)14-27-32(22(4)45)42-43(33(24)27)19-31(46)44-28(15-36(16-29(36)44)20-48-12-7-2)35(47)41-34-21(3)10-11-30(37)40-34/h6-7,10-11,13-14,17-18,28-29H,1-2,8-9,12,15-16,19-20H2,3-5H3,(H,40,41,47)/t28-,29+,36-/m0/s1	LCTANYJICLSULR-WEPHICOPSA-N	511875	(1R,3S,5S)-2-(2-(3-acetyl-7-(but-3-en-1-yl)-5- (2-methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-((allyloxy)methyl)-N-(6-bromo- 3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 189	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511875&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318238	459629127							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072498	CC(F)c1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C31H31BrFN7O3/c1-15-6-7-25(32)36-29(15)37-30(43)23-10-31(5)11-24(31)40(23)26(42)14-39-28-21(16(2)33)8-19(20-12-34-18(4)35-13-20)9-22(28)27(38-39)17(3)41/h6-9,12-13,16,23-24H,10-11,14H2,1-5H3,(H,36,37,43)/t16?,23-,24+,31-/m0/s1	VJUVOZNGULJKAJ-AAOMARRKSA-N	511876	(1R,3S,5R)-2-(2-(3-acetyl-7-(1-fluoroethyl)- 5-(2-methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 190	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511876&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			154031202	459629128							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072499	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCOCC2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34BrN9O4/c1-18(43)29-22-10-23(21-13-34-19(2)35-14-21)36-15-25(22)41(39-29)17-28(44)42-24(11-32(3)12-26(32)42)31(45)38-30-20(4-5-27(33)37-30)16-40-6-8-46-9-7-40/h4-5,10,13-15,24,26H,6-9,11-12,16-17H2,1-3H3,(H,37,38,45)/t24-,26+,32-/m0/s1	KYANKXPMGZXLPY-OSJZMRHLSA-N	511877	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- (morpholinomethyl)pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 192	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511877&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317890	459629129							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072500	COc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2cn1)C(C)=O	InChI=1S/C28H27BrN8O4/c1-14-5-6-22(29)33-25(14)34-26(40)19-8-28(3)9-21(28)37(19)23(39)13-36-20-12-30-18(7-17(20)24(35-36)15(2)38)16-10-31-27(41-4)32-11-16/h5-7,10-12,19,21H,8-9,13H2,1-4H3,(H,33,34,40)/t19-,21+,28-/m0/s1	NMMLWINHOZYCIK-AXTPWFNZSA-N	511878	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methoxypyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 193	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511878&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420583	459629130							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072501	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(N)nc1	InChI=1S/C27H26BrN9O3/c1-13-4-5-21(28)33-24(13)34-25(40)18-7-27(3)8-20(27)37(18)22(39)12-36-19-11-30-17(15-9-31-26(29)32-10-15)6-16(19)23(35-36)14(2)38/h4-6,9-11,18,20H,7-8,12H2,1-3H3,(H2,29,31,32)(H,33,34,40)/t18-,20+,27-/m0/s1	VDHJQAXYWIHBGT-SRLOGKKOSA-N	511879	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- aminopyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 194	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511879&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319109	459629131							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072502	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(N)nc1	InChI=1S/C27H25BrFN9O3/c1-12-4-16(29)23(28)34-24(12)35-25(41)18-6-27(3)7-20(27)38(18)21(40)11-37-19-10-31-17(14-8-32-26(30)33-9-14)5-15(19)22(36-37)13(2)39/h4-5,8-10,18,20H,6-7,11H2,1-3H3,(H2,30,32,33)(H,34,35,41)/t18-,20+,27-/m0/s1	VSHIUEZVKJAGGN-SRLOGKKOSA-N	511880	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- aminopyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 195	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511880&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317668	459629132							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072503	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(OC(F)(F)F)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28F3N7O4/c1-15-5-8-24(44-30(31,32)33)36-27(15)37-28(43)22-10-29(4)11-23(29)40(22)25(42)14-39-21-7-6-18(19-12-34-17(3)35-13-19)9-20(21)26(38-39)16(2)41/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,36,37,43)/t22-,23+,29-/m0/s1	URBSSZYCJJSUCN-CTWZREHQSA-N	511881	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(3-methyl-6- (trifluoromethoxy)pyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 196	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511881&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317885	459629133							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072504	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnco2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H27BrN8O4/c1-16-4-7-26(32)36-29(16)37-30(43)23-9-31(25-13-33-15-44-25)10-24(31)40(23)27(42)14-39-22-6-5-19(20-11-34-18(3)35-12-20)8-21(22)28(38-39)17(2)41/h4-8,11-13,15,23-24H,9-10,14H2,1-3H3,(H,36,37,43)/t23-,24+,31+/m0/s1	KAIMWQIPIOOMRA-BKZGZDJESA-N	511882	(1R,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-(oxazol-5-yl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 197	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511882&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317498	459629134							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072505	COc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)c(F)cc3C)c2cn1)C(C)=O	InChI=1S/C28H26BrFN8O4/c1-13-5-17(30)24(29)34-25(13)35-26(41)19-7-28(3)8-21(28)38(19)22(40)12-37-20-11-31-18(6-16(20)23(36-37)14(2)39)15-9-32-27(42-4)33-10-15/h5-6,9-11,19,21H,7-8,12H2,1-4H3,(H,34,35,41)/t19-,21+,28-/m0/s1	KXHCVJZIJKBGCF-AXTPWFNZSA-N	511883	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methoxypyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 198	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511883&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422870	459629135							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072506	Cc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)c(F)cc3C)c2cn1)C(N)=O	InChI=1S/C27H25BrFN9O3/c1-12-4-16(29)23(28)34-25(12)35-26(41)18-6-27(3)7-20(27)38(18)21(39)11-37-19-10-33-17(14-8-31-13(2)32-9-14)5-15(19)22(36-37)24(30)40/h4-5,8-10,18,20H,6-7,11H2,1-3H3,(H2,30,40)(H,34,35,41)/t18-,20+,27-/m0/s1	PLBPBHJKRXXBNO-SRLOGKKOSA-N	511884	1-(2-((1R,3S,5R)-3-((6-bromo-5-fluoro-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridine-3-carboxamide::US11084800, Cpd No. 199	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511884&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318337	459629136							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072507	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)[nH+]c1	InChI=1S/C28H27BrN8O3/c1-14-5-6-23(29)33-26(14)34-27(40)20-8-28(4)9-22(28)37(20)24(39)13-36-21-12-32-19(17-10-30-16(3)31-11-17)7-18(21)25(35-36)15(2)38/h5-7,10-12,20,22H,8-9,13H2,1-4H3,(H,33,34,40)/p+1/t20-,22+,28-/m0/s1	AGKIXYNCQISUOU-PGKWVRKKSA-O	511885	5-(3-acetyl-1-(2-((1R,3S,5R)-3-((6-bromo-3- methylpyridin-2-yl)carbamoyl)-5-methyl-2- azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1H- pyrazolo[3,4-c]pyridin-5-yl)-2- methylpyrimidine 1-oxide::US11084800, Cpd No. 200	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511885&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157107007	459629137							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072508	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cc(nn3)C3CC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H33BrN10O3/c1-18-4-9-29(35)38-32(18)39-33(48)27-11-34(17-43-15-25(40-42-43)21-5-6-21)12-28(34)45(27)30(47)16-44-26-8-7-22(23-13-36-20(3)37-14-23)10-24(26)31(41-44)19(2)46/h4,7-10,13-15,21,27-28H,5-6,11-12,16-17H2,1-3H3,(H,38,39,48)/t27-,28+,34-/m0/s1	YGNLYBQQZSMPET-FPQPQGOJSA-N	511886	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((4-cyclopropyl-1H-1,2,3-triazol-1- yl)methyl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 201	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511886&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161909630	459629138							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072509	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cc(nn3)[Si](C)(C)C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrN10O3Si/c1-19-7-10-28(35)38-32(19)39-33(48)26-12-34(18-43-16-29(40-42-43)49(4,5)6)13-27(34)45(26)30(47)17-44-25-9-8-22(23-14-36-21(3)37-15-23)11-24(25)31(41-44)20(2)46/h7-11,14-16,26-27H,12-13,17-18H2,1-6H3,(H,38,39,48)/t26-,27+,34-/m0/s1	QLDLKYFPCBHHAD-MZXMJASYSA-N	511887	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)- 5-((4-(trimethylsilyl)-1H-1,2,3-triazol-1- yl)methyl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 202	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511887&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160447730	459629139							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072510	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3ccnn3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrN10O3/c1-17-4-7-26(32)36-29(17)37-30(45)24-11-31(16-40-9-8-35-39-40)12-25(31)42(24)27(44)15-41-23-6-5-20(21-13-33-19(3)34-14-21)10-22(23)28(38-41)18(2)43/h4-10,13-14,24-25H,11-12,15-16H2,1-3H3,(H,36,37,45)/t24-,25+,31-/m0/s1	OQSHYAKJBLKXEQ-NTWBYJAHSA-N	511888	(1R,3S,5R)-5-((1H-1,2,3-triazol-1-yl)methyl)- 2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 203	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511888&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160071130	459629140							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072511	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CC3(COC3)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H35BrN8O4/c1-19(44)30-24-8-21(23-11-36-20(2)37-12-23)4-6-25(24)42(40-30)14-29(45)43-26(9-33(3)10-27(33)43)32(46)39-31-22(5-7-28(35)38-31)13-41-15-34(16-41)17-47-18-34/h4-8,11-12,26-27H,9-10,13-18H2,1-3H3,(H,38,39,46)/t26-,27+,33-/m0/s1	OFRFDDQQVICDKI-VCQOIINCSA-N	511889	(1R,3S,5R)-N-(3-(2-oxa-6- azaspiro[3.3]heptan-6-ylmethyl)-6- bromopyridin-acetyl-5-(2-methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 204	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511889&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533548	459629141							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072512	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-14-6-7-23(30)34-27(14)35-28(41)21-9-29(5)10-22(29)38(21)24(40)13-37-26-15(2)33-20(18-11-31-17(4)32-12-18)8-19(26)25(36-37)16(3)39/h6-8,11-12,21-22H,9-10,13H2,1-5H3,(H,34,35,41)/t21-,22+,29-/m0/s1	GACOHCQBGUVOEM-KERYWQKISA-N	511890	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 205	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511890&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158193974	459629142							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072513	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CN3C[C@@H]4CCC[C@@H]4C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C35H38BrN9O3/c1-19-7-8-30(36)40-33(19)41-34(48)27-10-35(18-43-15-22-5-4-6-23(22)16-43)11-29(35)45(27)31(47)17-44-28-14-39-26(24-12-37-21(3)38-13-24)9-25(28)32(42-44)20(2)46/h7-9,12-14,22-23,27,29H,4-6,10-11,15-18H2,1-3H3,(H,40,41,48)/t22-,23+,27-,29-,35+/m0/s1	CLLJFZPJLXFLDT-SLXNVZEUSA-N	511891	(1S,3S,5S)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-S-(((3aR,6a5)- hexahydrocyclopenta[c]pyrrol-2(1H)- yl)methyl)-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 206	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511891&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157615708	459629143							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072514	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CN3CC4(C3)CCCC4)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C35H38BrN9O3/c1-20-6-7-29(36)40-32(20)41-33(48)26-11-35(19-43-17-34(18-43)8-4-5-9-34)12-28(35)45(26)30(47)16-44-27-15-39-25(23-13-37-22(3)38-14-23)10-24(27)31(42-44)21(2)46/h6-7,10,13-15,26,28H,4-5,8-9,11-12,16-19H2,1-3H3,(H,40,41,48)/t26-,28-,35+/m0/s1	KHCAEBPJGFOJIR-DZSWEVNLSA-N	511892	(1S,3S,5S)-5-((2-azaspiro[3.4]octan-2- yl)methyl)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2-::US11084800, Cpd No. 207	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511892&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159132619	459629144							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072515	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(OC2COC2)nc1	InChI=1S/C32H32BrN7O5/c1-16-5-6-25(33)36-29(16)37-30(43)23-9-32(4)10-24(32)40(23)26(42)13-39-28-17(2)7-19(8-22(28)27(38-39)18(3)41)20-11-34-31(35-12-20)45-21-14-44-15-21/h5-8,11-12,21,23-24H,9-10,13-15H2,1-4H3,(H,36,37,43)/t23-,24+,32-/m0/s1	BAAXAYJGTXFUGT-XNSHOJTPSA-N	511893	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- (oxetan-3-yloxy)pyrimidin-5-yl)-1H-indazol- 1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2- yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3- carboxamide::US11084800, Cpd No. 208	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511893&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319016	459629145							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072516	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrFN8O3/c1-13-6-19(31)26(30)35-27(13)36-28(42)21-8-29(5)9-22(29)39(21)23(41)12-38-25-14(2)34-20(17-10-32-16(4)33-11-17)7-18(25)24(37-38)15(3)40/h6-7,10-11,21-22H,8-9,12H2,1-5H3,(H,35,36,42)/t21-,22+,29-/m0/s1	NDQFQNJHVXNEFN-KERYWQKISA-N	511894	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-N-(6-bromo-5-fluoro-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 209	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511894&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137462271	459629146							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072517	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(nc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-14-6-7-22(30)34-27(14)35-28(41)20-9-29(5)10-21(29)38(20)23(40)13-37-26-15(2)8-19(18-11-31-17(4)32-12-18)33-25(26)24(36-37)16(3)39/h6-8,11-12,20-21H,9-10,13H2,1-5H3,(H,34,35,41)/t20-,21+,29-/m0/s1	ULQCBGLPVXXHOG-FONBTEPMSA-N	511895	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-pyrazolo[4,3- b]pyridin-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 210	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511895&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161126555	459629147							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072518	NC(=O)c1cc(-c2cccnc2)n(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)n1	InChI=1S/C21H19BrFN7O3/c22-17-4-1-5-18(26-17)27-21(33)16-7-13(23)10-29(16)19(31)11-30-15(8-14(28-30)20(24)32)12-3-2-6-25-9-12/h1-6,8-9,13,16H,7,10-11H2,(H2,24,32)(H,26,27,33)/t13-,16+/m1/s1	MRQLSSZUMWTNJA-CJNGLKHVSA-N	511896	1-(2-((2S,4R)-2-((6-bromopyridin-2- yl)carbamoyl)-4-fluoropyrrolidin-1-yl)-2- oxoethyl)-5-(pyridin-3-yl)-1H-pyrazole-3- carboxamide::US11084800, Cpd No. 211	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511896&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318910	459629148							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072519	Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(cc1-c1ccco1)C(N)=O	InChI=1S/C23H23BrN6O4/c1-12-5-6-18(24)26-21(12)27-22(33)15-9-23(2)10-17(23)30(15)19(31)11-29-14(16-4-3-7-34-16)8-13(28-29)20(25)32/h3-8,15,17H,9-11H2,1-2H3,(H2,25,32)(H,26,27,33)/t15-,17+,23-/m0/s1	URFLAWAVLAZXIU-JCEJCQQGSA-N	511897	(1R,3S,5R)-N-(6-bromo-3-methylpyridin-2- yl)-2-(2-(3-carbamoyl-5-(furan-2-yl)-1H- pyrazol-1-yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 212	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511897&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317481	459629149							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072520	Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(cc1C(N)=O)-c1ccco1	InChI=1S/C23H23BrN6O4/c1-12-5-6-18(24)26-21(12)27-22(33)15-9-23(2)10-17(23)30(15)19(31)11-29-14(20(25)32)8-13(28-29)16-4-3-7-34-16/h3-8,15,17H,9-11H2,1-2H3,(H2,25,32)(H,26,27,33)/t15-,17+,23-/m0/s1	QRINMUYLQNELSM-JCEJCQQGSA-N	511898	(1R,3S,5R)-N-(6-bromo-3-methylpyridin-2- yl)-2-(2-(5-carbamoyl-3-(furan-2-yl)-1H- pyrazol-1-yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 213	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511898&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318750	459629150							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072521	Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(cc1-c1cccs1)C(N)=O	InChI=1S/C23H23BrN6O3S/c1-12-5-6-18(24)26-21(12)27-22(33)15-9-23(2)10-17(23)30(15)19(31)11-29-14(16-4-3-7-34-16)8-13(28-29)20(25)32/h3-8,15,17H,9-11H2,1-2H3,(H2,25,32)(H,26,27,33)/t15-,17+,23-/m0/s1	XWBIJBCXIIJTRM-JCEJCQQGSA-N	511899	(1R,3S,5R)-N-(6-bromo-3-methylpyridin-2- yl)-2-(2-(3-carbamoyl-5-(thiophen-2-yl)-1H- pyrazol-1-yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 214	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511899&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318895	459629151							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072522	Cc1ncc(cn1)-c1cc(nn1CC(=O)N1C[C@H](F)C[C@H]1C(=O)Nc1cccc(Br)n1)C(N)=O	InChI=1S/C21H20BrFN8O3/c1-11-25-7-12(8-26-11)15-6-14(20(24)33)29-31(15)10-19(32)30-9-13(23)5-16(30)21(34)28-18-4-2-3-17(22)27-18/h2-4,6-8,13,16H,5,9-10H2,1H3,(H2,24,33)(H,27,28,34)/t13-,16+/m1/s1	BPIKHFREDGQFBK-CJNGLKHVSA-N	511900	1-(2-((2S,4R)-2-((6-bromopyridin-2- yl)carbamoyl)-4-fluoropyrrolidin-1-yl)-2- oxoethyl)-5-(2-methylpyrimidin-5-yl)-1H- pyrazole-3-carboxamide::US11084800, Cpd No. 215	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511900&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317671	459629152							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072523	Cc1ncc(cn1)-c1cc(C(N)=O)n(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)n1	InChI=1S/C21H20BrFN8O3/c1-11-25-7-12(8-26-11)14-6-15(20(24)33)31(29-14)10-19(32)30-9-13(23)5-16(30)21(34)28-18-4-2-3-17(22)27-18/h2-4,6-8,13,16H,5,9-10H2,1H3,(H2,24,33)(H,27,28,34)/t13-,16+/m1/s1	UVIOOBAKEJVGMG-CJNGLKHVSA-N	511901	1-(2-((2S,4R)-2-((6-bromopyridin-2- yl)carbamoyl)-4-fluoropyrrolidin-1-yl)-2- oxoethyl)-3-(2-methylpyrimidin-5-yl)-1H- pyrazole-5-carboxamide::US11084800, Cpd No. 216	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511901&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161203886	459629153							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072524	CC(=O)c1n(CC(=O)N2[C@@H]3C[C@]3(C)CC2C(=O)Nc2nc(Br)ccc2C)nc2c(cc(cc12)-c1cnc(C)nc1)C(F)(F)F	InChI=1S/C30H27BrF3N7O3/c1-14-5-6-23(31)37-27(14)38-28(44)21-9-29(4)10-22(29)41(21)24(43)13-40-26(15(2)42)19-7-17(18-11-35-16(3)36-12-18)8-20(25(19)39-40)30(32,33)34/h5-8,11-12,21-22H,9-10,13H2,1-4H3,(H,37,38,44)/t21?,22-,29+/m1/s1	CEPGJAHFKGGCTD-LIMXNJOHSA-N	511902	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrimidin-5-yl)-7-(trifluoromethyl)- 2H-indazol-2-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 217	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511902&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157556018	459629154							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072525	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H28BrN9O3/c1-15-5-6-24(31)34-28(15)35-29(43)21-9-30(4)10-23(30)40(21)26(42)14-38-22-12-32-20(8-19(22)27(37-38)17(3)41)18-11-33-25-7-16(2)36-39(25)13-18/h5-8,11-13,21,23H,9-10,14H2,1-4H3,(H,34,35,43)/t21-,23+,30-/m0/s1	LZJSMEAFAKOQTD-AZMCGESQSA-N	511903	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrazolo[1,5-a]pyrimidin-6-yl)-1H- pyrazolo[3,4-c]pyridin-1-yl)acetyl)-N-(6- bromo-3-methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 219::US11084800, Cpd No. 617	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511903&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159501011	459629155							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072526	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-14-4-5-23(29)34-26(14)35-27(41)20-7-28(13-30)8-22(28)38(20)24(40)12-37-21-11-33-19(17-9-31-16(3)32-10-17)6-18(21)25(36-37)15(2)39/h4-6,9-11,20,22H,7-8,12-13H2,1-3H3,(H,34,35,41)/t20-,22-,28+/m0/s1	CENYYYSLQPGQNQ-IKSSWHGMSA-N	511904	(1S,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (fluoromethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 235	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511904&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157555596	459629156							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072527	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C(F)CF	InChI=1S/C31H30BrF2N7O3/c1-15-5-6-25(32)37-29(15)38-30(44)23-9-31(4)10-24(31)41(23)26(43)14-40-28-20(22(34)11-33)7-18(19-12-35-17(3)36-13-19)8-21(28)27(39-40)16(2)42/h5-8,12-13,22-24H,9-11,14H2,1-4H3,(H,37,38,44)/t22?,23-,24+,31-/m0/s1	CWYQYHQFLBAEDC-UOMJZUGYSA-N	511905	(1R,3S,5R)-2-(2-(3- acetyl-7-(1,2- difluoroethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 237	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511905&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157716538	459629157							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072528	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)C(O)CF	InChI=1S/C31H31BrFN7O4/c1-15-5-6-25(32)36-29(15)37-30(44)22-9-31(4)10-24(31)40(22)26(43)14-39-28-20(23(42)11-33)7-18(19-12-34-17(3)35-13-19)8-21(28)27(38-39)16(2)41/h5-8,12-13,22-24,42H,9-11,14H2,1-4H3,(H,36,37,44)/t22-,23?,24+,31-/m0/s1	FOMWECUZBPQSFS-KYPDNYFVSA-N	511867	(1R,3S,5R)-2-(2-(3-acetyl-7-(2-fluoro-1- hydroxyethyl)-5-(2-methylpyrimidin-5-yl)- 1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 179::US11084800, Cpd No. 238	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511867&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158094525	459629119							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072529	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CC#N)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26BrN9O3/c1-15-4-5-24(30)35-27(15)36-28(42)21-9-29(6-7-31)10-23(29)39(21)25(41)14-38-22-13-34-20(18-11-32-17(3)33-12-18)8-19(22)26(37-38)16(2)40/h4-5,8,11-13,21,23H,6,9-10,14H2,1-3H3,(H,35,36,42)/t21-,23-,29+/m0/s1	HTCXRCWYYZWFOY-HKLKAILGSA-N	511907	(1S,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (cyanomethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 239	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511907&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158579941	459629158							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072530	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(CC#N)C[C@@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26BrN9O3/c1-15-4-5-24(30)35-27(15)36-28(42)21-9-29(6-7-31)10-23(29)39(21)25(41)14-38-22-13-34-20(18-11-32-17(3)33-12-18)8-19(22)26(37-38)16(2)40/h4-5,8,11-13,21,23H,6,9-10,14H2,1-3H3,(H,35,36,42)/t21-,23+,29-/m1/s1	HTCXRCWYYZWFOY-XZFDQLJLSA-N	511908	(1S,3R,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (cyanomethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 240	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511908&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158579943	459629159							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072531	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27BrN8O3/c1-13-5-6-22(29)33-27(13)34-28(40)26-19-7-17(19)11-36(26)23(39)12-37-25-14(2)32-21(18-9-30-16(4)31-10-18)8-20(25)24(35-37)15(3)38/h5-6,8-10,17,19,26H,7,11-12H2,1-4H3,(H,33,34,40)/t17-,19-,26+/m1/s1	SHOBNLCFMBRYFT-AZZGJVAJSA-N	511909	(1R,2S,5S)-3-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-3- azabicyclo[3.1.0]hexane- 2-carboxamide::US11084800, Cpd No. 241	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511909&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160837174	459629160							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072532	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3C[C@@H]4CCC[C@@H]4C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C35H38BrN9O3/c1-19-7-8-30(36)40-33(19)41-34(48)27-10-35(18-43-15-22-5-4-6-23(22)16-43)11-29(35)45(27)31(47)17-44-28-14-39-26(24-12-37-21(3)38-13-24)9-25(28)32(42-44)20(2)46/h7-9,12-14,22-23,27,29H,4-6,10-11,15-18H2,1-3H3,(H,40,41,48)/t22-,23+,27-,29+,35-/m0/s1	CLLJFZPJLXFLDT-RRHWXWFRSA-N	511910	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (((3aR,6a5)- hexahydrocyclopenta [c]pyrrol-2(1H)- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 245	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511910&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157615707	459629161							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072533	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(C3)CCCC4)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C35H38BrN9O3/c1-20-6-7-29(36)40-32(20)41-33(48)26-11-35(19-43-17-34(18-43)8-4-5-9-34)12-28(35)45(26)30(47)16-44-27-15-39-25(23-13-37-22(3)38-14-23)10-24(27)31(42-44)21(2)46/h6-7,10,13-15,26,28H,4-5,8-9,11-12,16-19H2,1-3H3,(H,40,41,48)/t26-,28+,35-/m0/s1	KHCAEBPJGFOJIR-SQCCVTMQSA-N	511911	(1R,3S,5R)-5-(2- azaspiro[3.4]octan-2- ylmethyl)-2-(2-(3-  acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 246	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511911&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159132620	459629162							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072534	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cc(nn3)C3CC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN11O3/c1-17-4-7-28(34)38-31(17)39-32(48)25-9-33(16-43-14-24(40-42-43)20-5-6-20)10-27(33)45(25)29(47)15-44-26-13-37-23(21-11-35-19(3)36-12-21)8-22(26)30(41-44)18(2)46/h4,7-8,11-14,20,25,27H,5-6,9-10,15-16H2,1-3H3,(H,38,39,48)/t25-,27+,33-/m0/s1	HFEYOXMLYMTDQS-PHZRBTHJSA-N	511912	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-  methylpyridin-2-yl)-5- ((4-cyclopropyl-1H- 1,2,3-triazol-1- yl)methyl)-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 247	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511912&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533549	459629163							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072535	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN(CCO)CCO)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C32H35BrFN9O5/c1-17-8-22(34)29(33)38-30(17)39-31(48)24-10-32(16-41(4-6-44)5-7-45)11-26(32)43(24)27(47)15-42-25-14-37-23(20-12-35-19(3)36-13-20)9-21(25)28(40-42)18(2)46/h8-9,12-14,24,26,44-45H,4-7,10-11,15-16H2,1-3H3,(H,38,39,48)/t24-,26+,32-/m0/s1	XNAQPAVRZMSUGY-OSJZMRHLSA-N	511913	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-((bis(2- hydroxyethyl)amino) methyl)-N-(6-bromo- 5-fluoro-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 248	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511913&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161756336	459629164							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072536	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CC#N)CC2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H25BrFN9O3/c1-14-6-19(31)26(30)36-27(14)37-28(43)21-8-29(4-5-32)9-23(29)40(21)24(42)13-39-22-12-35-20(17-10-33-16(3)34-11-17)7-18(22)25(38-39)15(2)41/h6-7,10-12,21,23H,4,8-9,13H2,1-3H3,(H,36,37,43)/t21?,23-,29+/m1/s1	FKHKPQIXIOQZRS-DGJQCNORSA-N	511914	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-(cyanomethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 249	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511914&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158057961	459629165							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072537	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(F)(F)C3)CC2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrF3N9O3/c1-15-4-20(33)27(32)39-28(15)40-29(47)22-6-30(12-42-13-31(34,35)14-42)7-24(30)44(22)25(46)11-43-23-10-38-21(18-8-36-17(3)37-9-18)5-19(23)26(41-43)16(2)45/h4-5,8-10,22,24H,6-7,11-14H2,1-3H3,(H,39,40,47)/t22?,24-,30+/m1/s1	OXSCSAWHNFFDHU-FUGJBEEWSA-N	511915	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-((3,3- difluoroazetidin-1- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxomide::US11084800, Cpd No. 250	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511915&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160128216	459629166							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072538	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CF)CC2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25BrF2N8O3/c1-13-4-18(31)25(29)35-26(13)36-27(42)20-6-28(12-30)7-22(28)39(20)23(41)11-38-21-10-34-19(16-8-32-15(3)33-9-16)5-17(21)24(37-38)14(2)40/h4-5,8-10,20,22H,6-7,11-12H2,1-3H3,(H,35,36,42)/t20?,22-,28+/m1/s1	OMHAWZLUKLWDON-WEVBPGBPSA-N	511916	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-(fluoromethyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 251	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511916&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160034597	459629167							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072539	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(C3)CCCC4)CC2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrFN9O3/c1-19-8-24(37)31(36)41-32(19)42-33(49)26-10-35(18-44-16-34(17-44)6-4-5-7-34)11-28(35)46(26)29(48)15-45-27-14-40-25(22-12-38-21(3)39-13-22)9-23(27)30(43-45)20(2)47/h8-9,12-14,26,28H,4-7,10-11,15-18H2,1-3H3,(H,41,42,49)/t26?,28-,35+/m1/s1	RILAWWXNPQFGNA-GLJQAPPBSA-N	511917	(1R,3S,5R)-5-(2- azaspirp[3.4]octan-2- ylmethyl)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazole[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxomide::US11084800, Cpd No. 252	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511917&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160635121	459629168							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072540	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3C[C@@H]4CCC[C@@H]4C3)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrFN9O3/c1-18-7-25(37)32(36)41-33(18)42-34(49)27-9-35(17-44-14-21-5-4-6-22(21)15-44)10-29(35)46(27)30(48)16-45-28-13-40-26(23-11-38-20(3)39-12-23)8-24(28)31(43-45)19(2)47/h7-8,11-13,21-22,27,29H,4-6,9-10,14-17H2,1-3H3,(H,41,42,49)/t21-,22+,27-,29+,35-/m0/s1	MHKZJNDQXPJHJI-ARJMASQASA-N	511918	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-(((3aR,6aS)- hexahydrocyclopenta [c]pyrrol-2(1H)- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 253	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511918&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159567917	459629169							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072541	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2cnc(cc12)-c1cnc(C)[n+]([O-])c1	InChI=1S/C28H26BrFN8O4/c1-13-5-18(30)25(29)33-26(13)34-27(41)20-7-28(4)8-22(28)38(20)23(40)12-36-21-10-32-19(6-17(21)24(35-36)14(2)39)16-9-31-15(3)37(42)11-16/h5-6,9-11,20,22H,7-8,12H2,1-4H3,(H,33,34,41)/t20-,22+,28-/m0/s1	UOYFOBIZEIFNLX-PGKWVRKKSA-N	511919	5-(3-acetyl-1-(2- ((1R,3S,5R)-3-((6- bromo-5-fluoro-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 2-yl)-2-oxoethyl)- 1H-pyrazolo[3,4- c]pyridin-5-yl)-2- methylpyrimidine 1- oxide::US11084800, Cpd No. 254	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511919&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161153134	459629170							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072542	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2COCCF)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrFN8O4/c1-16(41)27-20-8-21(19-11-33-17(2)34-12-19)35-13-23(20)39(38-27)14-26(42)40-22(9-30(3)10-24(30)40)29(43)37-28-18(15-44-7-6-32)4-5-25(31)36-28/h4-5,8,11-13,22,24H,6-7,9-10,14-15H2,1-3H3,(H,36,37,43)/t22-,24+,30-/m0/s1	JVBUVGHUSFBTKP-RVVHDCIOSA-N	511920	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-((2- fluoroethoxy)methyl) pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 255	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511920&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533550	459629171							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072543	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(OC(F)(F)F)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27F3N8O4/c1-14-5-6-23(44-29(30,31)32)36-26(14)37-27(43)20-8-28(4)9-22(28)40(20)24(42)13-39-21-12-35-19(17-10-33-16(3)34-11-17)7-18(21)25(38-39)15(2)41/h5-7,10-12,20,22H,8-9,13H2,1-4H3,(H,36,37,43)/t20-,22+,28-/m0/s1	RAQRYYDIUNXWNE-PGKWVRKKSA-N	511921	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-methyl-N-(3- methyl-6- (trifluoromethoxy) pyrimidin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 256	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511921&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533551	459629172							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072544	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1)C(F)=C(C)C	InChI=1S/C28H32FN7O3/c1-14(2)25(29)15(3)33-27(39)21-8-28(6)9-23(28)36(21)24(38)13-35-22-12-32-20(18-10-30-17(5)31-11-18)7-19(22)26(34-35)16(4)37/h7,10-12,15,21,23H,8-9,13H2,1-6H3,(H,33,39)/t15-,21-,23+,28-/m0/s1	XBCACFLGCWBRND-HFJBZXMUSA-N	511922	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-((S)-3-fluoro-4- methylpent-3-en-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 257	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511922	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511922&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420519	459629173							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072545	CC(C)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-16(2)8-19-6-7-26(32)36-29(19)37-30(43)23-10-31(5)11-25(31)40(23)27(42)15-39-24-14-35-22(20-12-33-18(4)34-13-20)9-21(24)28(38-39)17(3)41/h6-7,9,12-14,16,23,25H,8,10-11,15H2,1-5H3,(H,36,37,43)/t23-,25+,31-/m0/s1	YTQRVQJJJAKLBO-QXTPGCHQSA-N	511923	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- isobutylpyridin-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 258	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511923	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511923&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162012465	459629174							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072546	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1)[C@H]1CC1(Cl)Cl	InChI=1S/C27H29Cl2N7O3/c1-13(18-6-27(18,28)29)33-25(39)20-7-26(4)8-22(26)36(20)23(38)12-35-21-11-32-19(16-9-30-15(3)31-10-16)5-17(21)24(34-35)14(2)37/h5,9-11,13,18,20,22H,6-8,12H2,1-4H3,(H,33,39)/t13-,18-,20+,22-,26+/m1/s1	XHWACCGUFLMWTC-ZIUKDBIMSA-N	511924	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-((R)-1-((R)-2,2- dichlorocyclopropyl) ethyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 259	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511924&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161715367	459629175							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072547	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-14-4-5-23(29)34-26(14)35-27(41)20-7-28(13-30)8-22(28)38(20)24(40)12-37-21-11-33-19(17-9-31-16(3)32-10-17)6-18(21)25(36-37)15(2)39/h4-6,9-11,20,22H,7-8,12-13H2,1-3H3,(H,34,35,41)/t20-,22+,28-/m0/s1	CENYYYSLQPGQNQ-PGKWVRKKSA-N	511925	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (fluoromethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 260	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511925&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157555597	459629176							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072548	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(F)(F)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C31H30BrF2N9O3/c1-16-4-5-25(32)38-28(16)39-29(46)22-7-30(13-41-14-31(33,34)15-41)8-24(30)43(22)26(45)12-42-23-11-37-21(19-9-35-18(3)36-10-19)6-20(23)27(40-42)17(2)44/h4-6,9-11,22,24H,7-8,12-15H2,1-3H3,(H,38,39,46)/t22-,24+,30-/m0/s1	CNXPGPAQJVNFNK-RVVHDCIOSA-N	511926	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((3,3-difluoroazetidin- 1-yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 261	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511926&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157637225	459629177							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072549	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN(CCO)CCO)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C32H36BrN9O5/c1-18-4-5-27(33)37-30(18)38-31(47)24-11-32(17-40(6-8-43)7-9-44)12-26(32)42(24)28(46)16-41-25-15-36-23(21-13-34-20(3)35-14-21)10-22(25)29(39-41)19(2)45/h4-5,10,13-15,24,26,43-44H,6-9,11-12,16-17H2,1-3H3,(H,37,38,47)/t24-,26+,32-/m0/s1	SXWWKBZPSLLXSP-OSJZMRHLSA-N	511927	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-((bis(2- hydroxyethyl)amino) methyl)-N-(6-bromo- 3-methylpyridin-2-yl)- 2-azabicyclo[3.1.0] hexane-3-carboxamide::US11084800, Cpd No. 262	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511927&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160968130	459629178							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072550	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)c(F)cc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H34BrFN8O3/c1-16-7-20(21-12-35-19(4)36-13-21)9-22-27(18(3)43)39-41(28(16)22)14-26(44)42-24(10-32(11-25(32)42)15-40(5)6)31(45)38-30-17(2)8-23(34)29(33)37-30/h7-9,12-13,24-25H,10-11,14-15H2,1-6H3,(H,37,38,45)/t24-,25+,32-/m0/s1	WPLYIOJIIRGGGZ-UNTHUGQZSA-N	511929	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6-  bromo-5-fluoro-3- methylpyridin-2-yl)-5- ((dimethylamino) methyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US11084800, Cpd No. 263	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511929&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161569763	459629180							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072551	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)c(F)cc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C30H31BrFN9O3/c1-15-6-20(32)27(31)36-28(15)37-29(44)22-8-30(14-39(4)5)9-24(30)41(22)25(43)13-40-23-12-35-21(18-10-33-17(3)34-11-18)7-19(23)26(38-40)16(2)42/h6-7,10-12,22,24H,8-9,13-14H2,1-5H3,(H,36,37,44)/t22-,24+,30-/m0/s1	AMEMYKMWWNSHNL-RVVHDCIOSA-N	511930	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)-5- ((dimethylamino)methyl)- 2-azabicyclo[3.1.0]  hexane-3-carboxamide::US11084800, Cpd No. 264	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511930&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146436038	459629181							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072552	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCc3ccccc3C2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C37H36BrN9O3/c1-21(48)34-27-12-28(26-15-39-22(2)40-16-26)41-17-30(27)46(44-34)20-33(49)47-29(13-37(3)14-31(37)47)36(50)43-35-25(8-9-32(38)42-35)19-45-11-10-23-6-4-5-7-24(23)18-45/h4-9,12,15-17,29,31H,10-11,13-14,18-20H2,1-3H3,(H,42,43,50)/t29-,31+,37-/m0/s1	MHLOMEGIMUNYHV-ITODGKAWSA-N	511931	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-((3,4- dihydroisoquinolin- 2(1H)- yl)methyl)pyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 265	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511931&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159568098	459629182							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072553	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(nc(cc12)-c1cnc(C)nc1)C(F)(F)F	InChI=1S/C29H26BrF3N8O3/c1-13-5-6-21(30)37-26(13)38-27(44)19-8-28(4)9-20(28)41(19)22(43)12-40-24-17(23(39-40)14(2)42)7-18(36-25(24)29(31,32)33)16-10-34-15(3)35-11-16/h5-7,10-11,19-20H,8-9,12H2,1-4H3,(H,37,38,44)/t19-,20+,28-/m0/s1	MUTLTUAQRCEMNB-BCDQWZCSSA-N	511932	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-7- (trifluoromethyl)-1H- pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5-  methyl-2-  azabicyclo[3.1.0] hexane-3-carboxamide::US11084800, Cpd No. 269	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511932&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159677296	459629183							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072554	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(O)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C31H32BrN9O4/c1-16-4-5-26(32)36-29(16)37-30(45)23-7-31(15-39-12-20(43)13-39)8-25(31)41(23)27(44)14-40-24-11-35-22(19-9-33-18(3)34-10-19)6-21(24)28(38-40)17(2)42/h4-6,9-11,20,23,25,43H,7-8,12-15H2,1-3H3,(H,36,37,45)/t23-,25+,31-/m0/s1	YWOYUSKSLOTYGF-QXTPGCHQSA-N	511933	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((3-hydroxyazetidin-1- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 270	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511933&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162035494	459629184							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072555	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(nc(cc12)-c1cnc(C)nc1)C(F)(F)F	InChI=1S/C29H25BrF4N8O3/c1-12-5-17(31)25(30)38-26(12)39-27(45)19-7-28(4)8-20(28)42(19)21(44)11-41-23-16(22(40-41)13(2)43)6-18(37-24(23)29(32,33)34)15-9-35-14(3)36-10-15/h5-6,9-10,19-20H,7-8,11H2,1-4H3,(H,38,39,45)/t19-,20+,28-/m0/s1	YGRKHLVSGDAQCK-BCDQWZCSSA-N	511934	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-7- (trifluoromethyl)-1H-  pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 271	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511934	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511934&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161910801	459629185							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072556	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)\C=N\O)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrN9O4/c1-14-4-5-23(29)34-26(14)35-27(41)20-7-28(13-33-42)8-22(28)38(20)24(40)12-37-21-11-32-19(17-9-30-16(3)31-10-17)6-18(21)25(36-37)15(2)39/h4-6,9-11,13,20,22,42H,7-8,12H2,1-3H3,(H,34,35,41)/b33-13+/t20-,22+,28-/m0/s1	WUNYPEPYBZJJQH-QORDIAENSA-N	511935	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- N-(6-bromo-3 - methylpyridin-2-yl)-5- ((E)- (hydroxyimino)methyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US11084800, Cpd No. 272	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511935	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511935&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162459712	459629186					C02658		1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072557	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)C#N)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H24BrN9O3/c1-14-4-5-23(29)34-26(14)35-27(41)20-7-28(13-30)8-22(28)38(20)24(40)12-37-21-11-33-19(17-9-31-16(3)32-10-17)6-18(21)25(36-37)15(2)39/h4-6,9-11,20,22H,7-8,12H2,1-3H3,(H,34,35,41)/t20-,22+,28-/m0/s1	XEFQOMKIFSRBBM-PGKWVRKKSA-N	511936	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- cyano-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 273	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511936&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161686387	459629187							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072558	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CC#N)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26BrN9O3/c1-15-4-5-24(30)35-27(15)36-28(42)21-9-29(6-7-31)10-23(29)39(21)25(41)14-38-22-13-34-20(18-11-32-17(3)33-12-18)8-19(22)26(37-38)16(2)40/h4-5,8,11-13,21,23H,6,9-10,14H2,1-3H3,(H,35,36,42)/t21-,23+,29-/m0/s1	HTCXRCWYYZWFOY-IXQRDTAUSA-N	511937	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (cyanomethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 274	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511937&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158579942	459629188							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072559	COc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2c(C)n1)C(C)=O	InChI=1S/C29H29BrN8O4/c1-14-6-7-22(30)34-26(14)35-27(41)20-9-29(4)10-21(29)38(20)23(40)13-37-25-15(2)33-19(8-18(25)24(36-37)16(3)39)17-11-31-28(42-5)32-12-17/h6-8,11-12,20-21H,9-10,13H2,1-5H3,(H,34,35,41)/t20-,21+,29-/m0/s1	UTKSNLGDNHOGLG-FONBTEPMSA-N	511938	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methoxypyrimidin-5- yl)-7-methyl-1H- pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0] hexane-3-carboxamide::US11084800, Cpd No. 275	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511938&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161188671	459629189							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072560	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CC3CC2CO3)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C33H34BrN9O4/c1-17(44)30-23-7-24(20-10-35-18(2)36-11-20)37-12-26(23)42(40-30)15-29(45)43-25(8-33(3)9-27(33)43)32(46)39-31-19(4-5-28(34)38-31)13-41-14-22-6-21(41)16-47-22/h4-5,7,10-12,21-22,25,27H,6,8-9,13-16H2,1-3H3,(H,38,39,46)/t21?,22?,25-,27+,33-/m0/s1	AAFTWIDFAGNTQN-VLTVPXDNSA-N	511939	(1R,3S,5R)-N-(3-(2- oxa-5- azabicyclo[2.2.1]heptan- 5-ylmethyl)-6- bromopyridin-2-yl)-2- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- 5-methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 277	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511939&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157051278	459629190							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072561	COCc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1	InChI=1S/C30H30BrN7O4/c1-16-5-8-24(31)34-28(16)35-29(41)22-10-30(3)11-23(30)38(22)26(40)14-37-21-7-6-18(9-20(21)27(36-37)17(2)39)19-12-32-25(15-42-4)33-13-19/h5-9,12-13,22-23H,10-11,14-15H2,1-4H3,(H,34,35,41)/t22-,23+,30-/m0/s1	CEUPCMBLLBKBLS-BURCIIJTSA-N	511940	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- (methoxymethyl)pyrimidin- 5-yl)-1H- indazol-1-yl)acetyl)-  N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 278	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511940&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157557853	459629191							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072562	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23+,29-/m0/s1	OCXAGXCMZACNEC-CTWZREHQSA-N	386545	(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10287301, Compound 485::US10822352, Comp No. 485::US11084800, Cpd No. 279	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386545&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126642840	404855695							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072563	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23-,29+/m0/s1	OCXAGXCMZACNEC-SBZVUBOMSA-N	511942	(1S,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 280	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511942&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159957490	459629193							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072564	CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]3(C)C[C@@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23+,29-/m1/s1	OCXAGXCMZACNEC-RLPNJSHFSA-N	511943	(1S,3R,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 281	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511943&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159957489	459629194							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072565	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)C(O)CO)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O5/c1-14-4-5-24(30)34-27(14)35-28(43)20-7-29(23(41)13-39)8-22(29)38(20)25(42)12-37-21-11-33-19(17-9-31-16(3)32-10-17)6-18(21)26(36-37)15(2)40/h4-6,9-11,20,22-23,39,41H,7-8,12-13H2,1-3H3,(H,34,35,43)/t20-,22+,23?,29+/m0/s1	DPBNKEAMAKQFEO-VJZKFCLVSA-N	511944	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((S)-1,2- dihydroxyethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 282	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511944&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157874070	459629195							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072566	CC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-5-29-9-21(28(41)35-27-15(2)6-7-24(30)34-27)38(23(29)10-29)25(40)14-37-22-13-33-20(18-11-31-17(4)32-12-18)8-19(22)26(36-37)16(3)39/h6-8,11-13,21,23H,5,9-10,14H2,1-4H3,(H,34,35,41)/t21-,23+,29-/m0/s1	HCVRATLBPXLSPF-IXQRDTAUSA-N	511945	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ethyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 284	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511945&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158441308	459629196							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072567	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)C2COC(C)(C)O2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C32H33BrN8O5/c1-16-6-7-26(33)37-29(16)38-30(44)22-9-32(25-15-45-31(4,5)46-25)10-24(32)41(22)27(43)14-40-23-13-36-21(19-11-34-18(3)35-12-19)8-20(23)28(39-40)17(2)42/h6-8,11-13,22,24-25H,9-10,14-15H2,1-5H3,(H,37,38,44)/t22-,24+,25?,32+/m0/s1	CPMUJVUZMIPVJY-PJYIQAQNSA-N	511946	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((S)-2,2-dimethyl-1,3- dioxolan-4-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 285	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511946&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157651050	459629197							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072568	CC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O3/c1-5-30-11-23(29(41)35-28-16(2)6-9-25(31)34-28)38(24(30)12-30)26(40)15-37-22-8-7-19(20-13-32-18(4)33-14-20)10-21(22)27(36-37)17(3)39/h6-10,13-14,23-24H,5,11-12,15H2,1-4H3,(H,34,35,41)/t23-,24+,30-/m0/s1	RSRUEPMUVRUELT-BBANNHEPSA-N	511947	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6-  bromo-3-  methylpyridin-2-yl)-5-  ethyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 286	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511947&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160717735	459629198							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072569	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CCS(C)(=N)=O)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O4S/c1-17-6-7-26(33)37-30(17)38-31(44)24-12-32(8-9-46(5,34)45)13-25(32)41(24)27(43)16-40-29-18(2)10-21(22-14-35-20(4)36-15-22)11-23(29)28(39-40)19(3)42/h6-7,10-11,14-15,24-25,34H,8-9,12-13,16H2,1-5H3,(H,37,38,44)/t24-,25+,32-,46?/m0/s1	IYBHLFXDILYUCN-LOEJORENSA-N	511948	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (2-(S- methylsulfonimidoyl) ethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 287	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511948&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158839537	459629199							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072570	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CCS(C)(=O)=O)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34BrN7O5S/c1-17-6-7-26(33)36-30(17)37-31(43)24-12-32(8-9-46(5,44)45)13-25(32)40(24)27(42)16-39-29-18(2)10-21(22-14-34-20(4)35-15-22)11-23(29)28(38-39)19(3)41/h6-7,10-11,14-15,24-25H,8-9,12-13,16H2,1-5H3,(H,36,37,43)/t24-,25+,32-/m0/s1	GHUAFXNYSWFVCP-UNTHUGQZSA-N	511949	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6-  bromo-3- methylpyridin-2-yl)-5- (2-  (methylsulfonyl)ethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 288	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511949&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158260195	459629200							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072571	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2C(C)(C)COCC2(C)C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C36H42BrN9O4/c1-20(47)31-24-10-25(23-13-38-21(2)39-14-23)40-15-27(24)44(43-31)17-30(48)46-26(11-36(7)12-28(36)46)33(49)42-32-22(8-9-29(37)41-32)16-45-34(3,4)18-50-19-35(45,5)6/h8-10,13-15,26,28H,11-12,16-19H2,1-7H3,(H,41,42,49)/t26-,28+,36-/m0/s1	LXRDDMPUROJZGE-FOYSLLOYSA-N	511950	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- ((3,3,5,5-  tetramethylmorpholino) methyl)pyridin-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 289	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511950&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159486699	459629201							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072572	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(nc1)C1(O)COC1	InChI=1S/C32H32BrN7O5/c1-16-5-6-24(33)36-28(16)37-29(43)22-9-31(4)10-23(31)40(22)25(42)13-39-27-17(2)7-19(8-21(27)26(38-39)18(3)41)20-11-34-30(35-12-20)32(44)14-45-15-32/h5-8,11-12,22-23,44H,9-10,13-15H2,1-4H3,(H,36,37,43)/t22-,23+,31-/m0/s1	QSTQGYLWHPQYGP-LWPQGVMLSA-N	511951	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-(3- hydroxyoxetan-3- yl)pyrimidin-5-yl)-7- methyl-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 290	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511951&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422927	459629202							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072573	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(nc1)C1(F)COC1	InChI=1S/C32H31BrFN7O4/c1-16-5-6-24(33)37-28(16)38-29(44)22-9-31(4)10-23(31)41(22)25(43)13-40-27-17(2)7-19(8-21(27)26(39-40)18(3)42)20-11-35-30(36-12-20)32(34)14-45-15-32/h5-8,11-12,22-23H,9-10,13-15H2,1-4H3,(H,37,38,44)/t22-,23+,31-/m0/s1	CQJOBXFDYVOKMO-LWPQGVMLSA-N	511952	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-(3- fluorooxetan-3- yl)pyrimidin-5-yl)-7- methyl-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 291	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511952&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317959	459629203							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072574	Cc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C3COC3)c2c1	InChI=1S/C31H32BrN7O3/c1-16-5-6-25(32)35-29(16)36-30(41)23-9-31(4)10-24(31)39(23)26(40)13-38-28-17(2)7-19(20-11-33-18(3)34-12-20)8-22(28)27(37-38)21-14-42-15-21/h5-8,11-12,21,23-24H,9-10,13-15H2,1-4H3,(H,35,36,41)/t23-,24+,31-/m0/s1	WXDXEVPTGHQMRY-JLELKNTQSA-N	511953	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2-(2-(7- methyl-5-(2- methylpyrimidin-5- yl)-3-(oxetan-3-yl)- 1H-indazol-1- yl)acetyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 292	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511953	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511953&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317502	459629204							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072575	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1ccc(C)nc1F	InChI=1S/C29H27BrFN7O3/c1-14-5-8-23(30)34-27(14)35-28(41)20-10-29(4)11-22(29)38(20)24(40)13-37-21-12-32-19(9-18(21)25(36-37)16(3)39)17-7-6-15(2)33-26(17)31/h5-9,12,20,22H,10-11,13H2,1-4H3,(H,34,35,41)/t20-,22+,29-/m0/s1	ACLZEJYWWJKLFR-ZRDJEALESA-N	511954	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-fluoro-6- methylpyridin-3-yl)- 1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 293	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511954&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157071390	459629205							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072576	COCc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2cn1)C(C)=O	InChI=1S/C29H29BrN8O4/c1-15-5-6-23(30)34-27(15)35-28(41)20-8-29(3)9-22(29)38(20)25(40)13-37-21-12-31-19(7-18(21)26(36-37)16(2)39)17-10-32-24(14-42-4)33-11-17/h5-7,10-12,20,22H,8-9,13-14H2,1-4H3,(H,34,35,41)/t20-,22+,29-/m0/s1	RYZMZIXKGSHEPW-ZRDJEALESA-N	511955	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- (methoxymethyl) pyrimidin-5-yl)-1H- pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 294	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511955&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160768433	459629206							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072577	COC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O4/c1-15-5-6-24(30)34-27(15)35-28(41)21-8-29(14-42-4)9-23(29)38(21)25(40)13-37-22-12-33-20(18-10-31-17(3)32-11-18)7-19(22)26(36-37)16(2)39/h5-7,10-12,21,23H,8-9,13-14H2,1-4H3,(H,34,35,41)/t21-,23+,29-/m0/s1	MTYDYZDUGBOYPW-IXQRDTAUSA-N	511956	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5-  (methoxymethyl)-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 295	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511956&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159670534	459629207							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072578	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrN8O3/c1-19-7-8-28(35)38-32(19)39-33(46)26-13-34(18-41-9-5-6-10-41)14-27(34)43(26)29(45)17-42-31-20(2)11-23(24-15-36-22(4)37-16-24)12-25(31)30(40-42)21(3)44/h7-8,11-12,15-16,26-27H,5-6,9-10,13-14,17-18H2,1-4H3,(H,38,39,46)/t26-,27+,34-/m0/s1	GYMKOHJLEQLHGK-MZXMJASYSA-N	511957	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (pyrrolidin-1-  ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 296	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511957&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158404334	459629208							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072579	CC(C)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C33H37BrN8O3/c1-17(2)37-16-33-11-25(32(45)39-31-18(3)7-8-27(34)38-31)42(26(33)12-33)28(44)15-41-30-19(4)9-22(23-13-35-21(6)36-14-23)10-24(30)29(40-41)20(5)43/h7-10,13-14,17,25-26,37H,11-12,15-16H2,1-6H3,(H,38,39,45)/t25-,26+,33-/m0/s1	YQMJMBPNHJSLIH-REYAJUCUSA-N	511958	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((isopropylamino)methyl)- 2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 297	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511958&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161987600	459629209							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072580	COC(=O)[C@@H]1CCCN1C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O5/c1-19-8-9-29(37)40-33(19)41-34(48)27-13-36(18-43-10-6-7-26(43)35(49)50-5)14-28(36)45(27)30(47)17-44-32-20(2)11-23(24-15-38-22(4)39-16-24)12-25(32)31(42-44)21(3)46/h8-9,11-12,15-16,26-28H,6-7,10,13-14,17-18H2,1-5H3,(H,40,41,48)/t26-,27-,28+,36-/m0/s1	QNNIGZANXSCPPE-LEAFCXKLSA-N	511959	US11084800, Cpd No. 298::methyl (((1R,3S,5R)- 2-(2-(3-acetyl-7- methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-((6-  bromo-3- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[3.1.0]hexan- 5-yl)methyl)-L- prolinate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511959&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160466841	459629210							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072581	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCC[C@H]3C(O)=O)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O5/c1-18-7-8-28(36)39-32(18)40-33(47)26-12-35(17-42-9-5-6-25(42)34(48)49)13-27(35)44(26)29(46)16-43-31-19(2)10-22(23-14-37-21(4)38-15-23)11-24(31)30(41-43)20(3)45/h7-8,10-11,14-15,25-27H,5-6,9,12-13,16-17H2,1-4H3,(H,48,49)(H,39,40,47)/t25-,26-,27+,35-/m0/s1	NZHRDFQCYLRFML-MEOLXUPJSA-N	511960	(((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-3-((6- bromo-3- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[3.1.0]hexan- 5-yl)methyl)-L- proline::US11084800, Cpd No. 299	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511960&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159928295	459629211							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072582	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(C)(C)C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H39BrN8O3/c1-18-8-9-27(35)39-31(18)40-32(46)25-12-34(17-38-33(5,6)7)13-26(34)43(25)28(45)16-42-30-19(2)10-22(23-14-36-21(4)37-15-23)11-24(30)29(41-42)20(3)44/h8-11,14-15,25-26,38H,12-13,16-17H2,1-7H3,(H,39,40,46)/t25-,26+,34-/m0/s1	BOHWSRIHOBULTQ-SCZOVYFASA-N	511962	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((tert- butylamino)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 300	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511962&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157411280	459629213							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072583	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2COCCF)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31BrFN7O4/c1-17(41)28-22-10-19(21-13-34-18(2)35-14-21)4-6-23(22)39(38-28)15-27(42)40-24(11-31(3)12-25(31)40)30(43)37-29-20(16-44-9-8-33)5-7-26(32)36-29/h4-7,10,13-14,24-25H,8-9,11-12,15-16H2,1-3H3,(H,36,37,43)/t24-,25+,31-/m0/s1	WRBSWBAZZACSRO-NTWBYJAHSA-N	511963	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-((2- fluoroethoxy)methyl) pyridin-2-yl)-5-methyl- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 301	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511963&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161582522	459629214							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072584	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2C(C)(C)CCCC2(C)C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C38H45BrN8O3/c1-22(48)33-27-15-24(26-18-40-23(2)41-19-26)9-11-28(27)45(44-33)21-32(49)47-29(16-38(7)17-30(38)47)35(50)43-34-25(10-12-31(39)42-34)20-46-36(3,4)13-8-14-37(46,5)6/h9-12,15,18-19,29-30H,8,13-14,16-17,20-21H2,1-7H3,(H,42,43,50)/t29-,30+,38-/m0/s1	WFNOWJRNUHKMFT-MTSKFENVSA-N	511964	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-((2,2,6,6- tetramethylpiperidin- 1-yl)methyl)pyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 302	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511964&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161490446	459629215							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072585	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)cn1	InChI=1S/C28H27BrN8O3/c1-14-5-6-23(29)33-26(14)34-27(40)20-8-28(4)9-22(28)37(20)24(39)13-36-21-12-32-18(19-11-30-15(2)10-31-19)7-17(21)25(35-36)16(3)38/h5-7,10-12,20,22H,8-9,13H2,1-4H3,(H,33,34,40)/t20-,22+,28-/m0/s1	SKAJIVCJDBAJNU-PGKWVRKKSA-N	511965	(1R,3S,5R)-2-(2-(3- acetyl-5-(5- methylpyrazin-2-yl)- 1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 303	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511965	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511965&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160857322	459629216							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072586	CC(=O)c1nn(CC(=O)N2C[C@@](F)(Cn3ccnn3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrFN10O3/c1-17-4-7-25(31)36-28(17)37-29(45)24-11-30(32,15-40-9-8-35-39-40)16-41(24)26(44)14-42-23-6-5-20(21-12-33-19(3)34-13-21)10-22(23)27(38-42)18(2)43/h4-10,12-13,24H,11,14-16H2,1-3H3,(H,36,37,45)/t24-,30-/m0/s1	VCQJGTCJYRXTAK-NGQVCNFZSA-N	511966	(2S,4R)-4-((1H-1,2,3- triazol-1-yl)methyl)-1- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US11084800, Cpd No. 304	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511966&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161261748	459629217							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072587	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCOCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrN8O4/c1-19-5-6-28(35)38-32(19)39-33(46)26-13-34(18-41-7-9-47-10-8-41)14-27(34)43(26)29(45)17-42-31-20(2)11-23(24-15-36-22(4)37-16-24)12-25(31)30(40-42)21(3)44/h5-6,11-12,15-16,26-27H,7-10,13-14,17-18H2,1-4H3,(H,38,39,46)/t26-,27+,34-/m0/s1	OUTLTULHQXVTJP-MZXMJASYSA-N	511967	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (morpholinomethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 305	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511967	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511967&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160103914	459629218							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072588	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCC(F)(F)CC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrF2N8O3/c1-19-5-6-28(36)41-32(19)42-33(49)26-13-34(18-44-9-7-35(37,38)8-10-44)14-27(34)46(26)29(48)17-45-31-20(2)11-23(24-15-39-22(4)40-16-24)12-25(31)30(43-45)21(3)47/h5-6,11-12,15-16,26-27H,7-10,13-14,17-18H2,1-4H3,(H,41,42,49)/t26-,27+,34-/m0/s1	QUPISBXSRKNRFE-MZXMJASYSA-N	511968	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((4,4- difluoropiperidin-1-  yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 306	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511968&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160523586	459629219							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072589	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(C)(C)C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H37BrN8O3/c1-18-7-10-27(34)38-30(18)39-31(45)25-12-33(17-37-32(4,5)6)13-26(33)42(25)28(44)16-41-24-9-8-21(22-14-35-20(3)36-15-22)11-23(24)29(40-41)19(2)43/h7-11,14-15,25-26,37H,12-13,16-17H2,1-6H3,(H,38,39,45)/t25-,26+,33-/m0/s1	QEFYRLWFLMXMRA-REYAJUCUSA-N	511969	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((tert- butylamino)methyl)-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 307	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511969&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160392072	459629220							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072590	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CC3CCC2C3)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrN8O3/c1-19(45)32-26-11-22(24-14-37-20(2)38-15-24)5-8-27(26)43(41-32)18-31(46)44-28(12-35(3)13-29(35)44)34(47)40-33-23(6-9-30(36)39-33)17-42-16-21-4-7-25(42)10-21/h5-6,8-9,11,14-15,21,25,28-29H,4,7,10,12-13,16-18H2,1-3H3,(H,39,40,47)/t21?,25?,28-,29+,35-/m0/s1	FDJGOJUTOTZWGJ-BVYNBACYSA-N	511970	(1R,3S,5R)-N-(3-(2- azabicyclo[2.2.1]heptan- 2-ylmethyl)-6- bromopyridin-2-yl)-2- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 308	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511970&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157997883	459629221							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072591	CC(C)n1cc(nn1)[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C33H33BrN10O3/c1-17(2)42-15-26(39-41-42)33-11-25(32(47)38-31-18(3)6-9-28(34)37-31)44(27(33)12-33)29(46)16-43-24-8-7-21(22-13-35-20(5)36-14-22)10-23(24)30(40-43)19(4)45/h6-10,13-15,17,25,27H,11-12,16H2,1-5H3,(H,37,38,47)/t25-,27+,33-/m0/s1	IJUOTZSMCLURMQ-PHZRBTHJSA-N	511971	(1R,3S,5S)-2-(2-(3-  acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (1-isopropyl-1H-1,2,3- triazol-4-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 309	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511971&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533552	459629222							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072592	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cccn3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30BrN9O3/c1-18-5-8-27(33)37-30(18)38-31(45)25-12-32(17-40-10-4-9-36-40)13-26(32)42(25)28(44)16-41-24-7-6-21(22-14-34-20(3)35-15-22)11-23(24)29(39-41)19(2)43/h4-11,14-15,25-26H,12-13,16-17H2,1-3H3,(H,37,38,45)/t25-,26+,32-/m0/s1	SKEJBLFMMJTNDG-BKQYKDOASA-N	511972	(1R,3S,5R)-5-((1H- pyrazol-1-yl)methyl)- 2-(2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 310	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511972&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318610	459629223							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072593	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3ccc(n3)C(C)(C)C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H38BrN9O3/c1-20-7-10-30(37)40-33(20)41-34(49)27-14-36(19-44-12-11-28(42-44)35(4,5)6)15-29(36)46(27)31(48)18-45-26-9-8-23(24-16-38-22(3)39-17-24)13-25(26)32(43-45)21(2)47/h7-13,16-17,27,29H,14-15,18-19H2,1-6H3,(H,40,41,49)/t27-,29+,36-/m0/s1	QRDFSCHETSQEFO-ZULCAZRWSA-N	511973	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((3-(tert-butyl)-1H- pyrazol-1-yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 311	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511973&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318523	459629224							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072594	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cncn3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrN10O3/c1-17-4-7-26(32)37-29(17)38-30(45)24-9-31(14-40-16-33-15-36-40)10-25(31)42(24)27(44)13-41-23-6-5-20(21-11-34-19(3)35-12-21)8-22(23)28(39-41)18(2)43/h4-8,11-12,15-16,24-25H,9-10,13-14H2,1-3H3,(H,37,38,45)/t24-,25+,31-/m0/s1	RHXSFVBEYKTWRM-NTWBYJAHSA-N	511974	(1R,3S,5R)-5-((1H- 1,2,4-triazol-1- yl)methyl)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 312	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511974&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318559	459629225							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072595	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cncn3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrN11O3/c1-16-4-5-25(31)37-28(16)38-29(45)22-7-30(13-40-15-32-14-36-40)8-24(30)42(22)26(44)12-41-23-11-35-21(19-9-33-18(3)34-10-19)6-20(23)27(39-41)17(2)43/h4-6,9-11,14-15,22,24H,7-8,12-13H2,1-3H3,(H,37,38,45)/t22-,24+,30-/m0/s1	NXDRKZYRPCHEBO-RVVHDCIOSA-N	511975	(1R,3S,5R)-5-((1H- 1,2,4-triazol-1- yl)methyl)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-  N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 313	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511975&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422921	459629226							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072596	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cnc(C)c3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C32H31BrN10O3/c1-17-5-6-27(33)38-30(17)39-31(46)24-8-32(15-41-13-18(2)37-16-41)9-26(32)43(24)28(45)14-42-25-12-36-23(21-10-34-20(4)35-11-21)7-22(25)29(40-42)19(3)44/h5-7,10-13,16,24,26H,8-9,14-15H2,1-4H3,(H,38,39,46)/t24-,26+,32-/m0/s1	DTEVRFWXIRCODN-OSJZMRHLSA-N	511976	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((4-methyl-1H- imidazol-1-yl)methyl)-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 314	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511976&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157910027	459629227							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072597	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cn3cnc(C)c3)C[C@@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN9O3/c1-18-5-8-28(34)38-31(18)39-32(46)26-10-33(16-41-14-19(2)37-17-41)11-27(33)43(26)29(45)15-42-25-7-6-22(23-12-35-21(4)36-13-23)9-24(25)30(40-42)20(3)44/h5-9,12-14,17,26-27H,10-11,15-16H2,1-4H3,(H,38,39,46)/t26-,27-,33+/m1/s1	UKZGRGWTNSJJNO-SJQIOTTESA-N	511977	(1R,3R,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((4-methyl-1H- imidazol-1-yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 315	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511977&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318239	459629228							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072598	CCc1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(CN(C)C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C33H37BrN8O3/c1-7-21-10-22(23-14-35-20(4)36-15-23)11-24-29(19(3)43)39-41(30(21)24)16-28(44)42-25(12-33(13-26(33)42)17-40(5)6)32(45)38-31-18(2)8-9-27(34)37-31/h8-11,14-15,25-26H,7,12-13,16-17H2,1-6H3,(H,37,38,45)/t25-,26+,33-/m0/s1	UGOVQOYEYOMCND-REYAJUCUSA-N	511978	(1R,3S,5R)-2-(2-(3- acetyl-7-ethyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-  methylpyridin-2-yl)-5- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 316	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511978&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161086498	459629229							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072599	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CCCF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrFN8O3/c1-16-5-6-25(31)36-28(16)37-29(43)22-10-30(7-4-8-32)11-24(30)40(22)26(42)15-39-23-14-35-21(19-12-33-18(3)34-13-19)9-20(23)27(38-39)17(2)41/h5-6,9,12-14,22,24H,4,7-8,10-11,15H2,1-3H3,(H,36,37,43)/t22-,24+,30-/m0/s1	MGZREXDRGBVQMN-RVVHDCIOSA-N	511979	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-  methylpyridin-2-yl)-5- (3-fluoropropyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 319	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511979&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159564224	459629230							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072600	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C30H32BrN9O3/c1-16-6-7-25(31)35-28(16)36-29(43)22-9-30(15-38(4)5)10-24(30)40(22)26(42)14-39-23-13-34-21(19-11-32-18(3)33-12-19)8-20(23)27(37-39)17(2)41/h6-8,11-13,22,24H,9-10,14-15H2,1-5H3,(H,35,36,43)/t22-,24+,30-/m0/s1	LBGLEADHYACJFZ-RVVHDCIOSA-N	511981	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 320	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511981&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159300433	459629232							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072601	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCC(C)(F)CC2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrFN9O3/c1-19(46)30-23-11-24(22-14-37-20(2)38-15-22)39-16-26(23)44(42-30)18-29(47)45-25(12-33(3)13-27(33)45)32(48)41-31-21(5-6-28(35)40-31)17-43-9-7-34(4,36)8-10-43/h5-6,11,14-16,25,27H,7-10,12-13,17-18H2,1-4H3,(H,40,41,48)/t25-,27+,33-/m0/s1	GPDBADBNCMFDIJ-PHZRBTHJSA-N	511982	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-((4- fluoro-4- methylpiperidin-1- yl)methyl)pyridin-2- yl)-5-methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 321	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511982&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158323509	459629233							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072602	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCC(C)(F)CC2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H38BrFN8O3/c1-20(46)31-25-13-22(24-16-38-21(2)39-17-24)5-7-26(25)44(42-31)19-30(47)45-27(14-34(3)15-28(34)45)33(48)41-32-23(6-8-29(36)40-32)18-43-11-9-35(4,37)10-12-43/h5-8,13,16-17,27-28H,9-12,14-15,18-19H2,1-4H3,(H,40,41,48)/t27-,28+,34-/m0/s1	QBJZZVWRWAFPOF-FPQPQGOJSA-N	511983	(1R,3S,5R)-2-(2-(3-  acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-((4-fluoro-4- methylpiperidin-1- yl)methyl)pyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 322	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511983&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160368978	459629234							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072603	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CCCF)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrFN8O3/c1-16(41)27-20-9-21(19-12-33-17(2)34-13-19)35-14-23(20)39(38-27)15-26(42)40-22(10-30(3)11-24(30)40)29(43)37-28-18(5-4-8-32)6-7-25(31)36-28/h6-7,9,12-14,22,24H,4-5,8,10-11,15H2,1-3H3,(H,36,37,43)/t22-,24+,30-/m0/s1	UPYBNWCQCVYDDB-RVVHDCIOSA-N	511984	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-(3- fluoropropyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 323	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511984&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161161141	459629235							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072604	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(nc(cc12)-c1cnc(C)nc1)C1CC1	InChI=1S/C31H31BrN8O3/c1-15-5-8-24(32)36-29(15)37-30(43)22-10-31(4)11-23(31)40(22)25(42)14-39-28-20(26(38-39)16(2)41)9-21(35-27(28)18-6-7-18)19-12-33-17(3)34-13-19/h5,8-9,12-13,18,22-23H,6-7,10-11,14H2,1-4H3,(H,36,37,43)/t22-,23+,31-/m0/s1	DDMKLYRJRNPORL-LWPQGVMLSA-N	511985	(1R,3S,5R)-2-(2-(3- acetyl-7-cyclopropyl- 5-(2-methylpyrimidin- 5-yl)-1H- pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 324	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511985&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533554	459629236							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072605	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C(F)CF)c12)-c1cnc(C)nc1	InChI=1S/C33H35BrF2N8O3/c1-17-6-7-27(34)39-31(17)40-32(47)25-10-33(16-42(4)5)11-26(33)44(25)28(46)15-43-30-22(24(36)12-35)8-20(21-13-37-19(3)38-14-21)9-23(30)29(41-43)18(2)45/h6-9,13-14,24-26H,10-12,15-16H2,1-5H3,(H,39,40,47)/t24?,25-,26+,33-/m0/s1	CUDZPTOGZCONJD-QPBQAUPTSA-N	511986	(1R,3S,5R)-2-(2-(3- acetyl-7-(1,2- difluoroethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 325	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511986&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157692502	459629237							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072606	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CCF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrFN8O3/c1-15-4-5-24(30)35-27(15)36-28(42)21-9-29(6-7-31)10-23(29)39(21)25(41)14-38-22-13-34-20(18-11-32-17(3)33-12-18)8-19(22)26(37-38)16(2)40/h4-5,8,11-13,21,23H,6-7,9-10,14H2,1-3H3,(H,35,36,42)/t21-,23+,29-/m0/s1	YHHQQHHKNOSZRO-IXQRDTAUSA-N	511987	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (2-fluoroethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 326	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511987&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161915610	459629238							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072607	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CCC(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrF2N8O3/c1-15-4-5-24(31)37-28(15)38-29(44)21-9-30(7-6-25(32)33)10-23(30)41(21)26(43)14-40-22-13-36-20(18-11-34-17(3)35-12-18)8-19(22)27(39-40)16(2)42/h4-5,8,11-13,21,23,25H,6-7,9-10,14H2,1-3H3,(H,37,38,44)/t21-,23+,30-/m0/s1	SFWFBWMNEDPMLH-AZMCGESQSA-N	511988	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- methylpyridin-2-yl)-5- (3,3-difluoropropyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 327	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511988&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160823619	459629239							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072608	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CC(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrF2N8O3/c1-14-4-5-23(30)36-27(14)37-28(43)20-7-29(9-24(31)32)8-22(29)40(20)25(42)13-39-21-12-35-19(17-10-33-16(3)34-11-17)6-18(21)26(38-39)15(2)41/h4-6,10-12,20,22,24H,7-9,13H2,1-3H3,(H,36,37,43)/t20-,22+,29-/m0/s1	BJEKFEXJJHUDSI-ZRDJEALESA-N	511989	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (2,2-difluoroethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 328	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511989&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157365967	459629240							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072609	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(CN2CCCC(F)(F)C2)nc1	InChI=1S/C34H35BrF2N8O3/c1-19-5-8-27(35)40-31(19)41-32(48)25-12-33(3)13-26(33)45(25)29(47)17-44-24-7-6-21(11-23(24)30(42-44)20(2)46)22-14-38-28(39-15-22)16-43-10-4-9-34(36,37)18-43/h5-8,11,14-15,25-26H,4,9-10,12-13,16-18H2,1-3H3,(H,40,41,48)/t25-,26+,33-/m0/s1	VCVSPYAZPMIGID-REYAJUCUSA-N	511990	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-((3,3- difluoropiperidin-1- yl)methyl)pyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 330	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511990&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161263317	459629241							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072610	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1C	InChI=1S/C30H30BrN7O3/c1-15-6-9-25(31)34-28(15)35-29(41)23-11-30(5)12-24(30)38(23)26(40)14-37-22-8-7-19(10-20(22)27(36-37)17(3)39)21-13-32-18(4)33-16(21)2/h6-10,13,23-24H,11-12,14H2,1-5H3,(H,34,35,41)/t23-,24+,30-/m0/s1	FONPLMNXZUKBGT-BBANNHEPSA-N	511991	(1R,3S,5R)-2-(2-(3- acetyl-5-(2,4- dimethylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 331	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511991&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158094791	459629242							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072611	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(OC(F)(F)F)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29F3N8O4/c1-14-6-7-23(45-30(31,32)33)37-27(14)38-28(44)21-9-29(5)10-22(29)41(21)24(43)13-40-26-15(2)36-20(18-11-34-17(4)35-12-18)8-19(26)25(39-40)16(3)42/h6-8,11-12,21-22H,9-10,13H2,1-5H3,(H,37,38,44)/t21-,22+,29-/m0/s1	CEHBYDDJLLJHKT-KERYWQKISA-N	511992	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)-  5-methyl-N-(3- methyl-6- (trifluoromethoxy)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 332	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511992&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533555	459629243							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072612	CC(C)c1cc(on1)[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C34H33BrN8O4/c1-17(2)24-11-28(47-41-24)34-12-26(33(46)39-32-18(3)6-9-29(35)38-32)43(27(34)13-34)30(45)16-42-25-8-7-21(22-14-36-20(5)37-15-22)10-23(25)31(40-42)19(4)44/h6-11,14-15,17,26-27H,12-13,16H2,1-5H3,(H,38,39,46)/t26-,27+,34+/m0/s1	FFHJPCZLUOWQMC-RCUDDFTLSA-N	511993	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (3-isopropylisoxazol- 5-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 333	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511993&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533556	459629244							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072613	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C27H25BrN8O3/c1-14(37)25-17-7-18(16-10-29-15(2)30-11-16)31-12-20(17)35(34-25)13-24(38)36-19(8-27(3)9-21(27)36)26(39)33-23-6-4-5-22(28)32-23/h4-7,10-12,19,21H,8-9,13H2,1-3H3,(H,32,33,39)/t19-,21+,27-/m0/s1	IVBIKNNEISFCQT-FCDUAZGNSA-N	511994	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-  methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromopyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 334	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511994&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			137462258	459629245							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072614	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cncc(Br)n2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrN9O3/c1-13(37)24-16-4-17(15-7-29-14(2)30-8-15)31-9-19(16)35(34-24)12-23(38)36-18(5-26(3)6-20(26)36)25(39)33-22-11-28-10-21(27)32-22/h4,7-11,18,20H,5-6,12H2,1-3H3,(H,32,33,39)/t18-,20+,26-/m0/s1	SZYNFDNFCIZJEG-UDJSKEQPSA-N	511995	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromopyrazin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 335	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511995&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160984587	459629246							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072615	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27BrN8O3/c1-14-26-18(8-19(32-14)17-11-30-16(3)31-12-17)25(15(2)38)35-36(26)13-24(39)37-20(9-28(4)10-21(28)37)27(40)34-23-7-5-6-22(29)33-23/h5-8,11-12,20-21H,9-10,13H2,1-4H3,(H,33,34,40)/t20-,21+,28-/m0/s1	HDDSQVHMNZXTMF-GTNJKRJXSA-N	511996	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromopyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 336	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511996&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158443959	459629247							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072616	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cncc(Br)n2)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C27H26BrN9O3/c1-13-25-17(5-18(32-13)16-8-30-15(3)31-9-16)24(14(2)38)35-36(25)12-23(39)37-19(6-27(4)7-20(27)37)26(40)34-22-11-29-10-21(28)33-22/h5,8-11,19-20H,6-7,12H2,1-4H3,(H,33,34,40)/t19-,20+,27-/m0/s1	UZXJWYMGBFQBCP-VKIDHGPPSA-N	511997	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromopyrazin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 337	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511997&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161240340	459629248							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072617	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(cs3)C(C)(C)C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H37BrN8O3S/c1-19-7-10-29(37)41-33(19)42-34(48)26-12-36(14-30-40-27(18-49-30)35(4,5)6)13-28(36)45(26)31(47)17-44-25-9-8-22(23-15-38-21(3)39-16-23)11-24(25)32(43-44)20(2)46/h7-11,15-16,18,26,28H,12-14,17H2,1-6H3,(H,41,42,48)/t26-,28+,36-/m0/s1	MDEKHBHZTAYMIE-FOYSLLOYSA-N	511998	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((4-(tert-butyl)thiazol- 2-yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 338	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511998&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317578	459629249							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072618	CCc1csc(C[C@]23C[C@H]2N([C@@H](C3)C(=O)Nc2nc(Br)ccc2C)C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)n1	InChI=1S/C34H33BrN8O3S/c1-5-23-17-47-29(38-23)13-34-11-26(33(46)40-32-18(2)6-9-28(35)39-32)43(27(34)12-34)30(45)16-42-25-8-7-21(22-14-36-20(4)37-15-22)10-24(25)31(41-42)19(3)44/h6-10,14-15,17,26-27H,5,11-13,16H2,1-4H3,(H,39,40,46)/t26-,27+,34-/m0/s1	CXYCIDFKYXMVSM-MZXMJASYSA-N	511999	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((4-ethylthiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 339	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511999&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318830	459629250							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072619	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(ccc2C)C(F)(F)F)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27F3N8O3/c1-14-5-6-22(29(30,31)32)36-26(14)37-27(43)20-8-28(4)9-23(28)40(20)24(42)13-39-21-12-35-19(17-10-33-16(3)34-11-17)7-18(21)25(38-39)15(2)41/h5-7,10-12,20,23H,8-9,13H2,1-4H3,(H,36,37,43)/t20-,23+,28-/m0/s1	IDGRDKIWYVYVJV-PYHHMDQSSA-N	512000	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)-  5-methyl-N-(3- methyl-6-  (trifluoromethyl)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 340	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512000&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533557	459629251							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072620	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(ccc2C)C(F)(F)F)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29F3N8O3/c1-14-6-7-22(30(31,32)33)37-27(14)38-28(44)21-9-29(5)10-23(29)41(21)24(43)13-40-26-15(2)36-20(18-11-34-17(4)35-12-18)8-19(26)25(39-40)16(3)42/h6-8,11-12,21,23H,9-10,13H2,1-5H3,(H,37,38,44)/t21-,23+,29-/m0/s1	BVIKIJCKUWDWHS-IXQRDTAUSA-N	512001	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5 -(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-methyl-N-(3- methyl-6- (trifluoromethyl)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 341	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512001&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157473741	459629252							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072621	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNCCCF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H36BrFN8O3/c1-18-6-7-27(34)39-31(18)40-32(46)25-12-33(17-36-9-5-8-35)13-26(33)43(25)28(45)16-42-30-19(2)10-22(23-14-37-21(4)38-15-23)11-24(30)29(41-42)20(3)44/h6-7,10-11,14-15,25-26,36H,5,8-9,12-13,16-17H2,1-4H3,(H,39,40,46)/t25-,26+,33-/m0/s1	JXQLZORENLJKCA-REYAJUCUSA-N	512002	(1R,3S,5R)-2-(2-(3-  acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (((3- fluoropropyl)amino) methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 342	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512002&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159054162	459629253							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072622	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C35H38BrN9O3/c1-19-6-7-28(36)40-32(19)41-33(48)26-11-35(18-43-16-34(17-43)8-5-9-34)12-27(35)45(26)29(47)15-44-31-20(2)39-25(23-13-37-22(4)38-14-23)10-24(31)30(42-44)21(3)46/h6-7,10,13-14,26-27H,5,8-9,11-12,15-18H2,1-4H3,(H,40,41,48)/t26-,27+,35-/m0/s1	RZJOTIPVYLRIST-ULQPQYINSA-N	512003	(1R,3S,5R)-5-(2- azaspiro[3.3]heptan-2- ylmethyl)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 344	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512003&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160771537	459629254							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072623	CN(C)CCC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(CF)c12)-c1cnc(C)nc1	InChI=1S/C34H38BrFN8O3/c1-19-7-8-28(35)39-32(19)40-33(47)26-13-34(9-6-10-42(4)5)14-27(34)44(26)29(46)18-43-31-23(15-36)11-22(24-16-37-21(3)38-17-24)12-25(31)30(41-43)20(2)45/h7-8,11-12,16-17,26-27H,6,9-10,13-15,18H2,1-5H3,(H,39,40,47)/t26-,27+,34-/m0/s1	RGMFSUPXSWCJSX-MZXMJASYSA-N	512004	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (3- (dimethylamino)propyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 345	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512004&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160619205	459629255							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072624	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34BrN9O3/c1-17-6-7-26(33)37-30(17)38-31(45)24-11-32(16-40-8-5-9-40)12-25(32)42(24)27(44)15-41-29-18(2)36-23(21-13-34-20(4)35-14-21)10-22(29)28(39-41)19(3)43/h6-7,10,13-14,24-25H,5,8-9,11-12,15-16H2,1-4H3,(H,37,38,45)/t24-,25+,32-/m0/s1	KDDFGKHKOLQUKG-UNTHUGQZSA-N	512005	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-(azetidin-1- ylmethyl)-N-(6- bromo-3-  methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 346	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512005&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159099800	459629256							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072625	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C33H36BrN9O3/c1-18-7-8-27(34)38-31(18)39-32(46)25-12-33(17-41-9-5-6-10-41)13-26(33)43(25)28(45)16-42-30-19(2)37-24(22-14-35-21(4)36-15-22)11-23(30)29(40-42)20(3)44/h7-8,11,14-15,25-26H,5-6,9-10,12-13,16-17H2,1-4H3,(H,38,39,46)/t25-,26+,33-/m0/s1	GAJCKTOZYAAHLQ-REYAJUCUSA-N	512006	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (pyrrolidin-1- ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 347	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512006&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158196172	459629257							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072626	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(nc(C)c12)-c1cnc(C)nc1	InChI=1S/C31H34BrN9O3/c1-16-7-8-25(32)36-29(16)37-30(44)23-10-31(15-39(5)6)11-24(31)41(23)26(43)14-40-28-17(2)35-22(20-12-33-19(4)34-13-20)9-21(28)27(38-40)18(3)42/h7-9,12-13,23-24H,10-11,14-15H2,1-6H3,(H,36,37,44)/t23-,24+,31-/m0/s1	FMVOHGROPXZFJU-JLELKNTQSA-N	512007	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((dimethylamino)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 348	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512007&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158080048	459629258							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072627	CC(C)c1cnc(C[C@]23C[C@H]2N([C@@H](C3)C(=O)Nc2nc(Br)ccc2C)C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)s1	InChI=1S/C35H35BrN8O3S/c1-18(2)27-16-39-30(48-27)13-35-11-26(34(47)41-33-19(3)6-9-29(36)40-33)44(28(35)12-35)31(46)17-43-25-8-7-22(23-14-37-21(5)38-15-23)10-24(25)32(42-43)20(4)45/h6-10,14-16,18,26,28H,11-13,17H2,1-5H3,(H,40,41,47)/t26-,28+,35-/m0/s1	XQNXWQAIIUHJSC-SQCCVTMQSA-N	512008	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((5-isopropylthiazol-2-  yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 349	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512008&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161784387	459629259							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072628	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(C)(C)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H39BrN8O3/c1-19-7-8-28(36)39-32(19)40-33(47)26-11-35(18-42-16-34(5,6)17-42)12-27(35)44(26)29(46)15-43-31-20(2)9-23(24-13-37-22(4)38-14-24)10-25(31)30(41-43)21(3)45/h7-10,13-14,26-27H,11-12,15-18H2,1-6H3,(H,39,40,47)/t26-,27+,35-/m0/s1	QKRIPCUFZMVSTI-ULQPQYINSA-N	512009	(1R,3S,5R)-2-(2-(3-  acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- dimethylazetidin-1- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 350::US11084800, Cpd No. 369	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512009&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160444001	459629260							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072629	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H36BrFN8O3/c1-19-6-7-28(35)39-32(19)40-33(47)26-12-34(18-42-8-4-5-9-42)13-27(34)44(26)29(46)17-43-31-23(14-36)10-22(24-15-37-21(3)38-16-24)11-25(31)30(41-43)20(2)45/h6-7,10-11,15-16,26-27H,4-5,8-9,12-14,17-18H2,1-3H3,(H,39,40,47)/t26-,27+,34-/m0/s1	GGHUEWLRRWXVOG-MZXMJASYSA-N	512010	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-  methylpyridin-2-yl)-5- (pyrrolidin-1- ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 351	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512010&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158247568	459629261							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072630	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(C)(C)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C34H38BrN9O3/c1-18-7-8-27(35)39-31(18)40-32(47)25-10-34(17-42-15-33(5,6)16-42)11-26(34)44(25)28(46)14-43-30-19(2)38-24(22-12-36-21(4)37-13-22)9-23(30)29(41-43)20(3)45/h7-9,12-13,25-26H,10-11,14-17H2,1-6H3,(H,39,40,47)/t25-,26+,34-/m0/s1	DDTGYXDIDXPEHG-SCZOVYFASA-N	512011	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((3,3- dimethylazetidin-1- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 352	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512011&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157775588	459629262							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072631	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)nc(cc12)-c1cnc(C)nc1	InChI=1S/C32H33BrFN9O3/c1-17-5-6-26(33)38-30(17)39-31(46)24-10-32(16-41-7-4-8-41)11-25(32)43(24)27(45)15-42-29-21(28(40-42)18(2)44)9-22(37-23(29)12-34)20-13-35-19(3)36-14-20/h5-6,9,13-14,24-25H,4,7-8,10-12,15-16H2,1-3H3,(H,38,39,46)/t24-,25+,32-/m0/s1	UEGWYWYSSNIGFV-UNTHUGQZSA-N	512012	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-(azetidin- 1-ylmethyl)-N-(6- bromo-3-  methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 353	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512012&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161067942	459629263							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072632	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)nc(cc12)-c1cnc(C)nc1	InChI=1S/C35H37BrFN9O3/c1-19-5-6-28(36)41-32(19)42-33(49)26-10-35(18-44-16-34(17-44)7-4-8-34)11-27(35)46(26)29(48)15-45-31-23(30(43-45)20(2)47)9-24(40-25(31)12-37)22-13-38-21(3)39-14-22/h5-6,9,13-14,26-27H,4,7-8,10-12,15-18H2,1-3H3,(H,41,42,49)/t26-,27+,35-/m0/s1	YXQKFCLBGQSVLX-ULQPQYINSA-N	512013	(1R,3S,5R)-5-(2- azaspiro[3.3]heptan-2- ylmethyl)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 354	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512013&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162043960	459629264							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072633	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(C)(C)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)nc(cc12)-c1cnc(C)nc1	InChI=1S/C34H37BrFN9O3/c1-18-6-7-27(35)40-31(18)41-32(48)25-9-34(17-43-15-33(4,5)16-43)10-26(34)45(25)28(47)14-44-30-22(29(42-44)19(2)46)8-23(39-24(30)11-36)21-12-37-20(3)38-13-21/h6-8,12-13,25-26H,9-11,14-17H2,1-5H3,(H,40,41,48)/t25-,26+,34-/m0/s1	GNYZSMPZYAEKIB-SCZOVYFASA-N	512014	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1 yl)acetyl)-N-(6-  bromo-3- methylpyridin-2-yl)-5- ((3,3- dimethylazetidin-1- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 355	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512014&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158313561	459629265							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072634	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCn3c(C2)nnc3C(F)(F)F)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32BrF3N12O3/c1-17(51)29-21-8-22(20-11-39-18(2)40-12-20)41-13-24(21)49(46-29)16-28(52)50-23(9-33(3)10-25(33)50)31(53)43-30-19(4-5-26(35)42-30)14-47-6-7-48-27(15-47)44-45-32(48)34(36,37)38/h4-5,8,11-13,23,25H,6-7,9-10,14-16H2,1-3H3,(H,42,43,53)/t23-,25+,33-/m0/s1	OHGUVAFLLMVJPI-BGEGRKSBSA-N	512015	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-((3- (trifluoromethyl)-5,6- dihydro- [1,2,4]triazolo[4,3- a]pyrazin-7(8H)- yl)methyl)pyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 356	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512015&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159993694	459629266							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072635	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCn3c(C2)nnc3C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H33BrF3N11O3/c1-18(51)30-23-10-20(22-13-40-19(2)41-14-22)4-6-24(23)49(46-30)17-29(52)50-25(11-34(3)12-26(34)50)32(53)43-31-21(5-7-27(36)42-31)15-47-8-9-48-28(16-47)44-45-33(48)35(37,38)39/h4-7,10,13-14,25-26H,8-9,11-12,15-17H2,1-3H3,(H,42,43,53)/t25-,26+,34-/m0/s1	ZHKQBHKREGUOQU-SCZOVYFASA-N	512016	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-((3- (trifluoromethyl)-5,6- dihydro- [1,2,4]triazolo[4,3- a]pyrazin-7(8H)- yl)methyl)pyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 357	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512016&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162121166	459629267							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072636	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnco3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30BrN9O4/c1-16-5-6-25(33)37-30(16)38-31(45)23-9-32(11-26-39-36-15-46-26)10-24(32)42(23)27(44)14-41-29-17(2)7-20(21-12-34-19(4)35-13-21)8-22(29)28(40-41)18(3)43/h5-8,12-13,15,23-24H,9-11,14H2,1-4H3,(H,37,38,45)/t23-,24+,32-/m0/s1	WHVJGQGCOQUZRO-XNSHOJTPSA-N	512017	(1R,3S,5R)-5-((1,3,4- oxadiazol-2- yl)methyl)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 359	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512017&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318030	459629268							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072637	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN9O4/c1-16-6-7-26(34)37-31(16)38-32(46)24-10-33(12-27-40-39-20(5)47-27)11-25(33)43(24)28(45)15-42-30-17(2)8-21(22-13-35-19(4)36-14-22)9-23(30)29(41-42)18(3)44/h6-9,13-14,24-25H,10-12,15H2,1-5H3,(H,37,38,46)/t24-,25+,33-/m0/s1	OGGKDICWMOPLLP-DVIHYUSWSA-N	512018	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((5-methyl-1,3,4- oxadiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 360	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512018&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319069	459629269							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072638	Cc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2cn1)C(N)=O	InChI=1S/C27H26BrN9O3/c1-13-4-5-21(28)33-25(13)34-26(40)18-7-27(3)8-20(27)37(18)22(38)12-36-19-11-32-17(15-9-30-14(2)31-10-15)6-16(19)23(35-36)24(29)39/h4-6,9-11,18,20H,7-8,12H2,1-3H3,(H2,29,39)(H,33,34,40)/t18-,20+,27-/m0/s1	XIZHGTXBHWDGAY-SRLOGKKOSA-N	512019	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridine-3- carboxamide::US11084800, Cpd No. 361	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512019&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318308	459629270							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072639	CC(C)c1nnc(o1)-c1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN9O4/c1-16(2)31-39-40-32(47-31)21-7-9-26(34)37-29(21)38-30(46)24-11-33(5)12-25(33)43(24)27(45)15-42-23-8-6-19(20-13-35-18(4)36-14-20)10-22(23)28(41-42)17(3)44/h6-10,13-14,16,24-25H,11-12,15H2,1-5H3,(H,37,38,46)/t24-,25+,33-/m0/s1	CZWMKKLZYJKDGE-DVIHYUSWSA-N	512020	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-(5-isopropyl- 1,3,4-oxadiazol-2- yl)pyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 362	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512020&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533558	459629271							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072640	COc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O4/c1-15(38)26-19-9-17(18-12-31-16(2)32-13-18)5-6-20(19)36(35-26)14-25(39)37-21(10-29(3)11-23(29)37)28(40)34-27-22(41-4)7-8-24(30)33-27/h5-9,12-13,21,23H,10-11,14H2,1-4H3,(H,33,34,40)/t21-,23+,29-/m0/s1	WAAAYEHNKVFWRF-IXQRDTAUSA-N	512021	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methoxypyridin-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 363	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512021&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533559	459629272							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072641	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CC(F)C2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H32BrFN8O3/c1-17(43)29-23-8-19(21-11-35-18(2)36-12-21)4-6-24(23)41(39-29)16-28(44)42-25(9-32(3)10-26(32)42)31(45)38-30-20(5-7-27(33)37-30)13-40-14-22(34)15-40/h4-8,11-12,22,25-26H,9-10,13-16H2,1-3H3,(H,37,38,45)/t25-,26+,32-/m0/s1	SHPCCJRSERIIEJ-BKQYKDOASA-N	512022	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3-((3- fluoroazetidin-1- yl)methyl)pyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 364	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512022&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160837489	459629273							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072642	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CC#N)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrN8O3/c1-16-9-20(21-13-34-18(3)35-14-21)10-22-27(17(2)41)38-39(28(16)22)15-26(42)40-23(11-31(4)12-24(31)40)30(43)37-29-19(7-8-33)5-6-25(32)36-29/h5-6,9-10,13-14,23-24H,7,11-12,15H2,1-4H3,(H,36,37,43)/t23-,24+,31-/m0/s1	JQTSGZMMVYIZFI-JLELKNTQSA-N	512023	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- (cyanomethyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 365	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512023&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158996233	459629274							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072643	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CC3CC4(CC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H38BrN7O3/c1-19-5-6-29(37)40-33(19)41-34(47)27-14-36(13-23-11-35(12-23)7-8-35)15-28(36)44(27)30(46)18-43-32-20(2)9-24(25-16-38-22(4)39-17-25)10-26(32)31(42-43)21(3)45/h5-6,9-10,16-17,23,27-28H,7-8,11-15,18H2,1-4H3,(H,40,41,47)/t27-,28+,36-/m0/s1	NCVPQDUVBFBHKS-DJSUPVAQSA-N	512024	(1R,3S,5R)-5-(5- azaspiro[2.3]hexan-5- ylmethyl)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 366	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512024&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159744277	459629275							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072644	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(CC#N)c2c1	InChI=1S/C29H27BrN8O2/c1-16-4-7-25(30)34-27(16)35-28(40)23-11-29(3)12-24(29)38(23)26(39)15-37-22-6-5-18(19-13-32-17(2)33-14-19)10-20(22)21(36-37)8-9-31/h4-7,10,13-14,23-24H,8,11-12,15H2,1-3H3,(H,34,35,40)/t23-,24+,29-/m0/s1	QAPXXAPTJOYKMY-IRYADYCUSA-N	512025	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-2- (2-(3-(cyanomethyl)- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 367	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512025&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160362697	459629276							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072645	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(c2c1)C(C)(C)C#N	InChI=1S/C31H31BrN8O2/c1-17-6-9-25(32)36-28(17)37-29(42)23-11-31(5)12-24(31)40(23)26(41)15-39-22-8-7-19(20-13-34-18(2)35-14-20)10-21(22)27(38-39)30(3,4)16-33/h6-10,13-14,23-24H,11-12,15H2,1-5H3,(H,36,37,42)/t23-,24+,31-/m0/s1	OGVRGKGDBYFNBZ-JLELKNTQSA-N	512026	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-2- (2-(3-(2-cyanopropan- 2-yl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 368	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512026&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159990151	459629277							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072646	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC(C)(C)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H39BrN8O3/c1-19-7-8-28(36)39-32(19)40-33(47)26-11-35(18-42-16-34(5,6)17-42)12-27(35)44(26)29(46)15-43-31-20(2)9-23(24-13-37-22(4)38-14-24)10-25(31)30(41-43)21(3)45/h7-10,13-14,26-27H,11-12,15-18H2,1-6H3,(H,39,40,47)/t26-,27+,35-/m0/s1	QKRIPCUFZMVSTI-ULQPQYINSA-N	512009	(1R,3S,5R)-2-(2-(3-  acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- dimethylazetidin-1- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 350::US11084800, Cpd No. 369	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512009&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160444001	459629260							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072647	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(CC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C34H36BrN9O3/c1-18-5-6-27(35)39-31(18)40-32(47)25-10-34(17-42-15-33(16-42)7-8-33)11-26(34)44(25)28(46)14-43-30-19(2)38-24(22-12-36-21(4)37-13-22)9-23(30)29(41-43)20(3)45/h5-6,9,12-13,25-26H,7-8,10-11,14-17H2,1-4H3,(H,39,40,47)/t25-,26+,34-/m0/s1	ZKJHPPIIWVJCQV-SCZOVYFASA-N	512028	(1R,3S,5R)-5-(5- azaspiro[2.3]hexan-5- ylmethyl)-2-(2-(3- acetyl-7-methyl-5-(2-  methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 370	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512028&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162144490	459629278							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072648	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC3=NCCO3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31BrN10O4/c1-16-4-5-25(32)38-28(16)39-29(45)22-9-31(15-37-30-33-6-7-46-30)10-24(31)42(22)26(44)14-41-23-13-36-21(19-11-34-18(3)35-12-19)8-20(23)27(40-41)17(2)43/h4-5,8,11-13,22,24H,6-7,9-10,14-15H2,1-3H3,(H,33,37)(H,38,39,45)/t22-,24+,31-/m0/s1	ZLAABGKYQRQDKJ-DEDGKJITSA-N	512029	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (((4,5-dihydrooxazol- 2-yl)amino)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 371	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512029&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162149567	459629279							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072649	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H32BrN9O4/c1-16-6-7-26(34)38-31(16)39-32(46)24-10-33(12-27-37-20(5)41-47-27)11-25(33)43(24)28(45)15-42-30-17(2)8-21(22-13-35-19(4)36-14-22)9-23(30)29(40-42)18(3)44/h6-9,13-14,24-25H,10-12,15H2,1-5H3,(H,38,39,46)/t24-,25+,33-/m0/s1	YRUMZYOIZLRFRJ-DVIHYUSWSA-N	512030	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((3-methyl-1,2,4- oxadiazol-5- yl)methyl)-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 372	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512030&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161997906	459629280							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072650	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cc(C)c(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O3/c1-15-6-7-25(31)34-28(15)35-29(41)23-10-30(5)11-24(30)38(23)26(40)14-37-22-8-16(2)20(19-12-32-18(4)33-13-19)9-21(22)27(36-37)17(3)39/h6-9,12-13,23-24H,10-11,14H2,1-5H3,(H,34,35,41)/t23-,24+,30-/m0/s1	PQIHJNCGPGUYOD-BBANNHEPSA-N	512031	(1R,3S,5R)-2-(2-(3- acetyl-6-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 373	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512031&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160278894	459629281							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072651	CCCCc1nnc(Cc2ccc(Br)nc2NC(=O)[C@@H]2C[C@]3(C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ncc23)-c2cnc(C)nc2)C=C)o1	InChI=1S/C35H35BrN10O4/c1-5-7-8-29-42-43-30(50-29)11-21-9-10-28(36)40-33(21)41-34(49)25-13-35(6-2)14-27(35)46(25)31(48)18-45-26-17-39-24(22-15-37-20(4)38-16-22)12-23(26)32(44-45)19(3)47/h6,9-10,12,15-17,25,27H,2,5,7-8,11,13-14,18H2,1,3-4H3,(H,40,41,49)/t25-,27+,35-/m0/s1	OVONIYSIQYBMGU-XLFBXBKGSA-N	512032	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-((5- butyl-1,3,4-oxadiazol-  2-yl)methyl)pyridin-2- yl)-5-vinyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 374	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512032&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160110721	459629282							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072652	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C(O)CO)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O5/c1-14(40)26-18-6-19(16-9-31-15(2)32-10-16)33-11-21(18)37(36-26)12-25(42)38-20(7-29(3)8-23(29)38)28(43)35-27-17(22(41)13-39)4-5-24(30)34-27/h4-6,9-11,20,22-23,39,41H,7-8,12-13H2,1-3H3,(H,34,35,43)/t20-,22?,23+,29-/m0/s1	NPSFHHGBVCULMC-CURROXBKSA-N	512033	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-(1,2- dihydroxyethyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 375	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512033&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159849238	459629283							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072653	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CC(O)CO)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O5/c1-15-4-5-25(31)35-28(15)36-29(44)22-8-30(7-19(42)14-40)9-24(30)39(22)26(43)13-38-23-12-34-21(18-10-32-17(3)33-11-18)6-20(23)27(37-38)16(2)41/h4-6,10-12,19,22,24,40,42H,7-9,13-14H2,1-3H3,(H,35,36,44)/t19?,22-,24+,30-/m0/s1	ZLUSSTFUXITBTK-UHLZJQMVSA-N	512034	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- (2,3- dihydroxypropyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 376	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512034&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162155858	459629284							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072654	CN(C)CC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(CF)c12)-c1cnc(C)nc1	InChI=1S/C33H36BrFN8O3/c1-18-6-7-27(34)38-31(18)39-32(46)25-12-33(8-9-41(4)5)13-26(33)43(25)28(45)17-42-30-22(14-35)10-21(23-15-36-20(3)37-16-23)11-24(30)29(40-42)19(2)44/h6-7,10-11,15-16,25-26H,8-9,12-14,17H2,1-5H3,(H,38,39,46)/t25-,26+,33-/m0/s1	TXZATOJAWIKFET-REYAJUCUSA-N	512035	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (2- (dimethylamino)ethyl)-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 377	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512035&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161017982	459629285							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072655	CN(C)CCCC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(CF)c12)-c1cnc(C)nc1	InChI=1S/C35H40BrFN8O3/c1-20-8-9-29(36)40-33(20)41-34(48)27-14-35(10-6-7-11-43(4)5)15-28(35)45(27)30(47)19-44-32-24(16-37)12-23(25-17-38-22(3)39-18-25)13-26(32)31(42-44)21(2)46/h8-9,12-13,17-18,27-28H,6-7,10-11,14-16,19H2,1-5H3,(H,40,41,48)/t27-,28+,35-/m0/s1	TVTCBQHALFEPQO-UFEHBCDASA-N	512036	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5-  (4- (dimethylamino)butyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 378	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512036&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161000038	459629286							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072656	CN(C)CCC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(ccc1C)C(F)(F)F)C(=O)Cn1nc(C(C)=O)c2cc(cc(CF)c12)-c1cnc(C)nc1	InChI=1S/C35H38F4N8O3/c1-19-7-8-27(35(37,38)39)42-32(19)43-33(50)26-13-34(9-6-10-45(4)5)14-28(34)47(26)29(49)18-46-31-23(15-36)11-22(24-16-40-21(3)41-17-24)12-25(31)30(44-46)20(2)48/h7-8,11-12,16-17,26,28H,6,9-10,13-15,18H2,1-5H3,(H,42,43,50)/t26-,28+,34-/m0/s1	MBOIIOGAAJUVMV-HOFKBBIZSA-N	512037	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-(3- (dimethylamino)propyl)- N-(3-methyl-6- (trifluoromethyl)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 380	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512037&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159518983	459629287							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072657	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C2COC(C)(C)O2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C32H33BrN8O5/c1-16(42)28-20-8-21(18-11-34-17(2)35-12-18)36-13-23(20)40(39-28)14-27(43)41-22(9-32(5)10-25(32)41)30(44)38-29-19(6-7-26(33)37-29)24-15-45-31(3,4)46-24/h6-8,11-13,22,24-25H,9-10,14-15H2,1-5H3,(H,37,38,44)/t22-,24?,25+,32-/m0/s1	LEDLTPZKUBWFOL-QCQURMOUSA-N	512038	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-(2,2- dimethyl-1,3- dioxolan-4-yl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 381	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512038&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159324186	459629288							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072658	CCC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O3/c1-5-8-30-10-22(29(42)36-28-16(2)6-7-25(31)35-28)39(24(30)11-30)26(41)15-38-23-14-34-21(19-12-32-18(4)33-13-19)9-20(23)27(37-38)17(3)40/h6-7,9,12-14,22,24H,5,8,10-11,15H2,1-4H3,(H,35,36,42)/t22-,24+,30-/m0/s1	VIHKQRSHYDZYPT-RVVHDCIOSA-N	512039	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- propyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 382	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512039&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161306372	459629289							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072659	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C2COC(=O)O2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C30H27BrN8O6/c1-14(40)26-18-6-19(16-9-32-15(2)33-10-16)34-11-21(18)38(37-26)12-25(41)39-20(7-30(3)8-23(30)39)28(42)36-27-17(4-5-24(31)35-27)22-13-44-29(43)45-22/h4-6,9-11,20,22-23H,7-8,12-13H2,1-3H3,(H,35,36,42)/t20-,22?,23+,30-/m0/s1	DYRBNOQHMIQMJV-YSAZIYLZSA-N	512040	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-(2-oxo- 1,3-dioxolan-4- yl)pyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 383	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512040&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157956950	459629290							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072660	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(COC(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrF2N8O4/c1-14-4-5-23(30)36-26(14)37-27(43)20-7-29(13-44-28(31)32)8-22(29)40(20)24(42)12-39-21-11-35-19(17-9-33-16(3)34-10-17)6-18(21)25(38-39)15(2)41/h4-6,9-11,20,22,28H,7-8,12-13H2,1-3H3,(H,36,37,43)/t20-,22+,29-/m0/s1	KCXWBEIAVNYZTN-ZRDJEALESA-N	512041	(1R,3S,5S)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- ((difluoromethoxy)methyl)- 2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 384	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512041&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318237	459629291							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072661	CC(C)C[C@]12C[C@H]1N([C@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-16(2)9-31-10-23(30(43)37-29-17(3)6-7-26(32)36-29)40(25(31)11-31)27(42)15-39-24-14-35-22(20-12-33-19(5)34-13-20)8-21(24)28(38-39)18(4)41/h6-8,12-14,16,23,25H,9-11,15H2,1-5H3,(H,36,37,43)/t23-,25-,31+/m1/s1	ODUBPUVAXZYBDF-NZLKIYMUSA-N	512042	(1R,3R,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- isobutyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 385	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512042&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159964733	459629292							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072662	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25BrClN7O3/c1-14(38)25-18-8-16(17-11-31-15(2)32-12-17)4-6-20(18)36(35-25)13-24(39)37-21(9-28(3)10-22(28)37)27(40)34-26-19(30)5-7-23(29)33-26/h4-8,11-12,21-22H,9-10,13H2,1-3H3,(H,33,34,40)/t21-,22+,28-/m0/s1	VHOIXGVXRKEANI-TYPXCFOJSA-N	512043	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- chloropyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 386	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512043&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161300639	459629293							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072663	Cc1ncc(cn1)-c1cc2c(C=C)nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2cn1	InChI=1S/C28H27BrN8O2/c1-5-19-18-8-20(17-11-30-16(3)31-12-17)32-13-22(18)36(35-19)14-25(38)37-21(9-28(4)10-23(28)37)27(39)34-26-15(2)6-7-24(29)33-26/h5-8,11-13,21,23H,1,9-10,14H2,2-4H3,(H,33,34,39)/t21-,23+,28-/m0/s1	NFUMOZOLHAIYLP-ZCUZBQTDSA-N	512044	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2-(2-(5-(2- methylpyrimidin-5- yl)-3-vinyl-1H- pyrazolo[3,4- c]pyridin-1-yl)acetyl)-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 387	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512044&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533560	459629294							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072664	CC(C)c1nc(cc2c(nn(CC(=O)N3C[C@H]4C[C@H]4[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O3/c1-14(2)25-27-21(9-22(34-25)19-10-32-17(5)33-11-19)26(16(4)40)37-39(27)13-24(41)38-12-18-8-20(18)28(38)30(42)36-29-15(3)6-7-23(31)35-29/h6-7,9-11,14,18,20,28H,8,12-13H2,1-5H3,(H,35,36,42)/t18-,20-,28+/m1/s1	YACBFODXMJBPBP-BSSDTTEXSA-N	512045	(1R,25,5S)-3-(2-(3- acetyl-7-isopropyl-5- (2-methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-3- azabicyclo[3.1.0]hexane-  2-carboxamide::US11084800, Cpd No. 388	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512045&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161859095	459629295							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072665	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)c3ncc[nH]3)c2c1			512046	(1R,3S,5R)-2-(2-(3- (1H-imidazole-2- carbonyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6-  bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 389	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512046&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420384	459629296							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072666	Cc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)N3CC4(CCC4)C3)c2c1	InChI=1S/C35H37BrN8O3/c1-19-6-7-27(36)39-31(19)40-32(46)25-12-34(4)13-26(34)44(25)28(45)16-43-30-20(2)10-22(23-14-37-21(3)38-15-23)11-24(30)29(41-43)33(47)42-17-35(18-42)8-5-9-35/h6-7,10-11,14-15,25-26H,5,8-9,12-13,16-18H2,1-4H3,(H,39,40,46)/t25-,26+,34-/m0/s1	PDUDQIGMZURKNT-SCZOVYFASA-N	512047	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2-(2-(7- methyl-5-(2- methylpyrimidin-5- yl)-3-(2- azaspiro[3.3]heptane- 2-carbonyl)-1H- indazol-1-yl)acetyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 390	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512047&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318301	459629297							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072667	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-12-5-20(30)26(29)34-27(12)35-28(41)25-18-6-16(18)10-37(25)22(40)11-38-24-13(2)33-21(17-8-31-15(4)32-9-17)7-19(24)23(36-38)14(3)39/h5,7-9,16,18,25H,6,10-11H2,1-4H3,(H,34,35,41)/t16-,18-,25+/m1/s1	BKGYRVOFXKCQOJ-UAYVVIHISA-N	512048	(1R,2S,5S)-3-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)-3- azabicyclo[3.1.0]hexane- 2-carboxamide::US11084800, Cpd No. 393	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512048&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146436053	459629298							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072668	COc1cc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C30H30BrN7O4/c1-15-6-7-25(31)34-28(15)35-29(41)22-10-30(4)11-24(30)38(22)26(40)14-37-21-9-23(42-5)19(18-12-32-17(3)33-13-18)8-20(21)27(36-37)16(2)39/h6-9,12-13,22,24H,10-11,14H2,1-5H3,(H,34,35,41)/t22-,24+,30-/m0/s1	AMOPSASSHGCIJX-RVVHDCIOSA-N	512049	(1R,3S,5R)-2-(2-(3- acetyl-6-methoxy-5- (2-methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5-  methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 394	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512049&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157162922	459629299							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072669	COC(=O)c1cc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2cc1-c1cnc(C)nc1	InChI=1S/C31H30BrN7O5/c1-15-6-7-25(32)35-28(15)36-29(42)23-10-31(4)11-24(31)39(23)26(41)14-38-22-9-20(30(43)44-5)19(18-12-33-17(3)34-13-18)8-21(22)27(37-38)16(2)40/h6-9,12-13,23-24H,10-11,14H2,1-5H3,(H,35,36,42)/t23-,24+,31-/m0/s1	OMDSWKNCXGBSMD-JLELKNTQSA-N	512050	US11084800, Cpd No. 395::US11447465, Cmp No. T-129::methyl 3-acetyl-1-(2- ((1R,3S,5R)-3-((6- bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-1H-indazole-6- carboxylate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512050&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153298463	459629300							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072670	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN(CCC(F)(F)F)CCC(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H35BrF6N8O3/c1-19(51)30-24-12-21(23-15-43-20(2)44-16-23)4-6-25(24)49(47-30)18-29(52)50-26(13-33(3)14-27(33)50)32(53)46-31-22(5-7-28(36)45-31)17-48(10-8-34(37,38)39)11-9-35(40,41)42/h4-7,12,15-16,26-27H,8-11,13-14,17-18H2,1-3H3,(H,45,46,53)/t26-,27+,33-/m0/s1	OQSUHCCPYNEWGG-VCQOIINCSA-N	512051	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(3-((bis(3,3,3- trifluoropropyl)amino) methyl)-6- bromopyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 396	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512051&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533561	459629301							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072671	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2Cc2nn[nH]n2)c2cnc(cc12)-c1cnc(C)nc1			512052	(1R,3S,5R)-N-(3- ((2H-tetrazol-5- yl)methyl)-6- bromopyridin-2-yl)-2- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 397	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512052&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153519884	459629302							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072672	CC(=O)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN8O4/c1-15-5-6-25(31)35-28(15)36-29(43)22-9-30(8-16(2)40)10-24(30)39(22)26(42)14-38-23-13-34-21(19-11-32-18(4)33-12-19)7-20(23)27(37-38)17(3)41/h5-7,11-13,22,24H,8-10,14H2,1-4H3,(H,35,36,43)/t22-,24+,30-/m0/s1	PDKXBGOFGWIHIF-RVVHDCIOSA-N	512053	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5-  (2-oxopropyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 398	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512053&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153519880	459629303							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072673	CN(C)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(c(Cl)cc12)-c1cnc(C)nc1	InChI=1S/C31H32BrClN8O3/c1-16(42)28-21-8-20(19-12-34-17(2)35-13-19)22(33)9-23(21)40(38-28)15-27(43)41-24(10-31(3)11-25(31)41)30(44)37-29-18(14-39(4)5)6-7-26(32)36-29/h6-9,12-13,24-25H,10-11,14-15H2,1-5H3,(H,36,37,44)/t24-,25+,31-/m0/s1	BZVTXAGXOFPFKZ-NTWBYJAHSA-N	512054	(1R,3S,5R)-2-(2-(3- acetyl-6-chloro-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- ((dimethylamino)methyl) pyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 399	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512054&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420435	459629304							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072674	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CCCN2CCOCC2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C34H38BrN9O4/c1-20(45)31-24-13-25(23-16-36-21(2)37-17-23)38-18-27(24)43(41-31)19-30(46)44-26(14-34(3)15-28(34)44)33(47)40-32-22(6-7-29(35)39-32)5-4-8-42-9-11-48-12-10-42/h6-7,13,16-18,26,28H,4-5,8-12,14-15,19H2,1-3H3,(H,39,40,47)/t26-,28+,34-/m0/s1	IFSSSEQYOMCECT-HOFKBBIZSA-N	512055	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3-(3- morpholinopropyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 400	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512055&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319002	459629305							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072675	CC(O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30BrFN8O3/c1-13-6-19(31)26(30)35-27(13)36-28(42)21-8-29(5)9-22(29)39(21)23(41)12-38-25-14(2)34-20(17-10-32-16(4)33-11-17)7-18(25)24(37-38)15(3)40/h6-7,10-11,15,21-22,40H,8-9,12H2,1-5H3,(H,35,36,42)/t15?,21-,22+,29-/m0/s1	ZMXADLWMMGVXJA-XJVBSMGQSA-N	512056	(1R,3S,5R)-N-(6- bromo-5-fluoro-3- methylpyridin-2-yl)-2- (2-(3-(1- hydroxyethyl)-7- methyl-5-(2-  methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 401	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512056&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162164156	459629306							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072676	CC(O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C28H29BrN8O3/c1-14-5-6-23(29)33-26(14)34-27(40)20-8-28(4)9-22(28)37(20)24(39)13-36-21-12-32-19(17-10-30-16(3)31-11-17)7-18(21)25(35-36)15(2)38/h5-7,10-12,15,20,22,38H,8-9,13H2,1-4H3,(H,33,34,40)/t15?,20-,22+,28-/m0/s1	YVYJJEQVJBKDGV-UTGRAXKDSA-N	512057	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-2- (2-(3-(1- hydroxyethyl)-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 402	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512057&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533562	459629307							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072677	Cc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C#N)c2c1	InChI=1S/C29H27BrN8O2/c1-15-5-6-24(30)34-27(15)35-28(40)22-9-29(4)10-23(29)38(22)25(39)14-37-26-16(2)7-18(8-20(26)21(11-31)36-37)19-12-32-17(3)33-13-19/h5-8,12-13,22-23H,9-10,14H2,1-4H3,(H,34,35,40)/t22-,23+,29-/m0/s1	GXFUDMOMGSSZRA-CTWZREHQSA-N	512058	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-2- (2-(3-cyano-7-methyl-  5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 407	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512058&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318056	459629308							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072678	CN(C)Cc1ccc(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(Cl)c12)-c1cnc(C)nc1	InChI=1S/C31H32BrClN8O3/c1-16(42)27-21-8-19(20-12-34-17(2)35-13-20)9-22(33)28(21)40(38-27)15-26(43)41-23(10-31(3)11-24(31)41)30(44)37-29-18(14-39(4)5)6-7-25(32)36-29/h6-9,12-13,23-24H,10-11,14-15H2,1-5H3,(H,36,37,44)/t23-,24+,31-/m0/s1	YHRIETOONINXBR-JLELKNTQSA-N	512059	(1R,3S,5R)-2-(2-(3- acetyl-7-chloro-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- ((dimethylamino)methyl) pyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 408	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512059&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318724	459629309							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072679	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H31BrFN9O4/c1-16-5-6-26(34)39-31(16)40-32(47)24-9-33(11-27-38-19(4)42-48-27)10-25(33)44(24)28(46)15-43-30-21(12-35)7-20(22-13-36-18(3)37-14-22)8-23(30)29(41-43)17(2)45/h5-8,13-14,24-25H,9-12,15H2,1-4H3,(H,39,40,47)/t24-,25+,33-/m0/s1	NLHIZAQFXLQEPE-DVIHYUSWSA-N	512060	(1R,3S,5R)-2-(2-(3- acetyl-7- (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((3-methyl-1,2,4- oxadiazol-5- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 409	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512060&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159813228	459629310							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072680	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27BrF2N8O3/c1-14-5-6-22(29)35-26(14)36-27(42)21-8-28(31,12-30)13-38(21)23(41)11-39-25-15(2)34-20(18-9-32-17(4)33-10-18)7-19(25)24(37-39)16(3)40/h5-7,9-10,21H,8,11-13H2,1-4H3,(H,35,36,42)/t21-,28-/m0/s1	RVGXJSATJNYEEG-KMRXNPHXSA-N	512061	(2S,4R)-1-(2-(3-  acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-4- fluoro-4- (fluoromethyl)pyrrolidine- 2-carboxamide::US11084800, Cpd No. 410	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512061&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160738651	459629311							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072681	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)NCc2cccc(Cl)c2F)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27ClFN7O3/c1-14-27-21(8-23(35-14)19-10-32-16(3)33-11-19)26(15(2)39)36-38(27)13-24(40)37-12-18-7-20(18)28(37)29(41)34-9-17-5-4-6-22(30)25(17)31/h4-6,8,10-11,18,20,28H,7,9,12-13H2,1-3H3,(H,34,41)/t18-,20-,28+/m1/s1	UQUKROKBDWXWGO-BSSDTTEXSA-N	512062	(1R,2S,5S)-3-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(3-chloro-2- fluorobenzyl)-3-  azabicyclo[3.1.0]hexane- 2-carboxamide::US11084800, Cpd No. 411	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512062&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153519887	459629312							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072682	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26ClFN6O3/c1-15(38)27-22-8-17(20-11-32-16(2)33-12-20)6-7-24(22)37(35-27)14-25(39)36-13-19-9-21(19)28(36)29(40)34-10-18-4-3-5-23(30)26(18)31/h3-8,11-12,19,21,28H,9-10,13-14H2,1-2H3,(H,34,40)/t19-,21-,28+/m1/s1	HRWLHGPPNASZNO-LUHXOMTRSA-N	512063	(1R,2S,5S)-3-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-3- azabicyclo[3.1.0]hexane- 2-carboxamide::US11084800, Cpd No. 412	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512063&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319014	459629313							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072683	CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)NCc2cccc(Cl)c2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28ClFN6O3/c1-15-7-19(21-11-33-17(3)34-12-21)8-23-27(16(2)39)36-38(28(15)23)14-25(40)37-13-20-9-22(20)29(37)30(41)35-10-18-5-4-6-24(31)26(18)32/h4-8,11-12,20,22,29H,9-10,13-14H2,1-3H3,(H,35,41)/t20-,22-,29+/m1/s1	WRXXHGBOGVULPB-GLUMPRPGSA-N	512064	(1R,2S,5S)-3-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- azabicyclo[3.1.0]hexane- 2-carboxamide::US11084800, Cpd No. 413	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512064&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318613	459629314							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072684	CC(C)N(C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)C(C)C	InChI=1S/C36H43BrN8O3/c1-19(2)43(20(3)4)18-36-13-28(35(48)41-34-21(5)9-10-30(37)40-34)45(29(36)14-36)31(47)17-44-33-22(6)11-25(26-15-38-24(8)39-16-26)12-27(33)32(42-44)23(7)46/h9-12,15-16,19-20,28-29H,13-14,17-18H2,1-8H3,(H,40,41,48)/t28-,29+,36-/m0/s1	QXMLHQIDXPAGJG-WEPHICOPSA-N	512065	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- ((diisopropylamino) methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 415	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512065&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420403	459629315							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072685	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN6O3/c1-16-5-8-26(31)34-28(16)35-29(40)24-10-30(4)11-25(30)37(24)27(39)15-36-14-22(17(2)38)21-9-19(6-7-23(21)36)20-12-32-18(3)33-13-20/h5-9,12-14,24-25H,10-11,15H2,1-4H3,(H,34,35,40)/t24-,25+,30-/m0/s1	TWJVQOKEHJOMPH-FVXXUCQHSA-N	512066	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 416	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512066&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319082	459629316							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072686	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrF3N8O3/c1-13-5-19(31)25(29)36-26(13)37-27(43)21-7-28(32,11-30)12-39(21)22(42)10-40-24-14(2)35-20(17-8-33-16(4)34-9-17)6-18(24)23(38-40)15(3)41/h5-6,8-9,21H,7,10-12H2,1-4H3,(H,36,37,43)/t21-,28-/m0/s1	KVZVPQIGIHOGLV-KMRXNPHXSA-N	512067	(2S,4R)-1-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 4-fluoro-4- (fluoromethyl)pyrrolidine- 2-carboxamide::US11084800, Cpd No. 417	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512067&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318296	459629317							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072687	CC(=O)c1nn(CC(=O)N2C[C@@](F)(CF)C[C@H]2C(=O)Nc2cncc(Br)n2)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24BrF2N9O3/c1-13-24-17(4-18(33-13)16-6-31-15(3)32-7-16)23(14(2)39)36-38(24)10-22(40)37-12-26(29,11-28)5-19(37)25(41)35-21-9-30-8-20(27)34-21/h4,6-9,19H,5,10-12H2,1-3H3,(H,34,35,41)/t19-,26-/m0/s1	PTSADODNSPDBEU-SIBVEZHUSA-N	512068	(2S,4R)-1-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromopyrazin-2- yl)-4-fluoro-4- (fluoromethyl)pyrrolidine- 2-carboxamide::US11084800, Cpd No. 418	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512068&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318247	459629318							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072688	CC(=O)c1nn(CC(=O)N2C[C@](F)(Cn3ccnn3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrFN10O3/c1-17-4-7-25(31)36-28(17)37-29(45)24-11-30(32,15-40-9-8-35-39-40)16-41(24)26(44)14-42-23-6-5-20(21-12-33-19(3)34-13-21)10-22(23)27(38-42)18(2)43/h4-10,12-13,24H,11,14-16H2,1-3H3,(H,36,37,45)/t24-,30+/m0/s1	VCQJGTCJYRXTAK-QABMSTFYSA-N	512069	(2S,4S)-4-((1H-1,2,3- triazol-1-yl)methyl)-1- (2-(3-acetyl-5-(2- methylpyrimidin-5- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US11084800, Cpd No. 419	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512069&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161261749	459629319							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072689	CN(C)C[C@]1(F)C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C30H32BrFN8O3/c1-17-6-9-25(31)35-28(17)36-29(43)24-11-30(32,15-38(4)5)16-39(24)26(42)14-40-23-8-7-20(21-12-33-19(3)34-13-21)10-22(23)27(37-40)18(2)41/h6-10,12-13,24H,11,14-16H2,1-5H3,(H,35,36,43)/t24-,30+/m0/s1	HFKYPZIYNQFXMI-QABMSTFYSA-N	512070	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- ((dimethylamino) methyl)-4- fluoropyrrolidine-2- carboxamide::US11084800, Cpd No. 420	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512070&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158463189	459629320							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072690	COC[C@]1(F)C[C@H](N(C1)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)Nc1nc(Br)ccc1C	InChI=1S/C29H29BrFN7O4/c1-16-5-8-24(30)34-27(16)35-28(41)23-10-29(31,15-42-4)14-37(23)25(40)13-38-22-7-6-19(20-11-32-18(3)33-12-20)9-21(22)26(36-38)17(2)39/h5-9,11-12,23H,10,13-15H2,1-4H3,(H,34,35,41)/t23-,29-/m0/s1	KLNAHNGVPSAVBV-IADCTJSHSA-N	512071	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- fluoro-4- (methoxymethyl) pyrrolidine-2-carboxamide::US11084800, Cpd No. 421	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512071&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317601	459629321							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072691	CC(=O)c1nn(CC(=O)N2C[C@](F)(CF)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrF2N7O3/c1-15-4-7-23(29)34-26(15)35-27(41)22-9-28(31,13-30)14-37(22)24(40)12-38-21-6-5-18(19-10-32-17(3)33-11-19)8-20(21)25(36-38)16(2)39/h4-8,10-11,22H,9,12-14H2,1-3H3,(H,34,35,41)/t22-,28+/m0/s1	NSJDTCLMYOVWIE-RBISFHTESA-N	512072	(2S,4S)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- fluoro-4- (fluoromethyl)pyrrolidine- 2-carboxamide::US11084800, Cpd No. 422	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512072&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317998	459629322							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072692	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30BrFN10O4/c1-14-6-21(34)29(33)39-30(14)40-31(47)23-8-32(10-25-38-18(5)42-48-25)9-24(32)44(23)26(46)13-43-28-15(2)37-22(19-11-35-17(4)36-12-19)7-20(28)27(41-43)16(3)45/h6-7,11-12,23-24H,8-10,13H2,1-5H3,(H,39,40,47)/t23-,24+,32-/m0/s1	PEASJFBPBSCWGG-XNSHOJTPSA-N	512073	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-l-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-((3-methyl-1,2,4- oxadiazol-5- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 423	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512073&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319012	459629323							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072693	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H31BrFN9O4/c1-15-6-20(21-12-36-18(4)37-13-21)8-22-28(17(3)45)41-43(29(15)22)14-27(46)44-24(32(47)40-31-16(2)7-23(35)30(34)39-31)9-33(10-25(33)44)11-26-38-19(5)42-48-26/h6-8,12-13,24-25H,9-11,14H2,1-5H3,(H,39,40,47)/t24-,25+,33-/m0/s1	QJCUSBXLKIMXBY-DVIHYUSWSA-N	512074	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-5-fluoro-3- methylpyridin-2-yl)-5- ((3-methyl-1,2,4- oxadiazol-5-  yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 424	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512074&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319030	459629324							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072694	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2nc(ccc2C)C(F)(F)F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32F3N9O4/c1-16-6-7-25(34(35,36)37)41-31(16)42-32(49)24-10-33(12-27-40-20(5)44-50-27)11-26(33)46(24)28(48)15-45-30-17(2)8-21(22-13-38-19(4)39-14-22)9-23(30)29(43-45)18(3)47/h6-9,13-14,24,26H,10-12,15H2,1-5H3,(H,41,42,49)/t24-,26+,33-/m0/s1	UNAUPFQAZABPBH-SVGJTRDOSA-N	512075	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-((3- methyl-1,2,4- oxadiazol-5- yl)methyl)-N-(3- methyl-6- (trifluoromethyl)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 425	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512075&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318896	459629325							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072695	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31BrN6O3/c1-16-6-7-26(32)35-29(16)36-30(41)24-10-31(5)11-25(31)38(24)27(40)15-37-14-23(18(3)39)22-9-20(8-17(2)28(22)37)21-12-33-19(4)34-13-21/h6-9,12-14,24-25H,10-11,15H2,1-5H3,(H,35,36,41)/t24-,25+,31-/m0/s1	UXNFPLOWFUTNEC-NTWBYJAHSA-N	512076	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5-  methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 426	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512076&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318628	459629326							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072696	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32ClFN8O4/c1-17-8-22(23-14-37-19(3)38-15-23)9-24-31(18(2)45)41-43(32(17)24)16-29(46)44-26(33(47)39-13-21-6-5-7-25(35)30(21)36)10-34(11-27(34)44)12-28-40-20(4)42-48-28/h5-9,14-15,26-27H,10-13,16H2,1-4H3,(H,39,47)/t26-,27+,34-/m0/s1	FVYGOHJZNHBPQM-MZXMJASYSA-N	512077	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-5-((3- methyl-1,2,4- oxadiazol-5- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 427	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512077&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318225	459629327							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072697	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2nc(Br)ccc2Cl)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H29BrClN9O4/c1-15-7-19(20-12-35-17(3)36-13-20)8-21-28(16(2)44)40-42(29(15)21)14-27(45)43-23(31(46)39-30-22(34)5-6-25(33)38-30)9-32(10-24(32)43)11-26-37-18(4)41-47-26/h5-8,12-13,23-24H,9-11,14H2,1-4H3,(H,38,39,46)/t23-,24+,32-/m0/s1	CWNICOXTDAAAAV-XNSHOJTPSA-N	512078	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- chloropyridin-2-yl)-5- ((3-methyl-1,2,4- oxadiazol-5-  yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 428	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512078&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317900	459629328							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072698	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CF)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H31BrFN9O4/c1-16-5-6-26(34)38-31(16)39-32(47)24-9-33(11-27-41-40-19(4)48-27)10-25(33)44(24)28(46)15-43-30-21(12-35)7-20(22-13-36-18(3)37-14-22)8-23(30)29(42-43)17(2)45/h5-8,13-14,24-25H,9-12,15H2,1-4H3,(H,38,39,47)/t24-,25+,33-/m0/s1	LBVXGMFGOPGEPK-DVIHYUSWSA-N	512079	(1R,3S,5R)-2-(2-(3- acetyl-7-  (fluoromethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5-  ((5-methyl-1,3,4- oxadiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 429	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512079&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318138	459629329							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072699	CC(=O)c1nn(CC(=O)N2C[C@](C)(F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H27BrFN7O3/c1-15-5-8-23(29)33-26(15)34-27(40)22-10-28(4,30)14-36(22)24(39)13-37-21-7-6-18(19-11-31-17(3)32-12-19)9-20(21)25(35-37)16(2)38/h5-9,11-12,22H,10,13-14H2,1-4H3,(H,33,34,40)/t22-,28+/m0/s1	VFRZWQFOZFTVMF-RBISFHTESA-N	512080	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- fluoro-4- methylpyrrolidine-2- carboxamide::US11084800, Cpd No. 430	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512080&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318013	459629330							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072700	Cc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)c(F)cc3C)c2c(C)n1)C(N)=O	InChI=1S/C28H27BrFN9O3/c1-12-5-17(30)24(29)35-26(12)36-27(42)19-7-28(4)8-20(28)39(19)21(40)11-38-23-13(2)34-18(15-9-32-14(3)33-10-15)6-16(23)22(37-38)25(31)41/h5-6,9-10,19-20H,7-8,11H2,1-4H3,(H2,31,41)(H,35,36,42)/t19-,20+,28-/m0/s1	VTCUVFKYMPVPJN-BCDQWZCSSA-N	512081	1-(2-((1R,3S,5R)-3- ((6-bromo-5-fluoro-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-7- methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridine-3- carboxamide::US11084800, Cpd No. 431	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512081&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161392120	459629331							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072701	CC(=O)c1nn(CC(=O)N2C[C@](C)(F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H28BrFN8O3/c1-14-6-7-22(29)34-26(14)35-27(41)21-9-28(5,30)13-37(21)23(40)12-38-25-15(2)33-20(18-10-31-17(4)32-11-18)8-19(25)24(36-38)16(3)39/h6-8,10-11,21H,9,12-13H2,1-5H3,(H,34,35,41)/t21-,28+/m0/s1	YDYVGOYZLMQYOA-RBTNQOKQSA-N	512082	(2S,4R)-1-(2-(3-  acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-4- fluoro-4- methylpyrrolidine-2- carboxamide::US11084800, Cpd No. 432	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512082&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318708	459629332							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072702	CC(=O)c1nn(CC(=O)N2C[C@](C)(F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrFN7O3/c1-15-6-7-23(30)34-27(15)35-28(41)22-10-29(5,31)14-37(22)24(40)13-38-26-16(2)8-19(20-11-32-18(4)33-12-20)9-21(26)25(36-38)17(3)39/h6-9,11-12,22H,10,13-14H2,1-5H3,(H,34,35,41)/t22-,29+/m0/s1	IZEYEPUZVHYGDZ-PZGXJGMVSA-N	512083	(2S,4R)-1-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-4- fluoro-4- methylpyrrolidine-2- carboxamide::US11084800, Cpd No. 433	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512083&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318807	459629333							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072703	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32ClFN8O4/c1-17-8-22(23-14-37-19(3)38-15-23)9-24-31(18(2)45)42-43(32(17)24)16-29(46)44-26(33(47)39-13-21-6-5-7-25(35)30(21)36)10-34(11-27(34)44)12-28-41-40-20(4)48-28/h5-9,14-15,26-27H,10-13,16H2,1-4H3,(H,39,47)/t26-,27+,34-/m0/s1	MKAWRNLGWVPLJZ-MZXMJASYSA-N	512084	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-5-((5- methyl-1,3,4- oxadiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 434	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512084&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318839	459629334							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072704	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)Nc2nc(ccc2C)C(F)(F)F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32F3N9O4/c1-16-6-7-25(34(35,36)37)40-31(16)41-32(49)24-10-33(12-27-43-42-20(5)50-27)11-26(33)46(24)28(48)15-45-30-17(2)8-21(22-13-38-19(4)39-14-22)9-23(30)29(44-45)18(3)47/h6-9,13-14,24,26H,10-12,15H2,1-5H3,(H,40,41,49)/t24-,26+,33-/m0/s1	WTAYWPPKYZAISL-SVGJTRDOSA-N	512085	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-((5- methyl-1,3,4- oxadiazol-2- yl)methyl)-N-(3- methyl-6-  (trifluoromethyl)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 435	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512085&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153519895	459629335							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072705	Cc1ncc(cn1)-c1cc2c(nn(CC(=O)N3C[C@H]4C[C@H]4[C@H]3C(=O)Nc3nc(Br)ccc3C)c2c(C)n1)C(N)=O	InChI=1S/C27H26BrN9O3/c1-12-4-5-20(28)33-26(12)34-27(40)24-17-6-15(17)10-36(24)21(38)11-37-23-13(2)32-19(16-8-30-14(3)31-9-16)7-18(23)22(35-37)25(29)39/h4-5,7-9,15,17,24H,6,10-11H2,1-3H3,(H2,29,39)(H,33,34,40)/t15-,17-,24+/m1/s1	SCFQYPXCKQYPSW-NZEOALSQSA-N	512086	1-(2-((1R,25,5S)-2- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-3-  azabicyclo[3.1.0]hexan-  3-yl)-2-oxoethyl)-7-  methyl-5-(2-  methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridine-3- carboxamide::US11084800, Cpd No. 436	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512086&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160794292	459629336							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072706	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-5-6-25(30)34-27(15)35-28(40)22-8-29(4)9-24(29)37(22)26(39)14-36-13-20(16(2)38)19-7-21(33-12-23(19)36)18-10-31-17(3)32-11-18/h5-7,10-13,22,24H,8-9,14H2,1-4H3,(H,34,35,40)/t22-,24+,29-/m0/s1	PQHSENUGRVCONP-KNAJXNNHSA-N	512087	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrrolo[2,3- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 437	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512087&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533563	459629337							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072707	CSCc1cc(F)c(Br)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H29BrFN7O3S/c1-15(40)26-20-7-17(19-11-33-16(2)34-12-19)5-6-22(20)38(37-26)13-25(41)39-23(9-30(3)10-24(30)39)29(42)36-28-18(14-43-4)8-21(32)27(31)35-28/h5-8,11-12,23-24H,9-10,13-14H2,1-4H3,(H,35,36,42)/t23-,24+,30-/m0/s1	VPYWCZCOWACGDB-BBANNHEPSA-N	512088	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-5-fluoro-3- ((methylthio)methyl) pyridin-2-yl)-5-methyl- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 438	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512088&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420515	459629338							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072708	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(I)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23FIN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(27)9-21(34)26(38)32-23-5-3-4-22(28)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	WRSLSBKICOLPDH-NQIIRXRSSA-N	512089	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro-N- (6-iodopyridin-2- yl)pyrrolidine-2- carboxamide::US11084800, Cpd No. 439	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512089&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318147	459629339							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072709	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccn2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H24FN7O3/c1-15(35)25-20-9-17(18-11-29-16(2)30-12-18)6-7-21(20)34(32-25)14-24(36)33-13-19(27)10-22(33)26(37)31-23-5-3-4-8-28-23/h3-9,11-12,19,22H,10,13-14H2,1-2H3,(H,28,31,37)/t19-,22+/m1/s1	IMGAZAADJGYAKA-KNQAVFIVSA-N	512090	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4-fluoro-N- (pyridin-2- yl)pyrrolidine-2- carboxamide::US11084800, Cpd No. 440	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512090&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158740595	459629340							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072710	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNc3ccn(CC(F)(F)F)n3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H34BrF3N10O3/c1-18-5-6-27(36)43-32(18)44-33(52)25-11-34(16-42-28-7-8-47(45-28)17-35(37,38)39)12-26(34)49(25)29(51)15-48-31-19(2)9-22(23-13-40-21(4)41-14-23)10-24(31)30(46-48)20(3)50/h5-10,13-14,25-26H,11-12,15-17H2,1-4H3,(H,42,45)(H,43,44,52)/t25-,26+,34-/m0/s1	UJLGIYQBBKZRFS-SCZOVYFASA-N	512091	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- (((1-(2,2,2- trifluoroethyl)-1H- pyrazol-3- yl)amino)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 441	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512091&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420503	459629341							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072711	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)ncc2c1	InChI=1S/C24H21BrFN7O2/c1-14-27-9-17(10-28-14)15-5-6-19-16(7-15)11-29-33(19)13-23(34)32-12-18(26)8-20(32)24(35)31-22-4-2-3-21(25)30-22/h2-7,9-11,18,20H,8,12-13H2,1H3,(H,30,31,35)/t18-,20+/m1/s1	QJRGCZKSOJAEOF-QUCCMNQESA-N	512092	(2S,4R)-N-(6- bromopyridin-2-yl)-4- fluoro-1-(2-(5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)pyrrolidine- 2-carboxamide::US11084800, Cpd No. 444	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512092&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317559	459629342							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072712	CCc1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H25BrFN7O2/c1-3-20-19-9-16(17-11-29-15(2)30-12-17)7-8-21(19)35(33-20)14-25(36)34-13-18(28)10-22(34)26(37)32-24-6-4-5-23(27)31-24/h4-9,11-12,18,22H,3,10,13-14H2,1-2H3,(H,31,32,37)/t18-,22+/m1/s1	GQOOUTKBUMIQDE-GCJKJVERSA-N	512093	(2S,4R)-N-(6- bromopyridin-2-yl)-1- (2-(3-ethyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamide::US11084800, Cpd No. 445	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512093&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318144	459629343							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072713	CN(C(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1cccc(Br)n1	InChI=1S/C27H25BrFN7O3/c1-15(37)26-20-9-17(18-11-30-16(2)31-12-18)7-8-21(20)36(33-26)14-25(38)35-13-19(29)10-22(35)27(39)34(3)24-6-4-5-23(28)32-24/h4-9,11-12,19,22H,10,13-14H2,1-3H3/t19-,22+/m1/s1	RSJVCCKPZXRZLB-KNQAVFIVSA-N	512094	(2S,4R)-1-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoro-N- methylpyrrolidine-2- carboxamide::US11084800, Cpd No. 446	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512094&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160715343	459629344							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072714	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nc(C)no3)C[C@H]2C(=O)Nc2cncc(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H29BrN10O4/c1-15-5-19(20-10-34-17(3)35-11-20)6-21-28(16(2)43)39-41(29(15)21)14-27(44)42-22(30(45)38-25-13-33-12-24(32)37-25)7-31(8-23(31)42)9-26-36-18(4)40-46-26/h5-6,10-13,22-23H,7-9,14H2,1-4H3,(H,37,38,45)/t22-,23+,31-/m0/s1	OKGIZXDZURHGIZ-LWPQGVMLSA-N	512095	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyrazin-2-yl)-5- ((3-methyl-1,2,4- oxadiazol-5- yl)methyl)-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 447	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512095&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318153	459629345							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072715	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(OC(F)(F)F)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H31F3N6O4/c1-16-6-7-26(45-32(33,34)35)38-29(16)39-30(44)24-10-31(5)11-25(31)41(24)27(43)15-40-14-23(18(3)42)22-9-20(8-17(2)28(22)40)21-12-36-19(4)37-13-21/h6-9,12-14,24-25H,10-11,15H2,1-5H3,(H,38,39,44)/t24-,25+,31-/m0/s1	XGHWAIDUKVJNHH-NTWBYJAHSA-N	512096	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indo1-1- yl)acetyl)-5-methyl-N- (3-methyl-6- (trifluoromethoxy)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 448	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512096&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318756	459629346							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072716	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Oc3ccccn3)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32N8O4/c1-19-12-22(23-16-36-21(3)37-17-23)13-24-31(20(2)43)40-41(32(19)24)18-30(44)42-25(14-34(4)15-26(34)42)33(45)39-27-8-7-10-29(38-27)46-28-9-5-6-11-35-28/h5-13,16-17,25-26H,14-15,18H2,1-4H3,(H,38,39,45)/t25-,26+,34-/m0/s1	RXTCPWYICDTSQQ-SCZOVYFASA-N	512097	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (6-(pyridin-2-  yloxy)pyridin-2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 449	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512097&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317872	459629347							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072717	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(ccc2C)-c2ccccn2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32N8O3/c1-19-8-10-26(25-7-5-6-12-35-25)38-32(19)39-33(45)28-14-34(4)15-29(34)42(28)30(44)18-41-27-11-9-22(23-16-36-21(3)37-17-23)13-24(27)31(40-41)20(2)43/h5-13,16-17,28-29H,14-15,18H2,1-4H3,(H,38,39,45)/t28-,29+,34-/m0/s1	VFIYLCBPNDFTMY-ZZMKVXQQSA-N	512098	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N- (5-methyl-[2,2'- bipyridin]-6-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 450	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512098&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318847	459629348							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072718	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(n2)-n2ccccc2=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32N8O4/c1-19-12-22(23-16-35-21(3)36-17-23)13-24-31(20(2)43)39-41(32(19)24)18-30(45)42-25(14-34(4)15-26(34)42)33(46)38-27-8-7-9-28(37-27)40-11-6-5-10-29(40)44/h5-13,16-17,25-26H,14-15,18H2,1-4H3,(H,37,38,46)/t25-,26+,34-/m0/s1	WJGSKSQVYRVRNN-SCZOVYFASA-N	512099	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (2-oxo-2H-[1,2'- bipyridin]-6'-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 451	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512099&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317899	459629349							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072719	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1ccncc1	InChI=1S/C29H27BrN6O3/c1-16-4-7-24(30)32-27(16)33-28(39)22-13-29(3)14-23(29)36(22)25(38)15-35-21-6-5-19(18-8-10-31-11-9-18)12-20(21)26(34-35)17(2)37/h4-12,22-23H,13-15H2,1-3H3,(H,32,33,39)/t22-,23+,29-/m0/s1	GKBHWAHURZJBQH-CTWZREHQSA-N	512100	(1R,3S,5R)-2-(2-(3- acetyl-5-(pyridin-4-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 452	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512100&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319000	459629350							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072720	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1ccc(C)cn1	InChI=1S/C30H29BrN6O3/c1-16-5-8-21(32-14-16)19-7-9-22-20(11-19)27(18(3)38)35-36(22)15-26(39)37-23(12-30(4)13-24(30)37)29(40)34-28-17(2)6-10-25(31)33-28/h5-11,14,23-24H,12-13,15H2,1-4H3,(H,33,34,40)/t23-,24+,30-/m0/s1	VTROBRNCQOEDMJ-BBANNHEPSA-N	512101	(1R,3S,5R)-2-(2-(3- acetyl-5-(5- methylpyridin-2-yl)- 1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 453	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512101&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318626	459629351							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072721	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-14-6-23(30)34-24(7-14)35-28(41)21-9-29(5)10-22(29)38(21)25(40)13-37-27-15(2)33-20(18-11-31-17(4)32-12-18)8-19(27)26(36-37)16(3)39/h6-8,11-12,21-22H,9-10,13H2,1-5H3,(H,34,35,41)/t21-,22+,29-/m0/s1	YMTKVIZNZQZUBM-KERYWQKISA-N	512102	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-4- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 455	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512102&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318068	459629352							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072722	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O3/c1-15-6-24(31)34-25(7-15)35-29(41)22-10-30(5)11-23(30)38(22)26(40)14-37-28-16(2)8-19(20-12-32-18(4)33-13-20)9-21(28)27(36-37)17(3)39/h6-9,12-13,22-23H,10-11,14H2,1-5H3,(H,34,35,41)/t22-,23+,30-/m0/s1	FIWHVGYMZSYFAL-BURCIIJTSA-N	512103	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- methylpyridin-2-yl)-5-  methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 456	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512103&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318749	459629353							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072723	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrFN6O3/c1-15-7-22(32)27(31)35-28(15)36-29(41)24-9-30(4)10-25(30)38(24)26(40)14-37-13-21(16(2)39)20-8-18(5-6-23(20)37)19-11-33-17(3)34-12-19/h5-8,11-13,24-25H,9-10,14H2,1-4H3,(H,35,36,41)/t24-,25+,30-/m0/s1	AQZJTPODBYGTGB-FVXXUCQHSA-N	512104	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromo-5-fluoro-3- methylpyridin-2-yl)-5 methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 457	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512104&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319190	459629354							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072724	CC(C)C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)C(O)=O	InChI=1S/C30H36N6O5/c1-15(2)7-22(29(40)41)33-28(39)23-10-30(6)11-24(30)36(23)25(38)14-35-27-16(3)8-19(20-12-31-18(5)32-13-20)9-21(27)26(34-35)17(4)37/h8-9,12-13,15,22-24H,7,10-11,14H2,1-6H3,(H,33,39)(H,40,41)/t22-,23-,24+,30-/m0/s1	FAFAURRDQKGJFV-WAHOFHFDSA-N	512105	((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carbonyl)-L- leucine::US11084800, Cpd No. 458	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512105&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318614	459629355							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072725	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(ccc2C)C(F)(F)F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H31F3N6O3/c1-16-6-7-25(32(33,34)35)38-29(16)39-30(44)24-10-31(5)11-26(31)41(24)27(43)15-40-14-23(18(3)42)22-9-20(8-17(2)28(22)40)21-12-36-19(4)37-13-21/h6-9,12-14,24,26H,10-11,15H2,1-5H3,(H,38,39,44)/t24-,26+,31-/m0/s1	WIJLVMDTKOJYRN-DHUXRJIASA-N	512106	(1R,3S,5R)-2-(2-(3-  acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-5-methyl-N- (3-methyl-6- (trifluoromethyl)pyridin- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 459	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512106&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146435654	459629356							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072726	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccn(-c3ccccn3)c2=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H32N8O4/c1-19-12-22(23-16-36-21(3)37-17-23)13-24-30(20(2)43)39-41(31(19)24)18-29(44)42-26(14-34(4)15-27(34)42)32(45)38-25-8-7-11-40(33(25)46)28-9-5-6-10-35-28/h5-13,16-17,26-27H,14-15,18H2,1-4H3,(H,38,45)/t26-,27+,34-/m0/s1	AHNAZWZMTFFYMB-MZXMJASYSA-N	512107	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (2-oxo-2H-[1,2'- bipyridin]-3-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 460	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512107&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319044	459629357							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072727	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(Br)ncc2F)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN8O3/c1-13(38)25-16-4-18(15-8-30-14(2)31-9-15)32-11-21(16)36(35-25)12-24(39)37-20(6-27(3)7-22(27)37)26(40)34-19-5-23(28)33-10-17(19)29/h4-5,8-11,20,22H,6-7,12H2,1-3H3,(H,33,34,40)/t20-,22+,27-/m0/s1	QMPFAMYHOUXPPU-ZIHSNCGMSA-N	512108	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(2-bromo-5- fluoropyridin-4-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 461	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512108&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160459257	459629358							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072728	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)N[C@H](Cc2ccccc2)C(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H34N6O5/c1-18-10-22(23-15-34-20(3)35-16-23)12-24-29(19(2)40)37-38(30(18)24)17-28(41)39-26(13-33(4)14-27(33)39)31(42)36-25(32(43)44)11-21-8-6-5-7-9-21/h5-10,12,15-16,25-27H,11,13-14,17H2,1-4H3,(H,36,42)(H,43,44)/t25-,26+,27-,33+/m1/s1	IRJIOQKNECURFK-CYNXIGLJSA-N	512109	((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2-  methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2-  azabicyclo[3.1.0]hexane- 3-carbonyl)-D- phenylalanine::US11084800, Cpd No. 462	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512109&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318335	459629359							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072729	CC(C)C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)C(O)=O	InChI=1S/C30H36N6O5/c1-15(2)7-22(29(40)41)33-28(39)23-10-30(6)11-24(30)36(23)25(38)14-35-27-16(3)8-19(20-12-31-18(5)32-13-20)9-21(27)26(34-35)17(4)37/h8-9,12-13,15,22-24H,7,10-11,14H2,1-6H3,(H,33,39)(H,40,41)/t22-,23+,24-,30+/m1/s1	FAFAURRDQKGJFV-IFVFNEAISA-N	512110	((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carbonyl)-D- leucine::US11084800, Cpd No. 464	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512110&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317937	459629360							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072730	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)cc(C(=O)C(F)(F)F)c2c1	InChI=1S/C30H26BrF3N6O3/c1-15-4-7-24(31)37-27(15)38-28(43)22-9-29(3)10-23(29)40(22)25(41)14-39-13-20(26(42)30(32,33)34)19-8-17(5-6-21(19)39)18-11-35-16(2)36-12-18/h4-8,11-13,22-23H,9-10,14H2,1-3H3,(H,37,38,43)/t22-,23+,29-/m0/s1	CLIYFWXPCJAKPL-CTWZREHQSA-N	512111	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2-(2-(5-(2-  methylpyrimidin-5- yl)-3-(2,2,2- trifluoroacetyl)-1H-  indol-1-yl)acetyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 465	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512111&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318119	459629361							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072731	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cc(F)c(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrFN7O3/c1-14-5-6-24(30)34-27(14)35-28(41)22-9-29(4)10-23(29)38(22)25(40)13-37-21-8-20(31)18(17-11-32-16(3)33-12-17)7-19(21)26(36-37)15(2)39/h5-8,11-12,22-23H,9-10,13H2,1-4H3,(H,34,35,41)/t22-,23+,29-/m0/s1	ANNZCOYAZIZQAC-CTWZREHQSA-N	512112	(1R,3S,5R)-2-(2-(3- acetyl-6-fluoro-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6-  bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 466	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512112&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420412	459629362							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072732	COC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O4/c1-15-5-8-23(30)33-26(15)34-27(39)21-10-29(3)11-22(29)37(21)24(38)14-36-20-7-6-17(18-12-31-16(2)32-13-18)9-19(20)25(35-36)28(40)41-4/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H,33,34,39)/t21-,22+,29-/m0/s1	BEAILMQHTFJYDQ-KERYWQKISA-N	512113	US11084800, Cpd No. 467::methyl 1-(2- ((1R,3S,5R)-3-((6- bromo-3-  methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-1H-indazole-3- carboxylate	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512113&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317465	459629363							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072733	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(O)=O)c2c1	InChI=1S/C28H26BrN7O4/c1-14-4-7-22(29)32-25(14)33-26(38)20-9-28(3)10-21(28)36(20)23(37)13-35-19-6-5-16(17-11-30-15(2)31-12-17)8-18(19)24(34-35)27(39)40/h4-8,11-12,20-21H,9-10,13H2,1-3H3,(H,39,40)(H,32,33,38)/t20-,21+,28-/m0/s1	ZVNHFULACWQHJH-GTNJKRJXSA-N	512114	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- carboxylic acid::US11084800, Cpd No. 469	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512114&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317867	459629364							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072734	Cc1ncc(cn1)-c1cc2c(cn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2cn1)C(=O)C(F)(F)F	InChI=1S/C29H25BrF3N7O3/c1-14-4-5-23(30)37-26(14)38-27(43)20-7-28(3)8-22(28)40(20)24(41)13-39-12-18(25(42)29(31,32)33)17-6-19(36-11-21(17)39)16-9-34-15(2)35-10-16/h4-6,9-12,20,22H,7-8,13H2,1-3H3,(H,37,38,43)/t20-,22+,28-/m0/s1	GLDOHZRCJOQQAZ-PGKWVRKKSA-N	512115	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2-(2-(5-(2- methylpyrimidin-5- yl)-3-(2,2,2- trifluoroacetyl)-1H- pyrrolo[2,3-c]pyridin- 1-yl)acetyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 470	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512115&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420443	459629365							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072735	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrFN7O3/c1-14-6-21(32)27(31)36-28(14)37-29(42)23-8-30(5)9-24(30)39(23)25(41)13-38-12-20(16(3)40)19-7-22(35-15(2)26(19)38)18-10-33-17(4)34-11-18/h6-7,10-12,23-24H,8-9,13H2,1-5H3,(H,36,37,42)/t23-,24+,30-/m0/s1	OJJIAFXJAUYFEX-BBANNHEPSA-N	512116	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrrolo[2,3- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 471	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512116&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317888	459629366							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072736	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O3/c1-15-6-7-25(31)35-28(15)36-29(41)23-9-30(5)10-24(30)38(23)26(40)14-37-13-21(17(3)39)20-8-22(34-16(2)27(20)37)19-11-32-18(4)33-12-19/h6-8,11-13,23-24H,9-10,14H2,1-5H3,(H,35,36,41)/t23-,24+,30-/m0/s1	PHSBRDXTSVWGSD-BBANNHEPSA-N	512117	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrrolo[2,3- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 472	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512117&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317676	459629367							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072737	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(F)cc(Br)n2)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C28H26BrFN8O3/c1-13-26-18(7-19(33-13)16-10-31-15(3)32-11-16)25(14(2)39)36-37(26)12-24(40)38-20(8-28(4)9-21(28)38)27(41)35-23-6-17(30)5-22(29)34-23/h5-7,10-11,20-21H,8-9,12H2,1-4H3,(H,34,35,41)/t20-,21+,28-/m0/s1	ALDNEHQYCJJQMP-GTNJKRJXSA-N	512118	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4-  c]pyridin-1-yl)acetyl)- N-(6-bromo-4- fluoropyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 473	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512118&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422900	459629368							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072738	CCNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H31BrN8O3/c1-5-32-29(42)26-20-10-18(19-13-33-17(3)34-14-19)7-8-21(20)38(37-26)15-25(40)39-22(11-30(4)12-23(30)39)28(41)36-27-16(2)6-9-24(31)35-27/h6-10,13-14,22-23H,5,11-12,15H2,1-4H3,(H,32,42)(H,35,36,41)/t22-,23+,30-/m0/s1	ZGDJGTGCCWXSKR-BURCIIJTSA-N	512119	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- ethyl-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 474	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512119&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318063	459629369							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072739	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2F)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN8O3/c1-13(38)24-16-6-18(15-9-30-14(2)31-10-15)32-11-20(16)36(35-24)12-23(39)37-19(7-27(3)8-21(27)37)26(40)34-25-17(29)4-5-22(28)33-25/h4-6,9-11,19,21H,7-8,12H2,1-3H3,(H,33,34,40)/t19-,21+,27-/m0/s1	LSZJHKCCJXQRHV-FCDUAZGNSA-N	512120	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-3- fluoropyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 481	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512120&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422905	459629370							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072740	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cc(F)c(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrFN6O3/c1-15-5-6-26(31)35-28(15)36-29(41)24-9-30(4)10-25(30)38(24)27(40)14-37-13-21(16(2)39)20-7-19(22(32)8-23(20)37)18-11-33-17(3)34-12-18/h5-8,11-13,24-25H,9-10,14H2,1-4H3,(H,35,36,41)/t24-,25+,30-/m0/s1	JABGENUPGHRTFC-FVXXUCQHSA-N	512121	(1R,3S,5R)-2-(2-(3- acetyl-6-fluoro-5-(2- methylpyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 482	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512121&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318576	459629371							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072741	CC(=O)c1c(C)n(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31BrN6O3/c1-16-6-9-26(32)35-29(16)36-30(41)24-11-31(5)12-25(31)38(24)27(40)15-37-17(2)28(18(3)39)22-10-20(7-8-23(22)37)21-13-33-19(4)34-14-21/h6-10,13-14,24-25H,11-12,15H2,1-5H3,(H,35,36,41)/t24-,25+,31-/m0/s1	FZTIUDCLXADUBB-NTWBYJAHSA-N	512122	(1R,3S,5R)-2-(2-(3- acetyl-2-methyl-5-(2- methylpyrimidin-5- yl)-1H-indol-1-  yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 483	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512122&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153456691	459629372							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072742	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H31BrFN9O4/c1-15-6-20(21-12-36-18(4)37-13-21)8-22-28(17(3)45)42-43(29(15)22)14-27(46)44-24(32(47)39-31-16(2)7-23(35)30(34)38-31)9-33(10-25(33)44)11-26-41-40-19(5)48-26/h6-8,12-13,24-25H,9-11,14H2,1-5H3,(H,38,39,47)/t24-,25+,33-/m0/s1	OECXNKXLMDGFQV-DVIHYUSWSA-N	512123	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-5-fluoro-3- methylpyridin-2-yl)-5- ((5-methyl-1,3,4- oxadiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 484	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512123&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317841	459629373							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072743	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)Nc2nc(Br)c(F)cc2C)c2c(C)nc(cc12)-c1cnc(C)nc1	InChI=1S/C32H30BrFN10O4/c1-14-6-21(34)29(33)38-30(14)39-31(47)23-8-32(10-25-41-40-18(5)48-25)9-24(32)44(23)26(46)13-43-28-15(2)37-22(19-11-35-17(4)36-12-19)7-20(28)27(42-43)16(3)45/h6-7,11-12,23-24H,8-10,13H2,1-5H3,(H,38,39,47)/t23-,24+,32-/m0/s1	IDPJIEKWKXEEMY-XNSHOJTPSA-N	512124	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-pyrazolo[3,4- c]pyridin-1-yl)acetyl)- N-(6-bromo-5-fluoro- 3-methylpyridin-2-yl)- 5-((5-methyl-1,3,4- oxadiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 485	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512124&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318123	459629374							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072744	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(Cc3nnc(C)o3)C[C@H]2C(=O)Nc2nc(Br)ccc2Cl)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H29BrClN9O4/c1-15-7-19(20-12-35-17(3)36-13-20)8-21-28(16(2)44)41-42(29(15)21)14-27(45)43-23(31(46)38-30-22(34)5-6-25(33)37-30)9-32(10-24(32)43)11-26-40-39-18(4)47-26/h5-8,12-13,23-24H,9-11,14H2,1-4H3,(H,37,38,46)/t23-,24+,32-/m0/s1	QEZMUHVOHAYNFC-XNSHOJTPSA-N	512125	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- chloropyridin-2-yl)-5- ((5-methyl-1,3,4- oxadiazol-2- yl)methyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 486	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512125&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146422889	459629375							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072745	CCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(=O)NCCC)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H35N7O3/c1-5-9-29-26(37)22-12-28(4)13-23(28)35(22)24(36)16-34-21-8-7-18(19-14-31-17(3)32-15-19)11-20(21)25(33-34)27(38)30-10-6-2/h7-8,11,14-15,22-23H,5-6,9-10,12-13,16H2,1-4H3,(H,29,37)(H,30,38)/t22-,23+,28-/m0/s1	HVUUJGJCZISMDH-JWZKTCGFSA-N	512126	1-(2-((1R,3S,5R)-5- methyl-3- (propylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-N-propyl-1H- indazole-3-  carboxamide::US11084800, Cpd No. 487	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512126&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158602488	459629376							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072746	CCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C27H32N6O3/c1-5-6-9-28-26(36)22-11-27(4)12-23(27)33(22)24(35)15-32-21-8-7-18(19-13-29-17(3)30-14-19)10-20(21)25(31-32)16(2)34/h7-8,10,13-14,22-23H,5-6,9,11-12,15H2,1-4H3,(H,28,36)/t22-,23+,27-/m0/s1	KWHLQBYANISVBV-OBTVHEKISA-N	512127	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-butyl-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 488	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512127&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317848	459629377							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072747	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(C)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H28BrN7O3/c1-15-7-24(30)33-25(8-15)34-28(40)22-10-29(4)11-23(29)37(22)26(39)14-36-21-6-5-18(19-12-31-17(3)32-13-19)9-20(21)27(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23+,29-/m0/s1	KGQAGBBDGHPWHV-CTWZREHQSA-N	512128	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- methylpyridin-2-yl)-5- methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 492	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512128&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318268	459629378							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072748	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C(O)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26BrN7O5/c1-14(38)26-19-6-16(18-11-31-15(2)32-12-18)4-5-20(19)36(35-26)13-25(39)37-21(9-29(3)10-22(29)37)27(40)34-24-8-17(28(41)42)7-23(30)33-24/h4-8,11-12,21-22H,9-10,13H2,1-3H3,(H,41,42)(H,33,34,40)/t21-,22+,29-/m0/s1	JIYDXXHSEYYUDI-KERYWQKISA-N	512129	2-((1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamido)-6- bromoisonicotinic acid::US11084800, Cpd No. 493	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512129&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317568	459629379							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072749	COc1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O4/c1-15-6-7-24(31)34-28(15)35-29(41)21-10-30(4)11-23(30)38(21)25(40)14-37-27-20(26(36-37)16(2)39)8-18(9-22(27)42-5)19-12-32-17(3)33-13-19/h6-9,12-13,21,23H,10-11,14H2,1-5H3,(H,34,35,41)/t21-,23+,30-/m0/s1	LPMRHVZMYDODBL-AZMCGESQSA-N	512130	(1R,3S,5R)-2-(2-(3- acetyl-7-methoxy-5- (2-methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3-  methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 494	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512130&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159418799	459629380							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072750	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCC(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C26H28N6O5/c1-13-5-16(17-9-27-15(3)28-10-17)6-18-23(14(2)33)30-31(24(13)18)12-21(34)32-19(7-26(4)8-20(26)32)25(37)29-11-22(35)36/h5-6,9-10,19-20H,7-8,11-12H2,1-4H3,(H,29,37)(H,35,36)/t19-,20+,26-/m0/s1	YHQHVEBIYCEPBP-UNVFRBQDSA-N	512131	((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carbonyl)glycine::US11084800, Cpd No. 495	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512131&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161918188	459629381							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072751	CNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H29BrN8O3/c1-15-5-8-23(30)34-26(15)35-27(40)21-10-29(3)11-22(29)38(21)24(39)14-37-20-7-6-17(18-12-32-16(2)33-13-18)9-19(20)25(36-37)28(41)31-4/h5-9,12-13,21-22H,10-11,14H2,1-4H3,(H,31,41)(H,34,35,40)/t21-,22+,29-/m0/s1	KOBRRJJYCGBQAI-KERYWQKISA-N	512132	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- methyl-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 496	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512132&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318114	459629382							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072752	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCC(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C27H30N6O5/c1-14-7-17(18-11-29-16(3)30-12-18)8-19-24(15(2)34)31-32(25(14)19)13-22(35)33-20(9-27(4)10-21(27)33)26(38)28-6-5-23(36)37/h7-8,11-12,20-21H,5-6,9-10,13H2,1-4H3,(H,28,38)(H,36,37)/t20-,21+,27-/m0/s1	UWEFNBBTENGYPM-ISCCLHIJSA-N	512133	3-((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamido)propanoic acid::US11084800, Cpd No. 497	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512133&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161210558	459629383							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072753	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCCC(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C28H32N6O5/c1-15-8-18(19-12-30-17(3)31-13-19)9-20-25(16(2)35)32-33(26(15)20)14-23(36)34-21(10-28(4)11-22(28)34)27(39)29-7-5-6-24(37)38/h8-9,12-13,21-22H,5-7,10-11,14H2,1-4H3,(H,29,39)(H,37,38)/t21-,22+,28-/m0/s1	BJOKEKONZHQRNR-TYPXCFOJSA-N	512134	4-((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3- carboxamido)butanoic acid::US11084800, Cpd No. 498	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512134&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157369337	459629384							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072754	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC(C)(C)c2cccc(Cl)c2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H34ClFN6O3/c1-17-10-20(21-14-36-19(3)37-15-21)11-22-29(18(2)42)39-40(30(17)22)16-27(43)41-25(12-33(6)13-26(33)41)31(44)38-32(4,5)23-8-7-9-24(34)28(23)35/h7-11,14-15,25-26H,12-13,16H2,1-6H3,(H,38,44)/t25-,26+,33-/m0/s1	RJFUONRXYVRXPC-REYAJUCUSA-N	512135	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2-(3- chloro-2- fluorophenyl)propan- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 502	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512135&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317993	459629385							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072755	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C(N)=O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H27BrN8O4/c1-14(39)26-19-6-16(18-11-32-15(2)33-12-18)4-5-20(19)37(36-26)13-25(40)38-21(9-29(3)10-22(29)38)28(42)35-24-8-17(27(31)41)7-23(30)34-24/h4-8,11-12,21-22H,9-10,13H2,1-3H3,(H2,31,41)(H,34,35,42)/t21-,22+,29-/m0/s1	RTZSDNWRCGKXRK-KERYWQKISA-N	512136	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- carbamoylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 503	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512136&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318615	459629386							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072756	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(OCc3ccccc3)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H32BrN7O4/c1-20(44)33-26-11-23(24-16-37-21(2)38-17-24)9-10-27(26)42(41-33)18-32(45)43-28(14-35(3)15-29(35)43)34(46)40-31-13-25(12-30(36)39-31)47-19-22-7-5-4-6-8-22/h4-13,16-17,28-29H,14-15,18-19H2,1-3H3,(H,39,40,46)/t28-,29+,35-/m0/s1	SPSLCSIFNFSIQM-AXJWHKOCSA-N	512137	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4- (benzyloxy)-6- bromopyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 504	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512137&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160902712	459629387							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072757	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC(Cc2ccccc2)Cc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C39H40N6O3/c1-24-15-29(30-21-40-26(3)41-22-30)18-32-36(25(2)46)43-44(37(24)32)23-35(47)45-33(19-39(4)20-34(39)45)38(48)42-31(16-27-11-7-5-8-12-27)17-28-13-9-6-10-14-28/h5-15,18,21-22,31,33-34H,16-17,19-20,23H2,1-4H3,(H,42,48)/t33-,34+,39-/m0/s1	HEORDKPMTASQQF-LSFNHRITSA-N	512138	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(1,3- diphenylpropan-2-yl)- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 505	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512138&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317798	459629388							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072758	CCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C26H30N6O3/c1-6-27-25(35)20-9-26(5)10-21(26)32(20)22(34)13-31-24-14(2)7-17(18-11-28-16(4)29-12-18)8-19(24)23(30-31)15(3)33/h7-8,11-12,20-21H,6,9-10,13H2,1-5H3,(H,27,35)/t20-,21+,26-/m0/s1	WSJNSXJCURPEEL-UZINWLIJSA-N	512139	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-ethyl-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 506	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512139&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319083	459629389							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072759	CCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C27H32N6O3/c1-6-7-28-26(36)21-10-27(5)11-22(27)33(21)23(35)14-32-25-15(2)8-18(19-12-29-17(4)30-13-19)9-20(25)24(31-32)16(3)34/h8-9,12-13,21-22H,6-7,10-11,14H2,1-5H3,(H,28,36)/t21-,22+,27-/m0/s1	HWPJXTSYVAHXFC-XXAUWVGASA-N	512140	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N- propyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 507	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512140&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318223	459629390							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072760	CCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C28H34N6O3/c1-6-7-8-29-27(37)22-11-28(5)12-23(28)34(22)24(36)15-33-26-16(2)9-19(20-13-30-18(4)31-14-20)10-21(26)25(32-33)17(3)35/h9-10,13-14,22-23H,6-8,11-12,15H2,1-5H3,(H,29,37)/t22-,23+,28-/m0/s1	QNAJLFRNGZHNFG-JWZKTCGFSA-N	512141	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-butyl-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 508	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512141&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317555	459629391							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072761	CCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C29H36N6O3/c1-6-7-8-9-30-28(38)23-12-29(5)13-24(29)35(23)25(37)16-34-27-17(2)10-20(21-14-31-19(4)32-15-21)11-22(27)26(33-34)18(3)36/h10-11,14-15,23-24H,6-9,12-13,16H2,1-5H3,(H,30,38)/t23-,24+,29-/m0/s1	ZLOMQGDALFIIBR-IRYADYCUSA-N	512142	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N- pentyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 509	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512142&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420419	459629392							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072762	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCC2CC2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C28H32N6O3/c1-15-7-19(20-12-29-17(3)30-13-20)8-21-25(16(2)35)32-33(26(15)21)14-24(36)34-22(9-28(4)10-23(28)34)27(37)31-11-18-5-6-18/h7-8,12-13,18,22-23H,5-6,9-11,14H2,1-4H3,(H,31,37)/t22-,23+,28-/m0/s1	BUFZDBMTEXUBTJ-JWZKTCGFSA-N	512143	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N- (cyclopropylmethyl)- 5-methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 510	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512143&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318639	459629393							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072763	CC(C)CNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C28H34N6O3/c1-15(2)11-31-27(37)22-9-28(6)10-23(28)34(22)24(36)14-33-26-16(3)7-19(20-12-29-18(5)30-13-20)8-21(26)25(32-33)17(4)35/h7-8,12-13,15,22-23H,9-11,14H2,1-6H3,(H,31,37)/t22-,23+,28-/m0/s1	ZEOILGZQQFOXJJ-JWZKTCGFSA-N	512144	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-isobutyl- 5-methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 512	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512144&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319036	459629394							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072764	CNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C25H28N6O3/c1-13-6-16(17-10-27-15(3)28-11-17)7-18-22(14(2)32)29-30(23(13)18)12-21(33)31-19(24(34)26-5)8-25(4)9-20(25)31/h6-7,10-11,19-20H,8-9,12H2,1-5H3,(H,26,34)/t19-,20+,25-/m0/s1	YKKYLKOOEDFIEQ-DFIYOIEZSA-N	512145	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N,5- dimethyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 513	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512145&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318274	459629395							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072765	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(CC(O)=O)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H28BrN7O5/c1-15(39)28-20-9-18(19-12-32-16(2)33-13-19)4-5-21(20)37(36-28)14-26(40)38-22(10-30(3)11-23(30)38)29(43)35-25-7-17(8-27(41)42)6-24(31)34-25/h4-7,9,12-13,22-23H,8,10-11,14H2,1-3H3,(H,41,42)(H,34,35,43)/t22-,23+,30-/m0/s1	YGCOVKSEQGFXGA-BURCIIJTSA-N	512146	2-(2-((1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamido)-6- bromopyridin-4-  yl)acetic acid::US11084800, Cpd No. 514	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512146&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318703	459629396							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072766	CCCc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C31H32BrN7O3/c1-5-6-19-9-26(32)35-27(10-19)36-30(42)24-12-31(4)13-25(31)39(24)28(41)16-38-23-8-7-20(21-14-33-18(3)34-15-21)11-22(23)29(37-38)17(2)40/h7-11,14-15,24-25H,5-6,12-13,16H2,1-4H3,(H,35,36,42)/t24-,25+,31-/m0/s1	CKSMBZUJXHVKKM-NTWBYJAHSA-N	512147	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- propylpyridin-2-yl)-5- methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 516	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512147&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317852	459629397							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072767	CC(C)CC(CC(C)C)NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C33H44N6O3/c1-18(2)9-25(10-19(3)4)36-32(42)27-13-33(8)14-28(33)39(27)29(41)17-38-31-20(5)11-23(24-15-34-22(7)35-16-24)12-26(31)30(37-38)21(6)40/h11-12,15-16,18-19,25,27-28H,9-10,13-14,17H2,1-8H3,(H,36,42)/t27-,28+,33-/m0/s1	QEQAEXAKMXHSTN-DWZXRANWSA-N	512148	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2,6- dimethylheptan-4-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 517	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512148&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160395076	459629398							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072768	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCCN)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H31N7O3/c1-15(34)24-19-9-17(18-12-29-16(2)30-13-18)5-6-20(19)32(31-24)14-23(35)33-21(10-26(3)11-22(26)33)25(36)28-8-4-7-27/h5-6,9,12-13,21-22H,4,7-8,10-11,14,27H2,1-3H3,(H,28,36)/t21-,22+,26-/m0/s1	ZAZNRNDMKNTRRM-VRUMLPLGSA-N	512149	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- aminopropyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 518	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512149&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318887	459629399							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072769	CNCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C27H33N7O3/c1-16(35)25-20-10-18(19-13-30-17(2)31-14-19)6-7-21(20)33(32-25)15-24(36)34-22(11-27(3)12-23(27)34)26(37)29-9-5-8-28-4/h6-7,10,13-14,22-23,28H,5,8-9,11-12,15H2,1-4H3,(H,29,37)/t22-,23+,27-/m0/s1	ZNOUJGWGTCXEHU-OBTVHEKISA-N	512150	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(3- (methylamino)propyl)-  2-azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 519	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512150&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318741	459629400							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072770	CN(C)CCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H35N7O3/c1-17(36)26-21-11-19(20-14-30-18(2)31-15-20)7-8-22(21)34(32-26)16-25(37)35-23(12-28(3)13-24(28)35)27(38)29-9-6-10-33(4)5/h7-8,11,14-15,23-24H,6,9-10,12-13,16H2,1-5H3,(H,29,38)/t23-,24+,28-/m0/s1	RLISPZVBNLKWCH-JPYHZWLXSA-N	512151	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- (dimethylamino)propyl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 520	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512151&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318236	459629401							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072771	CCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C26H30N6O3/c1-5-8-27-25(35)21-10-26(4)11-22(26)32(21)23(34)14-31-20-7-6-17(18-12-28-16(3)29-13-18)9-19(20)24(30-31)15(2)33/h6-7,9,12-13,21-22H,5,8,10-11,14H2,1-4H3,(H,27,35)/t21-,22+,26-/m0/s1	RPYPRDCUFBKQAQ-VRUMLPLGSA-N	512152	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- propyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 521	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512152&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318235	459629402							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072772	CCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C28H34N6O3/c1-5-6-7-10-29-27(37)23-12-28(4)13-24(28)34(23)25(36)16-33-22-9-8-19(20-14-30-18(3)31-15-20)11-21(22)26(32-33)17(2)35/h8-9,11,14-15,23-24H,5-7,10,12-13,16H2,1-4H3,(H,29,37)/t23-,24+,28-/m0/s1	HWIIAODHOPSCBL-JPYHZWLXSA-N	512153	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- pentyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 522	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512153&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317862	459629403							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072773	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCC(C)(C)C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H34N6O3/c1-16(35)25-20-9-18(19-12-29-17(2)30-13-19)7-8-21(20)33(32-25)14-24(36)34-22(10-28(6)11-23(28)34)26(37)31-15-27(3,4)5/h7-9,12-13,22-23H,10-11,14-15H2,1-6H3,(H,31,37)/t22-,23+,28-/m0/s1	WKGCUTYNVFJBPX-JWZKTCGFSA-N	512154	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- neopentyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 523	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512154&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318976	459629404							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072774	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30N6O3/c1-18(37)28-23-11-21(22-15-31-19(2)32-16-22)9-10-24(23)35(34-28)17-27(38)36-25(12-30(3)13-26(30)36)29(39)33-14-20-7-5-4-6-8-20/h4-11,15-16,25-26H,12-14,17H2,1-3H3,(H,33,39)/t25-,26+,30-/m0/s1	BEIKYMLKQIDHAL-MWSYKCOMSA-N	512155	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-benzyl-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 524	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512155&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318171	459629405							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072775	CCCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C30H38N6O3/c1-6-7-8-9-10-31-29(39)24-13-30(5)14-25(30)36(24)26(38)17-35-28-18(2)11-21(22-15-32-20(4)33-16-22)12-23(28)27(34-35)19(3)37/h11-12,15-16,24-25H,6-10,13-14,17H2,1-5H3,(H,31,39)/t24-,25+,30-/m0/s1	IYZSQHXZDWKEID-FVXXUCQHSA-N	512156	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-hexyl-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 525	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512156&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319184	459629406							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072776	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CO)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H30BrN7O4/c1-15-5-6-24(31)34-28(15)35-29(42)22-9-30(4)10-23(30)38(22)25(41)13-37-27-19(14-39)7-18(20-11-32-17(3)33-12-20)8-21(27)26(36-37)16(2)40/h5-8,11-12,22-23,39H,9-10,13-14H2,1-4H3,(H,34,35,42)/t22-,23+,30-/m0/s1	RJAHDAFRVCCJRV-BURCIIJTSA-N	512157	(1R,3S,5R)-2-(2-(3- acetyl-7-  (hydroxymethyl)-5-(2-  methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 526	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512157&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317981	459629407							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072777	CC(=O)OCc1cc(cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c12)C(C)=O)-c1cnc(C)nc1	InChI=1S/C32H32BrN7O5/c1-16-6-7-26(33)36-30(16)37-31(44)24-10-32(5)11-25(32)40(24)27(43)14-39-29-21(15-45-19(4)42)8-20(22-12-34-18(3)35-13-22)9-23(29)28(38-39)17(2)41/h6-9,12-13,24-25H,10-11,14-15H2,1-5H3,(H,36,37,44)/t24-,25+,32-/m0/s1	CAIRDPWDXOGURD-UNTHUGQZSA-N	512158	(3-acetyl-1-(2- ((1R,3S,5R)-3-((6- bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-1H-indazol-7- yl)methyl acetate::US11084800, Cpd No. 529	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512158&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			149867070	459629408							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072778	CCc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C30H30BrN7O3/c1-5-18-8-25(31)34-26(9-18)35-29(41)23-11-30(4)12-24(30)38(23)27(40)15-37-22-7-6-19(20-13-32-17(3)33-14-20)10-21(22)28(36-37)16(2)39/h6-10,13-14,23-24H,5,11-12,15H2,1-4H3,(H,34,35,41)/t23-,24+,30-/m0/s1	GTRSOGHZMJEDKW-BBANNHEPSA-N	512159	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-4-ethylpyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 532	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512159&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158363025	459629409							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072779	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC(CCc2ccccc2)(CCc2ccccc2)C(O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C42H44N6O5/c1-26-19-31(32-23-43-28(3)44-24-32)20-33-37(27(2)49)46-47(38(26)33)25-36(50)48-34(21-41(4)22-35(41)48)39(51)45-42(40(52)53,17-15-29-11-7-5-8-12-29)18-16-30-13-9-6-10-14-30/h5-14,19-20,23-24,34-35H,15-18,21-22,25H2,1-4H3,(H,45,51)(H,52,53)/t34-,35+,41-/m0/s1	WUVMHUNHCDSHQX-VQIMDNCTSA-N	512160	2-((1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamido)-2- phenethyl-4- phenylbutanoic acid::US11084800, Cpd No. 533	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512160&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161612381	459629410							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072780	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(CC(N)=O)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN8O4/c1-15(40)28-20-9-18(19-12-33-16(2)34-13-19)4-5-21(20)38(37-28)14-27(42)39-22(10-30(3)11-23(30)39)29(43)36-26-8-17(7-25(32)41)6-24(31)35-26/h4-6,8-9,12-13,22-23H,7,10-11,14H2,1-3H3,(H2,32,41)(H,35,36,43)/t22-,23+,30-/m0/s1	AZCHGHHCRNKDFH-BURCIIJTSA-N	512161	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4-(2- amino-2-oxoethyl)-6- bromopyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 534	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512161&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420398	459629411							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072781	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34N6O3/c1-19-12-23(24-16-34-21(3)35-17-24)13-25-29(20(2)39)36-37(30(19)25)18-28(40)38-26(14-32(4)15-27(32)38)31(41)33-11-10-22-8-6-5-7-9-22/h5-9,12-13,16-17,26-27H,10-11,14-15,18H2,1-4H3,(H,33,41)/t26-,27+,32-/m0/s1	WIXYGBOWBSIYGT-XKVZAPNPSA-N	512162	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N- phenethyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 536	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512162&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420470	459629412							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072782	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCCc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C33H36N6O3/c1-20-13-24(25-17-35-22(3)36-18-25)14-26-30(21(2)40)37-38(31(20)26)19-29(41)39-27(15-33(4)16-28(33)39)32(42)34-12-8-11-23-9-6-5-7-10-23/h5-7,9-10,13-14,17-18,27-28H,8,11-12,15-16,19H2,1-4H3,(H,34,42)/t27-,28+,33-/m0/s1	NOJSEIGBVGNTBB-DWZXRANWSA-N	512163	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (3-phenylpropyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 537	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512163&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318095	459629413							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072783	CC(C)c1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C31H32BrN7O3/c1-16(2)20-9-26(32)35-27(10-20)36-30(42)24-11-31(5)12-25(31)39(24)28(41)15-38-23-7-6-19(21-13-33-18(4)34-14-21)8-22(23)29(37-38)17(3)40/h6-10,13-14,16,24-25H,11-12,15H2,1-5H3,(H,35,36,42)/t24-,25+,31-/m0/s1	POYTVUFGQDNUET-NTWBYJAHSA-N	512164	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1-  yl)acetyl)-N-(6- bromo-4- isopropylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 541	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512164&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160267974	459629414							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072784	CC(C)Cc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C32H34BrN7O3/c1-17(2)8-20-9-27(33)36-28(10-20)37-31(43)25-12-32(5)13-26(32)40(25)29(42)16-39-24-7-6-21(22-14-34-19(4)35-15-22)11-23(24)30(38-39)18(3)41/h6-7,9-11,14-15,17,25-26H,8,12-13,16H2,1-5H3,(H,36,37,43)/t25-,26+,32-/m0/s1	WZQWEEMJZBUSNQ-BKQYKDOASA-N	512165	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-(6-  bromo-4-  isobutylpyridin-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 542	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512165&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161650392	459629415							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072785	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C#N)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H25BrN8O3/c1-15(39)27-20-8-18(19-12-32-16(2)33-13-19)4-5-21(20)37(36-27)14-26(40)38-22(9-29(3)10-23(29)38)28(41)35-25-7-17(11-31)6-24(30)34-25/h4-8,12-13,22-23H,9-10,14H2,1-3H3,(H,34,35,41)/t22-,23+,29-/m0/s1	UFKSUXBBOVIXSO-CTWZREHQSA-N	512166	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4-  cyanopyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 543	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512166&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161077152	459629416							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072786	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)-c2nnn[nH]2)c2ccc(cc12)-c1cnc(C)nc1			512167	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4-(1H-tetrazol- 5-yl)pyridin-2-yl)-5- methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 544	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512167&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158765568	459629417							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072787	CC(C)CCc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C33H36BrN7O3/c1-18(2)6-7-21-10-28(34)37-29(11-21)38-32(44)26-13-33(5)14-27(33)41(26)30(43)17-40-25-9-8-22(23-15-35-20(4)36-16-23)12-24(25)31(39-40)19(3)42/h8-12,15-16,18,26-27H,6-7,13-14,17H2,1-5H3,(H,37,38,44)/t26-,27+,33-/m0/s1	RRJQYNZKPYYSDS-VCQOIINCSA-N	512168	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- isopentylpyridin-2-yl)-  5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 545	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512168&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160707234	459629418							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072788	COCc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C30H30BrN7O4/c1-16(39)28-21-9-19(20-12-32-17(2)33-13-20)5-6-22(21)37(36-28)14-27(40)38-23(10-30(3)11-24(30)38)29(41)35-26-8-18(15-42-4)7-25(31)34-26/h5-9,12-13,23-24H,10-11,14-15H2,1-4H3,(H,34,35,41)/t23-,24+,30-/m0/s1	YDDAEAYUCIZPRF-BBANNHEPSA-N	512169	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- (methoxymethyl)pyrid in-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 546	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512169&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161882946	459629419							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072789	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)-c2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H30BrN7O3/c1-19(43)32-25-11-22(24-16-36-20(2)37-17-24)9-10-26(25)41(40-32)18-31(44)42-27(14-34(3)15-28(34)42)33(45)39-30-13-23(12-29(35)38-30)21-7-5-4-6-8-21/h4-13,16-17,27-28H,14-15,18H2,1-3H3,(H,38,39,45)/t27-,28+,34-/m0/s1	SPTXWKGDOIJFFV-FPQPQGOJSA-N	512170	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- phenylpyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 547	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512170&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160903156	459629420							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072790	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(CCc3ccccc3)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H34BrN7O3/c1-21(45)34-27-15-25(26-18-38-22(2)39-19-26)11-12-28(27)43(42-34)20-33(46)44-29(16-36(3)17-30(36)44)35(47)41-32-14-24(13-31(37)40-32)10-9-23-7-5-4-6-8-23/h4-8,11-15,18-19,29-30H,9-10,16-17,20H2,1-3H3,(H,40,41,47)/t29-,30+,36-/m0/s1	SVMUVGIRHHYRBG-BLBFUMABSA-N	512171	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- bromo-4- phenethylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 548	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512171&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160949020	459629421							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072791	CCCCc1cc(Br)nc(NC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(ccc23)-c2cnc(C)nc2)c1	InChI=1S/C32H34BrN7O3/c1-5-6-7-20-10-27(33)36-28(11-20)37-31(43)25-13-32(4)14-26(32)40(25)29(42)17-39-24-9-8-21(22-15-34-19(3)35-16-22)12-23(24)30(38-39)18(2)41/h8-12,15-16,25-26H,5-7,13-14,17H2,1-4H3,(H,36,37,43)/t25-,26+,32-/m0/s1	UDJVVTKKXYJTSV-BKQYKDOASA-N	512172	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4-butylpyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 549	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512172&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161061014	459629422							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072792	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H25BrF3N7O3/c1-14(41)26-19-6-16(17-11-34-15(2)35-12-17)4-5-20(19)39(38-26)13-25(42)40-21(9-28(3)10-22(28)40)27(43)37-24-8-18(29(31,32)33)7-23(30)36-24/h4-8,11-12,21-22H,9-10,13H2,1-3H3,(H,36,37,43)/t21-,22+,28-/m0/s1	FHUTVJGJRPNDRD-TYPXCFOJSA-N	512173	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4- (trifluoromethyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 550	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512173&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158036516	459629423							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072793	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NC3CC3)c2c1	InChI=1S/C31H31BrN8O3/c1-16-4-9-25(32)36-28(16)37-29(42)23-11-31(3)12-24(31)40(23)26(41)15-39-22-8-5-18(19-13-33-17(2)34-14-19)10-21(22)27(38-39)30(43)35-20-6-7-20/h4-5,8-10,13-14,20,23-24H,6-7,11-12,15H2,1-3H3,(H,35,43)(H,36,37,42)/t23-,24+,31-/m0/s1	REKKNQMLGKVEKU-JLELKNTQSA-N	512174	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- cyclopropyl-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 551	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512174&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318028	459629424							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072794	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCC(C)(C)C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H36N6O3/c1-17(36)26-21-11-19(20-14-31-18(2)32-15-20)7-8-22(21)34(33-26)16-25(37)35-23(12-29(6)13-24(29)35)27(38)30-10-9-28(3,4)5/h7-8,11,14-15,23-24H,9-10,12-13,16H2,1-6H3,(H,30,38)/t23-,24+,29-/m0/s1	OUWJBZRRUQYKAM-IRYADYCUSA-N	512175	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3,3- dimethylbutyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 552	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512175&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318679	459629425							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072795	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1ccccc1	InChI=1S/C31H32N6O3/c1-18(21-8-6-5-7-9-21)34-30(40)26-13-31(4)14-27(31)37(26)28(39)17-36-25-11-10-22(23-15-32-20(3)33-16-23)12-24(25)29(35-36)19(2)38/h5-12,15-16,18,26-27H,13-14,17H2,1-4H3,(H,34,40)/t18-,26-,27+,31-/m0/s1	AEXSLNWCUWVJPF-BULLSLEHSA-N	512176	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- ((S)-1-phenylethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 553	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512176&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318911	459629426							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072796	C[C@@H](COC(F)(F)F)NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C27H29F3N6O4/c1-14(13-40-27(28,29)30)33-25(39)21-8-26(4)9-22(26)36(21)23(38)12-35-20-6-5-17(18-10-31-16(3)32-11-18)7-19(20)24(34-35)15(2)37/h5-7,10-11,14,21-22H,8-9,12-13H2,1-4H3,(H,33,39)/t14-,21-,22+,26-/m0/s1	LBNNWPDQUVJUAN-FMZOCUNOSA-N	512177	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- ((S)-1- (trifluoromethoxy)propan- 2-yl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 554	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512177&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159302707	459629427							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072797	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(Cc3ccccc3)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H32BrN7O3/c1-20(44)33-26-14-24(25-17-37-21(2)38-18-25)9-10-27(26)42(41-33)19-32(45)43-28(15-35(3)16-29(35)43)34(46)40-31-13-23(12-30(36)39-31)11-22-7-5-4-6-8-22/h4-10,12-14,17-18,28-29H,11,15-16,19H2,1-3H3,(H,39,40,46)/t28-,29+,35-/m0/s1	MWYQCPKVVMJRCX-AXJWHKOCSA-N	512178	(1R,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(4- benzyl-6- bromopyridin-2-yl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 555	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512178&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159695585	459629428							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072798	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)-c2ccccc2O)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H30BrN7O4/c1-18(43)32-24-10-20(22-15-36-19(2)37-16-22)8-9-25(24)41(40-32)17-31(45)42-26(13-34(3)14-28(34)42)33(46)39-30-12-21(11-29(35)38-30)23-6-4-5-7-27(23)44/h4-12,15-16,26,28,44H,13-14,17H2,1-3H3,(H,38,39,46)/t26-,28+,34-/m0/s1	JPBYVZOZTMAPSL-HOFKBBIZSA-N	512179	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4-(2- hydroxyphenyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 556	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512179&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			158981762	459629429							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072799	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(COCc3ccccc3)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C36H34BrN7O4/c1-21(45)34-27-13-25(26-16-38-22(2)39-17-26)9-10-28(27)43(42-34)18-33(46)44-29(14-36(3)15-30(36)44)35(47)41-32-12-24(11-31(37)40-32)20-48-19-23-7-5-4-6-8-23/h4-13,16-17,29-30H,14-15,18-20H2,1-3H3,(H,40,41,47)/t29-,30+,36-/m0/s1	PJOAXLMYNKWSPK-BLBFUMABSA-N	512180	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4- 6-bromopyridin-2-yl)-  5-methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 557	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512180&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			160224024	459629430							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072800	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1ccccc1	InChI=1S/C31H32N6O3/c1-18(21-8-6-5-7-9-21)34-30(40)26-13-31(4)14-27(31)37(26)28(39)17-36-25-11-10-22(23-15-32-20(3)33-16-23)12-24(25)29(35-36)19(2)38/h5-12,15-16,18,26-27H,13-14,17H2,1-4H3,(H,34,40)/t18-,26+,27-,31+/m1/s1	AEXSLNWCUWVJPF-RUKQEVNISA-N	512181	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N-  ((R)-1-phenylethyl)-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 558	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512181&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318683	459629431							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072801	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC\C(F)=C(\C)c2ccccc2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H33FN6O3/c1-19(22-8-6-5-7-9-22)26(34)17-37-32(43)28-13-33(4)14-29(33)40(28)30(42)18-39-27-11-10-23(24-15-35-21(3)36-16-24)12-25(27)31(38-39)20(2)41/h5-12,15-16,28-29H,13-14,17-18H2,1-4H3,(H,37,43)/b26-19+/t28-,29+,33-/m0/s1	YHARXZFOBXBTMP-MBPCSPAQSA-N	512182	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-N-((E)-2- fluoro-3-phenylbut-2- en-1-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 559	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512182&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318173	459629432							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072802	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC\C(F)=C(\C)c2ccccc2)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C33H33FN6O3/c1-19(22-8-6-5-7-9-22)26(34)15-38-32(43)28-11-33(4)12-30(33)40(28)31(42)18-39-17-25(20(2)41)24-10-27(37-16-29(24)39)23-13-35-21(3)36-14-23/h5-10,13-14,16-17,28,30H,11-12,15,18H2,1-4H3,(H,38,43)/b26-19+/t28-,30+,33-/m0/s1	ILUOPJMMOPYUBK-NIBXVTHJSA-N	512183	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- N-((E)-2-fluoro-3- phenylbut-2-en-1-yl)-  5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 560	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512183&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533564	459629433							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072803	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC\C(F)=C(\C)c2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H35FN6O3/c1-19-11-24(25-15-36-22(4)37-16-25)12-26-31(21(3)42)39-40(32(19)26)18-30(43)41-28(13-34(5)14-29(34)41)33(44)38-17-27(35)20(2)23-9-7-6-8-10-23/h6-12,15-16,28-29H,13-14,17-18H2,1-5H3,(H,38,44)/b27-20+/t28-,29+,34-/m0/s1	BRIJBXMXXBKRPI-PLINUBIESA-N	511712	(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-((E)-2-fluoro-3-phenylbut-2-en- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 17::US11084800, Cpd No. 561	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511712&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			149821913	459628964							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072804	CC(C)NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-16(2)35-30(43)27-21-10-19(20-13-33-18(4)34-14-20)7-8-22(21)39(38-27)15-26(41)40-23(11-31(5)12-24(31)40)29(42)37-28-17(3)6-9-25(32)36-28/h6-10,13-14,16,23-24H,11-12,15H2,1-5H3,(H,35,43)(H,36,37,42)/t23-,24+,31-/m0/s1	FWNHBCFVRJGNKT-JLELKNTQSA-N	512185	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- isopropyl-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 562	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512185&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420410	459629434							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072805	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCC=C)c2c1	InChI=1S/C31H31BrN8O3/c1-5-10-33-30(43)27-21-11-19(20-14-34-18(3)35-15-20)7-8-22(21)39(38-27)16-26(41)40-23(12-31(4)13-24(31)40)29(42)37-28-17(2)6-9-25(32)36-28/h5-9,11,14-15,23-24H,1,10,12-13,16H2,2-4H3,(H,33,43)(H,36,37,42)/t23-,24+,31-/m0/s1	NKKSVPDSJQYSMF-JLELKNTQSA-N	512187	N-allyl-1-(2- ((1R,3S,5R)-3-((6- bromo-3-  methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 563	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512187&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318808	459629436							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072806	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCC#C)c2c1	InChI=1S/C31H29BrN8O3/c1-5-10-33-30(43)27-21-11-19(20-14-34-18(3)35-15-20)7-8-22(21)39(38-27)16-26(41)40-23(12-31(4)13-24(31)40)29(42)37-28-17(2)6-9-25(32)36-28/h1,6-9,11,14-15,23-24H,10,12-13,16H2,2-4H3,(H,33,43)(H,36,37,42)/t23-,24+,31-/m0/s1	JMDCKDYWUKZGQM-JLELKNTQSA-N	512188	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (2-methylpyrimidin-5- yl)-N-(prop-2-yn-1- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 564::US11447465, Cmp No. T-121	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512188&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318256	459629437							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072807	Cc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(I)c2c1	InChI=1S/C28H27BrIN7O2/c1-14-5-6-22(29)33-26(14)34-27(39)20-9-28(4)10-21(28)37(20)23(38)13-36-24-15(2)7-17(8-19(24)25(30)35-36)18-11-31-16(3)32-12-18/h5-8,11-12,20-21H,9-10,13H2,1-4H3,(H,33,34,39)/t20-,21+,28-/m0/s1	GWSTXBGBNSLXSM-GTNJKRJXSA-N	512189	(1R,3S,5R)-N-(6- bromo-3- methylpyridin-2-yl)-2- (2-(3-iodo-7-methyl-5-  (2-methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 565	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512189&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533565	459629438							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072808	CC(NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1)C1CC1	InChI=1S/C33H35BrN8O3/c1-17-5-10-27(34)38-30(17)39-31(44)25-12-33(4)13-26(33)42(25)28(43)16-41-24-9-8-21(22-14-35-19(3)36-15-22)11-23(24)29(40-41)32(45)37-18(2)20-6-7-20/h5,8-11,14-15,18,20,25-26H,6-7,12-13,16H2,1-4H3,(H,37,45)(H,38,39,44)/t18?,25-,26+,33-/m0/s1	CPCMRLKTIQZWQF-VMFILOKBSA-N	512190	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2-  azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- (1-cyclopropylethyl)- 5-(2-methylpyrimidin- 5-yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 566	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512190&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318585	459629439							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072809	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NC(C)(C)C#C)c2c1	InChI=1S/C33H33BrN8O3/c1-7-32(4,5)39-31(45)28-22-12-20(21-15-35-19(3)36-16-21)9-10-23(22)41(40-28)17-27(43)42-24(13-33(6)14-25(33)42)30(44)38-29-18(2)8-11-26(34)37-29/h1,8-12,15-16,24-25H,13-14,17H2,2-6H3,(H,39,45)(H,37,38,44)/t24-,25+,33-/m0/s1	FCBKOVVSPNAWDT-DVIHYUSWSA-N	512191	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- (2-methylbut-3-yn-2- yl)-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 567	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512191&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318146	459629440							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072810	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NC(C)(C)C3CC3)c2c1	InChI=1S/C34H37BrN8O3/c1-18-6-11-27(35)38-30(18)39-31(45)25-13-34(5)14-26(34)43(25)28(44)17-42-24-10-7-20(21-15-36-19(2)37-16-21)12-23(24)29(41-42)32(46)40-33(3,4)22-8-9-22/h6-7,10-12,15-16,22,25-26H,8-9,13-14,17H2,1-5H3,(H,40,46)(H,38,39,45)/t25-,26+,34-/m0/s1	LPNPTZRCCAUVSV-SCZOVYFASA-N	512192	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- (2-cyclopropylpropan- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 568	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512192&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318752	459629441							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072811	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NC(C)(C)C)c2c1	InChI=1S/C32H35BrN8O3/c1-17-7-10-25(33)36-28(17)37-29(43)23-12-32(6)13-24(32)41(23)26(42)16-40-22-9-8-19(20-14-34-18(2)35-15-20)11-21(22)27(39-40)30(44)38-31(3,4)5/h7-11,14-15,23-24H,12-13,16H2,1-6H3,(H,38,44)(H,36,37,43)/t23-,24+,32-/m0/s1	AEHFHGFZWVCZKN-XNSHOJTPSA-N	512193	1-(2-((1R,3S,5R)-3- ((6-bromo-3-  methylpyridin-2- yl)carbamoyl)-5- methyl-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- (tert-butyl)-5-(2- methylpyrimidin-5- yl)-1H-indazole-3-  carboxamide::US11084800, Cpd No. 570	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512193&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318790	459629442							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072812	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CN2CCC(CC2)S(C)(=O)=O)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H41BrN8O5S/c1-20-12-24(25-16-38-22(3)39-17-25)13-27-32(21(2)46)42-44(33(20)27)19-31(47)45-28(14-36(4)15-29(36)45)35(48)41-34-23(6-7-30(37)40-34)18-43-10-8-26(9-11-43)51(5,49)50/h6-7,12-13,16-17,26,28-29H,8-11,14-15,18-19H2,1-5H3,(H,40,41,48)/t28-,29+,36-/m0/s1	ANQZMSHYKXBATI-WEPHICOPSA-N	512194	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(6-  bromo-3-((4-  (methylsulfonyl)piperidin- 1-yl)methyl)pyridin-2- yl)-5-methyl-2-  azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 571	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512194&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			157172813	459629443							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072813	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(CC(F)(F)F)cc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H27BrF3N7O3/c1-15(42)27-20-8-18(19-12-35-16(2)36-13-19)4-5-21(20)40(39-27)14-26(43)41-22(10-29(3)11-23(29)41)28(44)38-25-7-17(6-24(31)37-25)9-30(32,33)34/h4-8,12-13,22-23H,9-11,14H2,1-3H3,(H,37,38,44)/t22-,23+,29-/m0/s1	VJYKJWNWAOQIAF-CTWZREHQSA-N	512195	(1R,3S,5R)-2-(2-(3- acetyl-5-(2-  methylpyrimidin-5-  yl)-1H-indazol-1- yl)acetyl)-N-(6- bromo-4-(2,2,2- trifluoroethyl)pyridin- 2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 572	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512195&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161319499	459629444							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072814	CC(NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1)C#C	InChI=1S/C32H31BrN8O3/c1-6-18(3)36-31(44)28-22-11-20(21-14-34-19(4)35-15-21)8-9-23(22)40(39-28)16-27(42)41-24(12-32(5)13-25(32)41)30(43)38-29-17(2)7-10-26(33)37-29/h1,7-11,14-15,18,24-25H,12-13,16H2,2-5H3,(H,36,44)(H,37,38,43)/t18?,24-,25+,32-/m0/s1	APAQGCSDNFUNJZ-VMTFFRNGSA-N	512196	1-(2-((1R,3S,5R)-3- ((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- (but-3-yn-2-yl)-5-(2- methylpyrimidin-5- yl)-1H-indazole-3- carboxamide::US11084800, Cpd No. 573	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512196&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420567	459629445							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072815	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H32N6O3/c1-18-10-22(23-15-32-20(3)33-16-23)11-24-28(19(2)38)35-36(29(18)24)17-27(39)37-25(12-31(4)13-26(31)37)30(40)34-14-21-8-6-5-7-9-21/h5-11,15-16,25-26H,12-14,17H2,1-4H3,(H,34,40)/t25-,26+,31-/m0/s1	PBTKHGBMCUGTJT-HEHLMWRFSA-N	512197	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-benzyl-5- methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 574	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512197&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318046	459629446							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072816	COc1ccccc1CNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H34N6O4/c1-18-10-22(23-15-33-20(3)34-16-23)11-24-29(19(2)39)36-37(30(18)24)17-28(40)38-25(12-32(4)13-27(32)38)31(41)35-14-21-8-6-7-9-26(21)42-5/h6-11,15-16,25,27H,12-14,17H2,1-5H3,(H,35,41)/t25-,27+,32-/m0/s1	SDNISLSAFBLWNA-HWSWFTITSA-N	512198	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2- methoxybenzyl)-5- methyl-2-  azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 575	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512198&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317858	459629447							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072817	COc1cccc(CNC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(cc(C)c23)-c2cnc(C)nc2)c1	InChI=1S/C32H34N6O4/c1-18-9-22(23-15-33-20(3)34-16-23)11-25-29(19(2)39)36-37(30(18)25)17-28(40)38-26(12-32(4)13-27(32)38)31(41)35-14-21-7-6-8-24(10-21)42-5/h6-11,15-16,26-27H,12-14,17H2,1-5H3,(H,35,41)/t26-,27+,32-/m0/s1	VDVREQPZGQTVAT-XKVZAPNPSA-N	512199	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- methoxybenzyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 576	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512199&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318908	459629448							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072818	COc1ccc(CNC(=O)[C@@H]2C[C@@]3(C)C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(cc(C)c23)-c2cnc(C)nc2)cc1	InChI=1S/C32H34N6O4/c1-18-10-22(23-15-33-20(3)34-16-23)11-25-29(19(2)39)36-37(30(18)25)17-28(40)38-26(12-32(4)13-27(32)38)31(41)35-14-21-6-8-24(42-5)9-7-21/h6-11,15-16,26-27H,12-14,17H2,1-5H3,(H,35,41)/t26-,27+,32-/m0/s1	VBKXVYWXQJTSCJ-XKVZAPNPSA-N	512200	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4-  methoxybenzyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 577	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512200&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318891	459629449							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072819	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCOC(F)(F)F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H27F3N6O4/c1-14(36)23-18-8-16(17-11-31-15(2)32-12-17)4-5-19(18)34(33-23)13-22(37)35-20(9-25(3)10-21(25)35)24(38)30-6-7-39-26(27,28)29/h4-5,8,11-12,20-21H,6-7,9-10,13H2,1-3H3,(H,30,38)/t20-,21+,25-/m0/s1	NRDJSXXERHOQLB-BKSPAHHJSA-N	512201	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-(2- (trifluoromethoxy)ethyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US11084800, Cpd No. 579	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512201&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159860992	459629450							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072820	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)c1ccccc1	InChI=1S/C32H34N6O3/c1-18-11-23(24-15-33-21(4)34-16-24)12-25-29(20(3)39)36-37(30(18)25)17-28(40)38-26(13-32(5)14-27(32)38)31(41)35-19(2)22-9-7-6-8-10-22/h6-12,15-16,19,26-27H,13-14,17H2,1-5H3,(H,35,41)/t19-,26-,27+,32-/m0/s1	SSVTXZVCBCRTMF-XGCAYVCWSA-N	512202	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- ((S)-1-phenylethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 580	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512202&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420480	459629451							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072821	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)c1ccccc1	InChI=1S/C32H34N6O3/c1-18-11-23(24-15-33-21(4)34-16-24)12-25-29(20(3)39)36-37(30(18)25)17-28(40)38-26(13-32(5)14-27(32)38)31(41)35-19(2)22-9-7-6-8-10-22/h6-12,15-16,19,26-27H,13-14,17H2,1-5H3,(H,35,41)/t19-,26+,27-,32+/m1/s1	SSVTXZVCBCRTMF-CMBIKMMXSA-N	512203	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- ((R)-1-phenylethyl)-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 581	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512203&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318161	459629452							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072822	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccccc2F)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31FN6O3/c1-17-9-21(22-14-33-19(3)34-15-22)10-23-28(18(2)39)36-37(29(17)23)16-27(40)38-25(11-31(4)12-26(31)38)30(41)35-13-20-7-5-6-8-24(20)32/h5-10,14-15,25-26H,11-13,16H2,1-4H3,(H,35,41)/t25-,26+,31-/m0/s1	RZHZGVWQTBWFRO-HEHLMWRFSA-N	512204	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2- fluorobenzyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 582	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512204&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420540	459629453							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072823	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccc(F)c2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31FN6O3/c1-17-8-21(22-14-33-19(3)34-15-22)10-24-28(18(2)39)36-37(29(17)24)16-27(40)38-25(11-31(4)12-26(31)38)30(41)35-13-20-6-5-7-23(32)9-20/h5-10,14-15,25-26H,11-13,16H2,1-4H3,(H,35,41)/t25-,26+,31-/m0/s1	HIONDKAIXBMWHT-HEHLMWRFSA-N	512205	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(3- fluorobenzyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 583	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512205&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317806	459629454							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072824	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccc(F)cc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H31FN6O3/c1-17-9-21(22-14-33-19(3)34-15-22)10-24-28(18(2)39)36-37(29(17)24)16-27(40)38-25(11-31(4)12-26(31)38)30(41)35-13-20-5-7-23(32)8-6-20/h5-10,14-15,25-26H,11-13,16H2,1-4H3,(H,35,41)/t25-,26+,31-/m0/s1	CVWLSDSRIUFUDJ-HEHLMWRFSA-N	512206	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(4-  fluorobenzyl)-5-  methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 584	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512206&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318154	459629455							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072825	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34N6O3/c1-18-8-6-7-9-22(18)14-35-31(41)26-12-32(5)13-27(32)38(26)28(40)17-37-30-19(2)10-23(24-15-33-21(4)34-16-24)11-25(30)29(36-37)20(3)39/h6-11,15-16,26-27H,12-14,17H2,1-5H3,(H,35,41)/t26-,27+,32-/m0/s1	TWNOBXTZHORIGB-XKVZAPNPSA-N	512207	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (2-methylbenzyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 585	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512207&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318991	459629456							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072826	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccc(C)c2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34N6O3/c1-18-7-6-8-22(9-18)14-35-31(41)26-12-32(5)13-27(32)38(26)28(40)17-37-30-19(2)10-23(24-15-33-21(4)34-16-24)11-25(30)29(36-37)20(3)39/h6-11,15-16,26-27H,12-14,17H2,1-5H3,(H,35,41)/t26-,27+,32-/m0/s1	HCCKFALOWCWJCU-XKVZAPNPSA-N	512208	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (3-methylbenzyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 586	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512208&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318129	459629457							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072827	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccc(C)cc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H34N6O3/c1-18-6-8-22(9-7-18)14-35-31(41)26-12-32(5)13-27(32)38(26)28(40)17-37-30-19(2)10-23(24-15-33-21(4)34-16-24)11-25(30)29(36-37)20(3)39/h6-11,15-16,26-27H,12-14,17H2,1-5H3,(H,35,41)/t26-,27+,32-/m0/s1	JLQKIABDLAVARF-XKVZAPNPSA-N	512209	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-  (4-methylbenzyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 587	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512209&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318203	459629458							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072828	C[C@@H](CC(C)(C)C)NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H38N6O3/c1-17(11-29(4,5)6)33-28(39)24-12-30(7)13-25(30)36(24)26(38)16-35-23-9-8-20(21-14-31-19(3)32-15-21)10-22(23)27(34-35)18(2)37/h8-10,14-15,17,24-25H,11-13,16H2,1-7H3,(H,33,39)/t17-,24-,25+,30-/m0/s1	HXQQNTXMTCMOGD-PLRSMPDZSA-N	512210	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((S)-4,4- dimethylpentan-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 588	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512210&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146435669	459629459							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072829	C[C@H](CC(C)(C)C)NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1	InChI=1S/C30H38N6O3/c1-17(11-29(4,5)6)33-28(39)24-12-30(7)13-25(30)36(24)26(38)16-35-23-9-8-20(21-14-31-19(3)32-15-21)10-22(23)27(34-35)18(2)37/h8-10,14-15,17,24-25H,11-13,16H2,1-7H3,(H,33,39)/t17-,24+,25-,30+/m1/s1	HXQQNTXMTCMOGD-LZCQYBHKSA-N	512211	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((R)-4,4- dimethylpentan-2-yl)- 5-methyl-2- azabicyclo[3.1.0]hexane-  3-carboxamide::US11084800, Cpd No. 589	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512211&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			153456675	459629460							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072830	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1cccc(Cl)c1F	InChI=1S/C31H30ClFN6O3/c1-16(21-6-5-7-23(32)28(21)33)36-30(42)25-11-31(4)12-26(31)39(25)27(41)15-38-24-9-8-19(20-13-34-18(3)35-14-20)10-22(24)29(37-38)17(2)40/h5-10,13-14,16,25-26H,11-12,15H2,1-4H3,(H,36,42)/t16-,25-,26+,31-/m0/s1	JAZBWDHUUZLUFA-USHZEXMSSA-N	512212	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((S)-1-(3- chloro-2- fluorophenyl)ethyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 590	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512212&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146435671	459629461							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072831	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ncccn2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30N8O3/c1-16-8-19(20-12-32-18(3)33-13-20)9-21-26(17(2)38)35-36(27(16)21)15-25(39)37-22(10-29(4)11-23(29)37)28(40)34-14-24-30-6-5-7-31-24/h5-9,12-13,22-23H,10-11,14-15H2,1-4H3,(H,34,40)/t22-,23+,29-/m0/s1	SIUSOIRXMFPZOS-CTWZREHQSA-N	512213	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5-  yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N- (pyrimidin-2-  ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 591	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512213&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318181	459629462							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072832	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccncn2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30N8O3/c1-16-7-19(20-11-31-18(3)32-12-20)8-22-26(17(2)38)35-36(27(16)22)14-25(39)37-23(9-29(4)10-24(29)37)28(40)33-13-21-5-6-30-15-34-21/h5-8,11-12,15,23-24H,9-10,13-14H2,1-4H3,(H,33,40)/t23-,24+,29-/m0/s1	JFCCRGSANDYKJF-IRYADYCUSA-N	512214	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (pyrimidin-4- ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 592	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512214&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318889	459629463							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072833	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cncnc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30N8O3/c1-16-5-20(21-12-32-18(3)33-13-21)6-22-26(17(2)38)35-36(27(16)22)14-25(39)37-23(7-29(4)8-24(29)37)28(40)34-11-19-9-30-15-31-10-19/h5-6,9-10,12-13,15,23-24H,7-8,11,14H2,1-4H3,(H,34,40)/t23-,24+,29-/m0/s1	XIJXGLPUGKSCTQ-IRYADYCUSA-N	512215	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (pyrimidin-5- ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 593	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512215&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318273	459629464							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072834	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccccn2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H31N7O3/c1-17-9-20(21-13-32-19(3)33-14-21)10-23-27(18(2)38)35-36(28(17)23)16-26(39)37-24(11-30(4)12-25(30)37)29(40)34-15-22-7-5-6-8-31-22/h5-10,13-14,24-25H,11-12,15-16H2,1-4H3,(H,34,40)/t24-,25+,30-/m0/s1	ZABFYWXIILVCJD-FVXXUCQHSA-N	512216	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (pyridin-2-ylmethyl)-2 azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 594	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512216&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318884	459629465							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072835	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccnc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H31N7O3/c1-17-8-21(22-14-32-19(3)33-15-22)9-23-27(18(2)38)35-36(28(17)23)16-26(39)37-24(10-30(4)11-25(30)37)29(40)34-13-20-6-5-7-31-12-20/h5-9,12,14-15,24-25H,10-11,13,16H2,1-4H3,(H,34,40)/t24-,25+,30-/m0/s1	RIHJNKQCAAPQMI-FVXXUCQHSA-N	512217	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (pyridin-3-ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 595	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512217&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318787	459629466							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072836	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2ccncc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H31N7O3/c1-17-9-21(22-14-32-19(3)33-15-22)10-23-27(18(2)38)35-36(28(17)23)16-26(39)37-24(11-30(4)12-25(30)37)29(40)34-13-20-5-7-31-8-6-20/h5-10,14-15,24-25H,11-13,16H2,1-4H3,(H,34,40)/t24-,25+,30-/m0/s1	IKJMQEHAVLIXBW-FVXXUCQHSA-N	512219	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N-  (pyridin-4-ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 596	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512219&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317883	459629468							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072837	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCc2cccnn2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C29H30N8O3/c1-16-8-19(20-12-30-18(3)31-13-20)9-22-26(17(2)38)35-36(27(16)22)15-25(39)37-23(10-29(4)11-24(29)37)28(40)32-14-21-6-5-7-33-34-21/h5-9,12-13,23-24H,10-11,14-15H2,1-4H3,(H,32,40)/t23-,24+,29-/m0/s1	DWWPCEHBJWCQMX-IRYADYCUSA-N	512220	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (pyridazin-3-  ylmethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 597	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512220&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317509	459629469							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072838	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1ccc(C)cc1	InChI=1S/C32H34N6O3/c1-18-6-8-22(9-7-18)19(2)35-31(41)27-13-32(5)14-28(32)38(27)29(40)17-37-26-11-10-23(24-15-33-21(4)34-16-24)12-25(26)30(36-37)20(3)39/h6-12,15-16,19,27-28H,13-14,17H2,1-5H3,(H,35,41)/t19-,27-,28+,32-/m0/s1	UXSBRNKWNIAFSV-DOCFEKRXSA-N	512221	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- ((S)-1-(p-tolyl)ethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 598	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512221&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318302	459629470							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072839	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1cccc(Cl)c1	InChI=1S/C31H31ClN6O3/c1-17(20-6-5-7-23(32)10-20)35-30(41)26-12-31(4)13-27(31)38(26)28(40)16-37-25-9-8-21(22-14-33-19(3)34-15-22)11-24(25)29(36-37)18(2)39/h5-11,14-15,17,26-27H,12-13,16H2,1-4H3,(H,35,41)/t17-,26-,27+,31-/m0/s1	AIRIYCTWGDXNOR-PTCGZINVSA-N	512222	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((S)-1-(3- chlorophenyl)ethyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 599	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512222&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319001	459629471							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072840	C[C@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1ccccc1F	InChI=1S/C31H31FN6O3/c1-17(22-7-5-6-8-24(22)32)35-30(41)26-12-31(4)13-27(31)38(26)28(40)16-37-25-10-9-20(21-14-33-19(3)34-15-21)11-23(25)29(36-37)18(2)39/h5-11,14-15,17,26-27H,12-13,16H2,1-4H3,(H,35,41)/t17-,26-,27+,31-/m0/s1	SMEZZHIDZHMGLZ-PTCGZINVSA-N	512223	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((S)-1-(2-  fluorophenyl)ethyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 600	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512223&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319111	459629472							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072841	C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)c1cccc(Cl)c1F	InChI=1S/C31H30ClFN6O3/c1-16(21-6-5-7-23(32)28(21)33)36-30(42)25-11-31(4)12-26(31)39(25)27(41)15-38-24-9-8-19(20-13-34-18(3)35-14-20)10-22(24)29(37-38)17(2)40/h5-10,13-14,16,25-26H,11-12,15H2,1-4H3,(H,36,42)/t16-,25+,26-,31+/m1/s1	JAZBWDHUUZLUFA-LNBQFTARSA-N	512224	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-((R)-1-(3- chloro-2- fluorophenyl)ethyl)-5- methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 601	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512224&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			146435673	459629473							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072842	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cc(cc(Br)n2)C(O)=O)c2c(CN)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H29BrN8O5/c1-14(40)26-20-5-16(19-11-33-15(2)34-12-19)4-18(10-32)27(20)38(37-26)13-25(41)39-21(8-30(3)9-22(30)39)28(42)36-24-7-17(29(43)44)6-23(31)35-24/h4-7,11-12,21-22H,8-10,13,32H2,1-3H3,(H,43,44)(H,35,36,42)/t21-,22+,30-/m0/s1	UJIOEHKNGYGVNB-ZQLNOWDWSA-N	512225	2-((1R,3S,5R)-2-(2-(3- acetyl-7- (aminomethyl)-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamido)-6- bromoisonicotinic acid::US11084800, Cpd No. 603	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512225&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161108211	459629474							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072843	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCC2CCCCC2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C32H40N6O3/c1-19-12-23(24-16-34-21(3)35-17-24)13-25-29(20(2)39)36-37(30(19)25)18-28(40)38-26(14-32(4)15-27(32)38)31(41)33-11-10-22-8-6-5-7-9-22/h12-13,16-17,22,26-27H,5-11,14-15,18H2,1-4H3,(H,33,41)/t26-,27+,32-/m0/s1	AUBCPOWGWKFMOF-XKVZAPNPSA-N	512226	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-N-(2-  cyclohexylethyl)-5-  methyl-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 604	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512226&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533566	459629475							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072844	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCN2CCCCC2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H39N7O3/c1-19-12-22(23-16-33-21(3)34-17-23)13-24-28(20(2)39)35-37(29(19)24)18-27(40)38-25(14-31(4)15-26(31)38)30(41)32-8-11-36-9-6-5-7-10-36/h12-13,16-17,25-26H,5-11,14-15,18H2,1-4H3,(H,32,41)/t25-,26+,31-/m0/s1	MMEINKCQBKEELV-HEHLMWRFSA-N	512227	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)acetyl)-5-methyl-N- (2-(piperidin-1- yl)ethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 605	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512227&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533567	459629476							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072845	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCC2CCOCC2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C31H38N6O4/c1-18-11-22(23-15-33-20(3)34-16-23)12-24-28(19(2)38)35-36(29(18)24)17-27(39)37-25(13-31(4)14-26(31)37)30(40)32-8-5-21-6-9-41-10-7-21/h11-12,15-16,21,25-26H,5-10,13-14,17H2,1-4H3,(H,32,40)/t25-,26+,31-/m0/s1	LWAGWULDELNBDB-HEHLMWRFSA-N	512228	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N- (2-(tetrahydro-2H- pyran-4-yl)ethyl)-2- azabicyclo[3.1.0]hexa  ne-3-carboxamide::US11084800, Cpd No. 606	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512228&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533568	459629477							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072846	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCN2CCOCC2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C30H37N7O4/c1-18-11-21(22-15-32-20(3)33-16-22)12-23-27(19(2)38)34-36(28(18)23)17-26(39)37-24(13-30(4)14-25(30)37)29(40)31-5-6-35-7-9-41-10-8-35/h11-12,15-16,24-25H,5-10,13-14,17H2,1-4H3,(H,31,40)/t24-,25+,30-/m0/s1	HLLJLKSDXVLGIL-FVXXUCQHSA-N	512229	(1R,3S,5R)-2-(2-(3- acetyl-7-methyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1-  yl)acetyl)-5-methyl-N-  (2-morpholinoethyl)-2- azabicyclo[3.1.0]hexane- 3-carboxamide::US11084800, Cpd No. 607	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512229&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533569	459629478							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072847	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc2cc(C)nn2c1	InChI=1S/C30H28BrN9O3/c1-15-5-6-24(31)34-28(15)35-29(43)21-9-30(4)10-23(30)40(21)26(42)14-38-22-12-32-20(8-19(22)27(37-38)17(3)41)18-11-33-25-7-16(2)36-39(25)13-18/h5-8,11-13,21,23H,9-10,14H2,1-4H3,(H,34,35,43)/t21-,23+,30-/m0/s1	LZJSMEAFAKOQTD-AZMCGESQSA-N	511903	(1R,3S,5R)-2-(2-(3-acetyl-5-(2- methylpyrazolo[1,5-a]pyrimidin-6-yl)-1H- pyrazolo[3,4-c]pyridin-1-yl)acetyl)-N-(6- bromo-3-methylpyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 219::US11084800, Cpd No. 617	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511903&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			159501011	459629155							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072848	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(cc(cc12)-c1cnc(C)nc1)-c1nn[nH]n1			512231	US11084800, Cpd No. 236	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512231&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533570	459629479							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072849	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(CNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)nc1	InChI=1S/C64H90BrN11O15/c1-43-20-24-52(65)72-61(43)73-62(85)50-35-64(3)36-51(64)76(50)58(82)40-75-49-23-21-45(34-47(49)60(74-75)44(2)77)46-37-68-53(69-38-46)39-70-57(81)42-91-33-31-89-29-27-67-56(80)41-90-32-30-88-28-26-66-54(78)25-22-48(63(86)87)71-55(79)18-16-14-12-10-8-6-4-5-7-9-11-13-15-17-19-59(83)84/h20-21,23-24,34,37-38,48,50-51H,4-19,22,25-33,35-36,39-42H2,1-3H3,(H,66,78)(H,67,80)(H,70,81)(H,71,79)(H,83,84)(H,86,87)(H,72,73,85)/t48-,50-,51+,64-/m0/s1	WRZDGFKVHPQYLO-GLZUZVLQSA-N	512232	US11084800, Cpd No. 242	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512232&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317495	459629480							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072850	CC(=O)c1nn(CC(=O)N2C[C@]3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)CC(=NO3)c2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H33BrN8O4/c1-20-10-11-30(37)40-34(20)41-35(48)29-15-36(14-28(43-49-36)24-8-6-5-7-9-24)19-44(29)31(47)18-45-33-21(2)12-25(26-16-38-23(4)39-17-26)13-27(33)32(42-45)22(3)46/h5-13,16-17,29H,14-15,18-19H2,1-4H3,(H,40,41,48)/t29-,36+/m0/s1	ZZUKBRDILMQRHO-RHBXAEEVSA-N	512233	US11084800, Cpd No. 243	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512233&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162265108	459629481							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072851	CC(=O)c1nn(CC(=O)N2CC3(C[C@H]2C(=O)Nc2nc(Br)ccc2C)CC(=NO3)C2CCCCC2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H39BrN8O4/c1-20-10-11-30(37)40-34(20)41-35(48)29-15-36(14-28(43-49-36)24-8-6-5-7-9-24)19-44(29)31(47)18-45-33-21(2)12-25(26-16-38-23(4)39-17-26)13-27(33)32(42-45)22(3)46/h10-13,16-17,24,29H,5-9,14-15,18-19H2,1-4H3,(H,40,41,48)/t29-,36?/m0/s1	XIIZLSGVRQPUII-FIMWSPJOSA-N	512234	US11084800, Cpd No. 244	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512234&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161719341	459629482							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072852	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)CCCC=C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(CCC=C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C39H43BrN8O4/c1-6-8-10-12-33(50)43-22-39-17-30(38(52)45-37-23(3)13-14-32(40)44-37)48(31(39)18-39)34(51)21-47-36-26(11-9-7-2)15-27(28-19-41-25(5)42-20-28)16-29(36)35(46-47)24(4)49/h6-7,13-16,19-20,30-31H,1-2,8-12,17-18,21-22H2,3-5H3,(H,43,50)(H,44,45,52)/t30-,31+,39-/m0/s1	VHOPSXVXUNTPJP-OGKPPLAJSA-N	512235	US11084800, Cpd No. 266	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512235&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318719	459629483							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072853	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C3CC3)c12)-c1cnc(C)nc1	InChI=1S/C34H37BrN8O3/c1-18-6-9-28(35)38-32(18)39-33(46)26-12-34(17-41(4)5)13-27(34)43(26)29(45)16-42-31-24(21-7-8-21)10-22(23-14-36-20(3)37-15-23)11-25(31)30(40-42)19(2)44/h6,9-11,14-15,21,26-27H,7-8,12-13,16-17H2,1-5H3,(H,38,39,46)/t26-,27+,34-/m0/s1	CUOINNOSCTYZFT-MZXMJASYSA-N	512236	US11084800, Cpd No. 317	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512236&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			149967556	459629484							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072854	CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(c12)C(F)(F)F)-c1cnc(C)nc1	InChI=1S/C32H32BrF3N8O3/c1-16-6-7-25(33)39-29(16)40-30(47)23-10-31(15-42(4)5)11-24(31)44(23)26(46)14-43-28-21(27(41-43)17(2)45)8-19(9-22(28)32(34,35)36)20-12-37-18(3)38-13-20/h6-9,12-13,23-24H,10-11,14-15H2,1-5H3,(H,39,40,47)/t23-,24+,31-/m0/s1	XHXHNZVUUPJVEN-JLELKNTQSA-N	512237	US11084800, Cpd No. 318	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512237&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			161715751	459629485							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072855	COC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1)C(=O)OC	InChI=1S/C66H94BrN11O15/c1-45-22-26-54(67)74-63(45)75-64(86)52-37-66(3)38-53(66)78(52)60(84)42-77-51-25-23-47(36-49(51)62(76-77)46(2)79)48-39-70-55(71-40-48)41-72-59(83)44-93-35-33-91-31-29-69-58(82)43-92-34-32-90-30-28-68-56(80)27-24-50(65(87)89-5)73-57(81)20-18-16-14-12-10-8-6-7-9-11-13-15-17-19-21-61(85)88-4/h22-23,25-26,36,39-40,50,52-53H,6-21,24,27-35,37-38,41-44H2,1-5H3,(H,68,80)(H,69,82)(H,72,83)(H,73,81)(H,74,75,86)/t50-,52-,53+,66-/m0/s1	UBTSRDODCQNHTI-DEZNTUCVSA-N	512238	US11084800, Cpd No. 329	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512238&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162468694	459629486							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072856	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2CC=C)c2c(CCCCCCC=C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C39H44BrN7O3/c1-6-8-9-10-11-12-14-27-17-28(29-21-41-25(4)42-22-29)18-30-35(24(3)48)45-46(36(27)30)23-34(49)47-31(19-39(5)20-32(39)47)38(50)44-37-26(13-7-2)15-16-33(40)43-37/h6-7,15-18,21-22,31-32H,1-2,8-14,19-20,23H2,3-5H3,(H,43,44,50)/t31-,32+,39-/m0/s1	TVDANDOZOPANKJ-WEIDRCEQSA-N	512239	US11084800, Cpd No. 343	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512239&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533571	459629487							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072857	COC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)C(=O)OC	InChI=1S/C66H94BrN11O15/c1-45-22-26-55(67)74-63(45)75-64(86)53-37-66(38-54(66)78(53)60(84)41-77-52-25-23-48(49-39-70-47(3)71-40-49)36-50(52)62(76-77)46(2)79)44-72-59(83)43-93-35-33-91-31-29-69-58(82)42-92-34-32-90-30-28-68-56(80)27-24-51(65(87)89-5)73-57(81)20-18-16-14-12-10-8-6-7-9-11-13-15-17-19-21-61(85)88-4/h22-23,25-26,36,39-40,51,53-54H,6-21,24,27-35,37-38,41-44H2,1-5H3,(H,68,80)(H,69,82)(H,72,83)(H,73,81)(H,74,75,86)/t51-,53-,54+,66-/m0/s1	RPPRRBWERBULTI-VPWODCPASA-N	512240	US11084800, Cpd No. 358	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512240&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533572	459629488							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072858	COC(=O)[C@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ccc12)-c1cnc(C)nc1)NC(=O)CCCCCCCCCCCCCCCCC(O)=O	InChI=1S/C65H92BrN11O15/c1-44-21-25-54(66)73-62(44)74-63(86)52-36-65(37-53(65)77(52)59(83)40-76-51-24-22-47(48-38-69-46(3)70-39-48)35-49(51)61(75-76)45(2)78)43-71-58(82)42-92-34-32-90-30-28-68-57(81)41-91-33-31-89-29-27-67-55(79)26-23-50(64(87)88-4)72-56(80)19-17-15-13-11-9-7-5-6-8-10-12-14-16-18-20-60(84)85/h21-22,24-25,35,38-39,50,52-53H,5-20,23,26-34,36-37,40-43H2,1-4H3,(H,67,79)(H,68,81)(H,71,82)(H,72,80)(H,84,85)(H,73,74,86)/t50-,52-,53+,65-/m0/s1	YGGSRTZFGFOCSU-AHFRHDIVSA-N	512241	US11084800, Cpd No. 379	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512241&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533573	459629489							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072859	COC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)C(=O)OC	InChI=1S/C67H96BrN11O15/c1-45-23-25-55(68)75-64(45)76-65(87)53-37-67(38-54(67)79(53)60(85)41-78-63-46(2)35-49(50-39-71-48(4)72-40-50)36-51(63)62(77-78)47(3)80)44-73-59(84)43-94-34-32-92-30-28-70-58(83)42-93-33-31-91-29-27-69-56(81)26-24-52(66(88)90-6)74-57(82)21-19-17-15-13-11-9-7-8-10-12-14-16-18-20-22-61(86)89-5/h23,25,35-36,39-40,52-54H,7-22,24,26-34,37-38,41-44H2,1-6H3,(H,69,81)(H,70,83)(H,73,84)(H,74,82)(H,75,76,87)/t52-,53-,54+,67-/m0/s1	ZXPCCLHPQCZKFJ-AULNKUJZSA-N	512242	US11084800, Cpd No. 391	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512242&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420554	459629490							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072860	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C65H92BrN11O15/c1-43-21-23-53(66)73-62(43)74-63(86)51-35-65(36-52(65)77(51)58(83)39-76-61-44(2)33-47(48-37-69-46(4)70-38-48)34-49(61)60(75-76)45(3)78)42-71-57(82)41-92-32-30-90-28-26-68-56(81)40-91-31-29-89-27-25-67-54(79)24-22-50(64(87)88)72-55(80)19-17-15-13-11-9-7-5-6-8-10-12-14-16-18-20-59(84)85/h21,23,33-34,37-38,50-52H,5-20,22,24-32,35-36,39-42H2,1-4H3,(H,67,79)(H,68,81)(H,71,82)(H,72,80)(H,84,85)(H,87,88)(H,73,74,86)/t50-,51-,52+,65-/m0/s1	UPBXDNUJKSUNJB-AHPZVLNKSA-N	512243	US11084800, Cpd No. 392	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512243&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420494	459629491							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072861	COC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCc1ncc(cn1)-c1cc(C)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(C)=O)c2c1)C(O)=O	InChI=1S/C66H94BrN11O15/c1-44-22-24-53(67)74-63(44)75-64(86)51-36-66(4)37-52(66)78(51)59(84)41-77-62-45(2)34-47(35-49(62)61(76-77)46(3)79)48-38-70-54(71-39-48)40-72-58(83)43-93-33-31-91-29-27-69-57(82)42-92-32-30-90-28-26-68-55(80)25-23-50(65(87)88)73-56(81)20-18-16-14-12-10-8-6-7-9-11-13-15-17-19-21-60(85)89-5/h22,24,34-35,38-39,50-52H,6-21,23,25-33,36-37,40-43H2,1-5H3,(H,68,80)(H,69,82)(H,72,83)(H,73,81)(H,87,88)(H,74,75,86)/t50-,51-,52+,66-/m0/s1	HKIJNLMGZMZAQO-LPTFZYTOSA-N	512244	US11084800, Cpd No. 403	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512244&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533574	459629492							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072862	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cc(cc12)-c1cnc(CNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)nc1	InChI=1S/C65H92BrN11O15/c1-43-21-23-52(66)73-62(43)74-63(86)50-35-65(4)36-51(65)77(50)58(83)40-76-61-44(2)33-46(34-48(61)60(75-76)45(3)78)47-37-69-53(70-38-47)39-71-57(82)42-92-32-30-90-28-26-68-56(81)41-91-31-29-89-27-25-67-54(79)24-22-49(64(87)88)72-55(80)19-17-15-13-11-9-7-5-6-8-10-12-14-16-18-20-59(84)85/h21,23,33-34,37-38,49-51H,5-20,22,24-32,35-36,39-42H2,1-4H3,(H,67,79)(H,68,81)(H,71,82)(H,72,80)(H,84,85)(H,87,88)(H,73,74,86)/t49-,50-,51+,65-/m0/s1	XSTKNWYIQLYEDY-HUCJMENOSA-N	512245	US11084800, Cpd No. 404	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512245&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318159	459629493							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072863	COC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCc1ncc(cn1)-c1cc2c(nn(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)c2cn1)C(C)=O)C(=O)OC	InChI=1S/C65H93BrN12O15/c1-44-22-24-53(66)74-62(44)75-63(86)50-35-65(3)36-52(65)78(50)59(84)41-77-51-39-69-49(34-47(51)61(76-77)45(2)79)46-37-70-54(71-38-46)40-72-58(83)43-93-33-31-91-29-27-68-57(82)42-92-32-30-90-28-26-67-55(80)25-23-48(64(87)89-5)73-56(81)20-18-16-14-12-10-8-6-7-9-11-13-15-17-19-21-60(85)88-4/h22,24,34,37-39,48,50,52H,6-21,23,25-33,35-36,40-43H2,1-5H3,(H,67,80)(H,68,82)(H,72,83)(H,73,81)(H,74,75,86)/t48-,50-,52+,65-/m0/s1	OLUNEIWTUWQFBW-CLOSOBQHSA-N	512246	US11084800, Cpd No. 405	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512246&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420407	459629494							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072864	COC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(ncc12)-c1cnc(C)nc1)C(=O)OC	InChI=1S/C65H93BrN12O15/c1-44-22-24-54(66)74-62(44)75-63(86)51-35-65(36-53(65)78(51)59(84)40-77-52-39-71-50(47-37-69-46(3)70-38-47)34-48(52)61(76-77)45(2)79)43-72-58(83)42-93-33-31-91-29-27-68-57(82)41-92-32-30-90-28-26-67-55(80)25-23-49(64(87)89-5)73-56(81)20-18-16-14-12-10-8-6-7-9-11-13-15-17-19-21-60(85)88-4/h22,24,34,37-39,49,51,53H,6-21,23,25-33,35-36,40-43H2,1-5H3,(H,67,80)(H,68,82)(H,72,83)(H,73,81)(H,74,75,86)/t49-,51-,53+,65-/m0/s1	JRJROHZJFODMHV-QYVKSAGFSA-N	512247	US11084800, Cpd No. 406	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512247&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420371	459629495							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072865	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(CNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)nc1	InChI=1S/C63H89BrN12O15/c1-42-20-22-51(64)72-60(42)73-61(85)48-33-63(3)34-50(63)76(48)57(82)39-75-49-37-67-47(32-45(49)59(74-75)43(2)77)44-35-68-52(69-36-44)38-70-56(81)41-91-31-29-89-27-25-66-55(80)40-90-30-28-88-26-24-65-53(78)23-21-46(62(86)87)71-54(79)18-16-14-12-10-8-6-4-5-7-9-11-13-15-17-19-58(83)84/h20,22,32,35-37,46,48,50H,4-19,21,23-31,33-34,38-41H2,1-3H3,(H,65,78)(H,66,80)(H,70,81)(H,71,79)(H,83,84)(H,86,87)(H,72,73,85)/t46-,48-,50+,63-/m0/s1	WZCACADWKYPTDP-HSIYWQFISA-N	512248	US11084800, Cpd No. 414	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512248&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318061	459629496							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072866	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2cnc(cc12)-c1cnc(C)nc1	InChI=1S/C63H89BrN12O15/c1-42-20-22-52(64)72-60(42)73-61(85)49-33-63(34-51(63)76(49)57(82)38-75-50-37-69-48(45-35-67-44(3)68-36-45)32-46(50)59(74-75)43(2)77)41-70-56(81)40-91-31-29-89-27-25-66-55(80)39-90-30-28-88-26-24-65-53(78)23-21-47(62(86)87)71-54(79)18-16-14-12-10-8-6-4-5-7-9-11-13-15-17-19-58(83)84/h20,22,32,35-37,47,49,51H,4-19,21,23-31,33-34,38-41H2,1-3H3,(H,65,78)(H,66,80)(H,70,81)(H,71,79)(H,83,84)(H,86,87)(H,72,73,85)/t47-,49-,51+,63-/m0/s1	VYGTZWQKTFOKQP-NVFQLKBQSA-N	512249	US11084800, Cpd No. 442	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512249&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533575	459629497							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072867	CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C92H121BrN16O22/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-75(114)94-42-21-20-22-65(99-87(127)68(35-40-79(120)121)102-90(130)71(45-59-27-31-63(113)32-28-59)103-86(126)67(98-57(6)111)34-39-78(118)119)85(125)101-69(36-41-80(122)123)88(128)104-70(44-58-25-29-62(112)30-26-58)89(129)100-66(33-38-77(116)117)84(124)97-52-92-47-72(91(131)106-83-53(2)24-37-74(93)105-83)109(73(92)48-92)76(115)51-108-82-54(3)43-60(61-49-95-56(5)96-50-61)46-64(82)81(107-108)55(4)110/h24-32,37,43,46,49-50,65-73,112-113H,7-23,33-36,38-42,44-45,47-48,51-52H2,1-6H3,(H,94,114)(H,97,124)(H,98,111)(H,99,127)(H,100,129)(H,101,125)(H,102,130)(H,103,126)(H,104,128)(H,116,117)(H,118,119)(H,120,121)(H,122,123)(H,105,106,131)/t65-,66-,67-,68-,69-,70-,71-,72-,73+,92-/m0/s1	OUESWPNQGAIDTA-FOAIRQFPSA-N	512250	US11084800, Cpd No. 443	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512250&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318122	459629498							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072868	CCCNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H33BrN8O3/c1-5-10-33-30(43)27-21-11-19(20-14-34-18(3)35-15-20)7-8-22(21)39(38-27)16-26(41)40-23(12-31(4)13-24(31)40)29(42)37-28-17(2)6-9-25(32)36-28/h6-9,11,14-15,23-24H,5,10,12-13,16H2,1-4H3,(H,33,43)(H,36,37,42)/t23-,24+,31-/m0/s1	BKDAJUBRABUYSP-JLELKNTQSA-N	512251	US11084800, Cpd No. 475	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512251&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420597	459629499							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072869	CCCCNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-5-6-11-34-31(44)28-22-12-20(21-15-35-19(3)36-16-21)8-9-23(22)40(39-28)17-27(42)41-24(13-32(4)14-25(32)41)30(43)38-29-18(2)7-10-26(33)37-29/h7-10,12,15-16,24-25H,5-6,11,13-14,17H2,1-4H3,(H,34,44)(H,37,38,43)/t24-,25+,32-/m0/s1	VZBOFOWWYRCREH-UNTHUGQZSA-N	512252	US11084800, Cpd No. 476	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512252&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318067	459629500							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072870	CCCCCNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H37BrN8O3/c1-5-6-7-12-35-32(45)29-23-13-21(22-16-36-20(3)37-17-22)9-10-24(23)41(40-29)18-28(43)42-25(14-33(4)15-26(33)42)31(44)39-30-19(2)8-11-27(34)38-30/h8-11,13,16-17,25-26H,5-7,12,14-15,18H2,1-4H3,(H,35,45)(H,38,39,44)/t25-,26+,33-/m0/s1	HCLDIWPYMPHOKF-REYAJUCUSA-N	512253	US11084800, Cpd No. 477	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512253&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318338	459629501							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072871	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCC3CC3)c2c1	InChI=1S/C32H33BrN8O3/c1-17-4-9-26(33)37-29(17)38-30(43)24-11-32(3)12-25(32)41(24)27(42)16-40-23-8-7-20(21-14-34-18(2)35-15-21)10-22(23)28(39-40)31(44)36-13-19-5-6-19/h4,7-10,14-15,19,24-25H,5-6,11-13,16H2,1-3H3,(H,36,44)(H,37,38,43)/t24-,25+,32-/m0/s1	YAMSPLOWRYHUDV-UNTHUGQZSA-N	512254	US11084800, Cpd No. 478	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512254&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319013	459629502							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072872	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCC3CCC3)c2c1	InChI=1S/C33H35BrN8O3/c1-18-7-10-27(34)38-30(18)39-31(44)25-12-33(3)13-26(33)42(25)28(43)17-41-24-9-8-21(22-15-35-19(2)36-16-22)11-23(24)29(40-41)32(45)37-14-20-5-4-6-20/h7-11,15-16,20,25-26H,4-6,12-14,17H2,1-3H3,(H,37,45)(H,38,39,44)/t25-,26+,33-/m0/s1	SMIZMRFCTDLWHF-REYAJUCUSA-N	512255	US11084800, Cpd No. 479	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512255&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318716	459629503							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072873	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCC(C)(C)C)c2c1	InChI=1S/C33H37BrN8O3/c1-18-7-10-26(34)38-29(18)39-30(44)24-12-33(6)13-25(33)42(24)27(43)16-41-23-9-8-20(21-14-35-19(2)36-15-21)11-22(23)28(40-41)31(45)37-17-32(3,4)5/h7-11,14-15,24-25H,12-13,16-17H2,1-6H3,(H,37,45)(H,38,39,44)/t24-,25+,33-/m0/s1	LQKNNXWNCJVAIO-DVIHYUSWSA-N	512256	US11084800, Cpd No. 480	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512256&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317503	459629504							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072874	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCCN)c2c1	InChI=1S/C30H32BrN9O3/c1-16-4-7-24(31)36-27(16)37-28(42)22-11-30(3)12-23(30)40(22)25(41)15-39-21-6-5-18(19-13-34-17(2)35-14-19)10-20(21)26(38-39)29(43)33-9-8-32/h4-7,10,13-14,22-23H,8-9,11-12,15,32H2,1-3H3,(H,33,43)(H,36,37,42)/t22-,23+,30-/m0/s1	WCQLSVDHELYINQ-BURCIIJTSA-N	512257	US11084800, Cpd No. 489	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512257&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319093	459629505							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072875	CNCCNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C31H34BrN9O3/c1-17-5-8-25(32)37-28(17)38-29(43)23-12-31(3)13-24(31)41(23)26(42)16-40-22-7-6-19(20-14-35-18(2)36-15-20)11-21(22)27(39-40)30(44)34-10-9-33-4/h5-8,11,14-15,23-24,33H,9-10,12-13,16H2,1-4H3,(H,34,44)(H,37,38,43)/t23-,24+,31-/m0/s1	MRPDOTPEKVBJDB-JLELKNTQSA-N	512258	US11084800, Cpd No. 490	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512258&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317566	459629506							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072876	CN(C)CCNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H36BrN9O3/c1-18-6-9-26(33)37-29(18)38-30(44)24-13-32(3)14-25(32)42(24)27(43)17-41-23-8-7-20(21-15-35-19(2)36-16-21)12-22(23)28(39-41)31(45)34-10-11-40(4)5/h6-9,12,15-16,24-25H,10-11,13-14,17H2,1-5H3,(H,34,45)(H,37,38,44)/t24-,25+,32-/m0/s1	FJGKKRYZNYHIEP-UNTHUGQZSA-N	512259	US11084800, Cpd No. 491	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512259&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420413	459629507							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072877	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(=O)NCC(F)(F)F)c2c1	InChI=1S/C30H28BrF3N8O3/c1-15-4-7-23(31)38-26(15)39-27(44)21-9-29(3)10-22(29)42(21)24(43)13-41-20-6-5-17(18-11-35-16(2)36-12-18)8-19(20)25(40-41)28(45)37-14-30(32,33)34/h4-8,11-12,21-22H,9-10,13-14H2,1-3H3,(H,37,45)(H,38,39,44)/t21-,22+,29-/m0/s1	BGLNFAOYSXMJSP-KERYWQKISA-N	512260	US11084800, Cpd No. 499	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512260&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533576	459629508							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072878	CC(C)CNC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-17(2)13-36-31(44)28-22-10-20(21-14-34-19(4)35-15-21)7-8-23(22)40(39-28)16-27(42)41-24(11-32(5)12-25(32)41)30(43)38-29-18(3)6-9-26(33)37-29/h6-10,14-15,17,24-25H,11-13,16H2,1-5H3,(H,36,44)(H,37,38,43)/t24-,25+,32-/m0/s1	ITMZILYZYXCCAC-UNTHUGQZSA-N	512261	US11084800, Cpd No. 500	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512261&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318020	459629509							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072879	Cc1ncc(cn1)-c1cc(C#N)c2n(CC(=O)N3[C@@H]4C[C@]4(C)C[C@H]3C(=O)Nc3nc(Br)ccc3C)nc(C(N)=O)c2c1	InChI=1S/C29H26BrN9O3/c1-14-4-5-22(30)35-27(14)36-28(42)20-8-29(3)9-21(29)39(20)23(40)13-38-25-17(10-31)6-16(18-11-33-15(2)34-12-18)7-19(25)24(37-38)26(32)41/h4-7,11-12,20-21H,8-9,13H2,1-3H3,(H2,32,41)(H,35,36,42)/t20-,21+,29-/m0/s1	KZFNTXURVVDPFU-FONBTEPMSA-N	512262	US11084800, Cpd No. 515	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512262&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533577	459629510							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072880	CCCCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C31H40N6O3/c1-6-7-8-9-10-11-32-30(40)25-14-31(5)15-26(31)37(25)27(39)18-36-29-19(2)12-22(23-16-33-21(4)34-17-23)13-24(29)28(35-36)20(3)38/h12-13,16-17,25-26H,6-11,14-15,18H2,1-5H3,(H,32,40)/t25-,26+,31-/m0/s1	LSJCNKVPJGELER-HEHLMWRFSA-N	512263	US11084800, Cpd No. 527	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512263&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319091	459629511							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072881	CCCCCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C32H42N6O3/c1-6-7-8-9-10-11-12-33-31(41)26-15-32(5)16-27(32)38(26)28(40)19-37-30-20(2)13-23(24-17-34-22(4)35-18-24)14-25(30)29(36-37)21(3)39/h13-14,17-18,26-27H,6-12,15-16,19H2,1-5H3,(H,33,41)/t26-,27+,32-/m0/s1	RPSMNKRILATHAQ-XKVZAPNPSA-N	512264	US11084800, Cpd No. 528	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512264&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420510	459629512							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072882	CCCCCCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C33H44N6O3/c1-6-7-8-9-10-11-12-13-34-32(42)27-16-33(5)17-28(33)39(27)29(41)20-38-31-21(2)14-24(25-18-35-23(4)36-19-25)15-26(31)30(37-38)22(3)40/h14-15,18-19,27-28H,6-13,16-17,20H2,1-5H3,(H,34,42)/t27-,28+,33-/m0/s1	RMMOFCVIFOOYKW-DWZXRANWSA-N	512265	US11084800, Cpd No. 530	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512265&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318736	459629513							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072883	CCCCCCCCCCNC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C34H46N6O3/c1-6-7-8-9-10-11-12-13-14-35-33(43)28-17-34(5)18-29(34)40(28)30(42)21-39-32-22(2)15-25(26-19-36-24(4)37-20-26)16-27(32)31(38-39)23(3)41/h15-16,19-20,28-29H,6-14,17-18,21H2,1-5H3,(H,35,43)/t28-,29+,34-/m0/s1	HQKAHEMBZYSTSS-ZZMKVXQQSA-N	512266	US11084800, Cpd No. 531	Complement factor D	Human		>10000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512266&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			142420529	459629514							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072884	CCC(=O)NCCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCOCCC(=O)NC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1	InChI=1S/C107H150BrN17O47/c1-7-89(130)109-30-9-8-10-79(115-102(144)82(22-27-94(137)138)118-105(147)85(36-73-14-18-77(129)19-15-73)119-101(143)81(114-71(6)127)21-26-93(135)136)100(142)117-83(23-28-95(139)140)103(145)120-84(35-72-12-16-76(128)17-13-72)104(146)116-80(20-25-92(133)134)99(141)110-31-33-150-45-152-47-154-49-156-51-158-53-160-55-162-57-164-59-166-61-168-63-170-65-172-66-171-64-169-62-167-60-165-58-163-56-161-54-159-52-157-50-155-48-153-46-151-44-149-32-29-90(131)113-43-107-38-86(106(148)122-98-67(2)11-24-88(108)121-98)125(87(107)39-107)91(132)42-124-97-68(3)34-74(75-40-111-70(5)112-41-75)37-78(97)96(123-124)69(4)126/h11-19,24,34,37,40-41,79-87,128-129H,7-10,20-23,25-33,35-36,38-39,42-66H2,1-6H3,(H,109,130)(H,110,141)(H,113,131)(H,114,127)(H,115,144)(H,116,146)(H,117,142)(H,118,147)(H,119,143)(H,120,145)(H,133,134)(H,135,136)(H,137,138)(H,139,140)(H,121,122,148)/t79-,80-,81-,82-,83-,84-,85-,86-,87+,107-/m0/s1	XDVXIAXXVNVAJZ-HNCHSMBISA-N	512267	US11084800, Cpd No. 535	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512267&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			162533578	459629515							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072885	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCCCc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C34H38N6O3/c1-21-14-25(26-18-36-23(3)37-19-26)15-27-31(22(2)41)38-39(32(21)27)20-30(42)40-28(16-34(4)17-29(34)40)33(43)35-13-9-8-12-24-10-6-5-7-11-24/h5-7,10-11,14-15,18-19,28-29H,8-9,12-13,16-17,20H2,1-4H3,(H,35,43)/t28-,29+,34-/m0/s1	UTHKDNXSYXHLNS-ZZMKVXQQSA-N	512268	US11084800, Cpd No. 538	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512268&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317556	459629516							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072886	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCCCCc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C35H40N6O3/c1-22-15-26(27-19-37-24(3)38-20-27)16-28-32(23(2)42)39-40(33(22)28)21-31(43)41-29(17-35(4)18-30(35)41)34(44)36-14-10-6-9-13-25-11-7-5-8-12-25/h5,7-8,11-12,15-16,19-20,29-30H,6,9-10,13-14,17-18,21H2,1-4H3,(H,36,44)/t29-,30+,35-/m0/s1	MDADSGLWPOTBQG-KQDQWFAOSA-N	512269	US11084800, Cpd No. 539	Complement factor D	Human		<1000							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512269&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135318265	459629517							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072887	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NCCCCCCc2ccccc2)c2c(C)cc(cc12)-c1cnc(C)nc1	InChI=1S/C36H42N6O3/c1-23-16-27(28-20-38-25(3)39-21-28)17-29-33(24(2)43)40-41(34(23)29)22-32(44)42-30(18-36(4)19-31(36)42)35(45)37-15-11-6-5-8-12-26-13-9-7-10-14-26/h7,9-10,13-14,16-17,20-21,30-31H,5-6,8,11-12,15,18-19,22H2,1-4H3,(H,37,45)/t30-,31+,36-/m0/s1	DNBYPINGBYFFIF-DGBOZFPNSA-N	512270	US11084800, Cpd No. 540	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512270&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135319188	459629518							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1072888	CCC(C)NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C32H35BrN8O3/c1-6-18(3)36-31(44)28-22-11-20(21-14-34-19(4)35-15-21)8-9-23(22)40(39-28)16-27(42)41-24(12-32(5)13-25(32)41)30(43)38-29-17(2)7-10-26(33)37-29/h7-11,14-15,18,24-25H,6,12-13,16H2,1-5H3,(H,36,44)(H,37,38,43)/t18?,24-,25+,32-/m0/s1	XNLVRTVXEKFBCL-VMTFFRNGSA-N	512271	US11084800, Cpd No. 569	Complement factor D	Human		 5500							US Patent		10.7270/Q2JW8J1N		aid1805791	US11084800	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X; Barrish, JC; Greenlee, W; Eastman, KJ	8/10/2021	1/23/2022	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512271&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135317573	459629519							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4